Parvovirus B19

Aus coViki

(Unterschied zwischen Versionen)

Wechseln zu: Navigation, Suche

Aktuelle Version vom 1. September 2020, 08:08 Uhr

Highly selected collection to answer the question: are there helper viruses. Got the idea when I realized that most non-covid causes of collapsing glomerulopathy are hiv, parvovirus, other virus, high interferon states, hlh, sle and some other connective tissue diseases. Parvo b19 makes some overlapping multisystem signs so its worth consideration.

Bib shows selection from 'parvovirus b19 OR parvovirus b19' pubmed on 08/21/2020

http://www.moremed.org/SiteSearch.php?S1=parvovirus+b19+OR+parvovirus-b19&S2=&S3=&submit=submit&px1=proxy.nationallizenzen.de&px2=&px3=&px4=&R=all&Y0=1500&Y1=2025

of utmost importance

20436917 2010. Chloroquine and its derivatives exacerbate B19V-associated anemia by promoting viral replication

Parvovirus B19(2) normal rated papers

top rated

15816155 2005. Seroprevalence of parvovirus B19 infection in daycare educators.
15473148 2004. Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors.
15635975 2004. Parvovirus B19 viraemia in Dutch blood donors.
8666078 1996. A school outbreak of parvovirus B19 infection investigated using salivary antibody assays.
7925671 1994. Parvovirus B19 outbreak on an adult ward.
7995362 1994. Low prevalence of antibody to human parvovirus B19 in Singapore.
2553464 1989. Concurrent outbreaks of influenza and parvovirus B19 in a boys' boarding school.
27748022 2016. Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature.
9541589 1998. Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties.
18816241 2008. Parvovirus B19 microepidemic in renal transplant recipients with thrombotic microangiopathy and allograft vasculitis.
29922597 2018. Recent Advances in Replication and Infection of Human Parvovirus B19.
26097496 2015. Human parvovirus B19: a mechanistic overview of infection and DNA replication.
25429305 2013. Parvovirus infection-induced DNA damage response.
22389649 2012. Genomic features of the human bocaviruses.
21331319 2010. Parvovirus infection-induced cell death and cell cycle arrest.
32395652 2020. Human parvovirus B19 frequency among blood donors after an epidemic outbreak: relevance of the epidemiological scenario for transfusion medicine.
27419073 2016. Atypical rashes in adult human Parvovirus B19 infection; atypical is typical.
32728330 2020. Therapeutic Plasma Exchange in Parvovirus B19-induced Acute Hepatic Failure.
24713910 2014. Fatal missed case of hemophagocytic lymphohistiocytosis co-infected with parvovirus B19 and Epstein-Barr virus in an infant: test hyperferritinaemia early.
28553047 2017. De Novo Collapsing Glomerulopathy in Renal Allograft in Association with BK Virus Nephropathy in a Child and Stabilization of Renal Function by Elimination of Viremia.
26397302 2015. Atypical exanthems associated with parvovirus B19 infection: similarities and differences between adults and children.
25269970 2014. Petechial rash associated with Parvovirus B19 in children: case report and literature review.
20956876 2010. Neurological impairment and arthritis in an immunocompetent child with human parvovirus B19 chronic infection.
26060378 2015. Effects of Parvovirus B19 Infection in Renal Transplant Recipients: A Retrospective Review of Three Cases.
25242697 2014. Primary Epstein-Barr virus infection and probable parvovirus B19 reactivation resulting in fulminant hepatitis and fulfilling five of eight criteria for hemophagocytic lymphohistiocytosis.
30173301 2019. Fatal parvovirus B19 infections: a report of two autopsy cases.
27043551 2016. The Impact of Specific Viruses on Clinical Outcome in Children Presenting with Acute Heart Failure.
27181552 2016. A False Positive Dengue Fever Rapid Diagnostic Test Result in a Case of Acute Parvovirus B19 Infection.
19602791 2009. Pulmonary thrombosis with transient antiphospholipid syndrome after mononucleosis-like illness.
18084119 2007. Symptoms associated with parvovirus B19 infection in adults: a pilot study.
14518687 2003. Acute parvovirus B19 infection mimicking chronic fatigue syndrome.
11993790 2002. A clinical study of adult human parvovirus B19 infection.
11993780 2002. Parvovirus B 19 infection in adults.
9745861 1998. Human parvovirus B19 infection resembling systemic lupus erythematosus.
28142135 2016. Frequency and Genotype of Human Parvovirus B19 among Iranian Hemodialysis and Peritoneal Dialysis Patients.
12389353 2002. Chronic human parvovirus B19 infection associated with interstitial lung disease.
12389336 2002. Human parvovirus B19 infection in children: uncommon clinical presentations.
10820178 2000. Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation.
25923759 2015. Glomeruloesclerose segmentar e focal (GESF) colapsante associada ao parvovirus B19: relato de caso.
20890043 2010. Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors.
2551923 1989. Immune response to B19 parvovirus and an antibody defect in persistent viral infection.
24403307 2014. Identification of past and recent parvovirus B19 infection in immunocompetent individuals by quantitative PCR and enzyme immunoassays: a dual-laboratory study.
19279179 2009. Parvovirus b19 infection localized in the intestinal mucosa and associated with severe inflammatory bowel disease.
19574588 2009. Pathophysiological mechanisms of parvovirus B19 infection.
19005147 2009. High prevalence of human parvovirus B19 DNA in myocardial autopsy samples from subjects without myocarditis or dilative cardiomyopathy.
11724892 2001. Fatal myocarditis associated with acute parvovirus B19 and human herpesvirus 6 coinfection.
2169746 1990. Rheumatologic manifestations of human parvovirus B19 infection in adults. Initial two-year clinical experience.
10048252 1999. Fifth disease in a small rural community. What are the consequences?
8883769 1996. Antenatal human parvovirus B19 infection and nonimmune hydrops fetalis presenting as severe preeclampsia.
18700174 2008. Human parvovirus B19 infection and autoimmunity.
17412298 2007. Human parvovirus B19 infection and antiphospholipid antibodies.
15990072 2005. Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red-cell aplasia.
12848949 2003. Parvovirus B19 infection and autoimmune disease.
19811260 2009. The infectious etiology of vasculitis.
10942624 2000. Haematological consequences of parvovirus B19 infection.
7663050 1995. B19 parvovirus.
2222383 1990. Parvovirus B19. A workshop organized by the German Association against Virus Diseases. April 1989.
2171481 1990. The human parvovirus B19.
31250332 2020. Upregulation of Pro-inflammatory Cytokine Genes by Parvovirus B19 in Human Bone Marrow Mesenchymal Stem Cells.
28377277 2017. Hydroxyurea inhibits parvovirus B19 replication in erythroid progenitor cells.
16764828 2006. Unscrambling the role of human parvovirus B19 signaling in systemic autoimmunity.
2833960 1988. B19 parvovirus replicates in circulating cells of acutely infected patients.
31177196 2019. Parvoviral infection with systemic impact and renal consequences.
20421866 2011. Parvovirus B19 as an etiological agent of acute pleuro-pericarditis.
17468770 2007. Parvovirus B19 pneumonia in a child undergoing allogeneic hematopoietic stem cell transplantation.
15258560 2004. Severe multiorgan failure after parvovirus B19 infection in an allogeneic stem cell transplant recipient.
28196283 2017. Detection of human parvovirus B19 DNA in 22% of 1815 cutaneous biopsies of a wide variety of dermatological conditions suggests viral persistence after primary infection and casts doubts on its pathogenic significance.
18522549 2008. Postrenal transplant hemophagocytic lymphohistiocytosis and thrombotic microangiopathy associated with parvovirus b19 infection.
12123207 2002. Treatment of parvovirus B-19 (PV B-19) infection allows for successful kidney transplantation without disease recurrence.
17194345 2006. Purpura de Schonlein-Henoch secundaria a parvovirus B19.
29411124 2018. Malignancy and chemotherapy induced haemophagocytic lymphohistiocytosis in children and adolescents-a single centre experience of 20 years.
12079921 2002. Self limiting lupus-like symptoms in patients with parvovirus B19 infection.
11688492 2001. Parvovirus arthropathy masquerading as the arthritis of Behcet's disease.
10976079 2000. Pathogenesis of human parvovirus B19 in rheumatic disease.
8129459 1994. Influence of previous exposure to human parvovirus B19 infection in explaining susceptibility to rheumatoid arthritis: an analysis of disease discordant twin pairs.
20427947 2010. RE: Reactive macrophage activation syndrome (MAS) in a patient with parvovirus B19 infection, lymphocytic lichenoid vasculitis, urticaria and angioedema.
20103968 2010. Reactive macrophage activation syndrome in a patient with parvovirus B19 infection, lymphocytic lichenoid vasculitis, urticaria and angioedema.
2852924 1988. Diseases caused by the human parvovirus B19.
17488170 2007. Parvovirus B19 infection in the immunocompromised host.
10705404 2000. Fulminant parvovirus infection following erythropoietin treatment in a patient with acquired immunodeficiency syndrome.
24777824 2014. Persistence of human parvovirus B19 in tissues from adult individuals: a comparison with serostatus and its clinical utility.
14979932 2004. Intravenous immunoglobulin treatment of four patients with juvenile polyarticular arthritis associated with persistent parvovirus B19 infection and antiphospholipid antibodies.
12794831 2003. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood.
12847688 2003. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
27294131 2016. Infection-Related Focal Segmental Glomerulosclerosis in Children.
29973155 2018. Extra-haematological manifestations related to human parvovirus B19 infection: retrospective study in 25 adults.
20727151 2010. Chronic hepatitis caused by persistent parvovirus B19 infection.
32646497 2020. Parvovirus B19 infection and kidney injury: report of 4 cases and analysis of immunization and viremia in an adult cohort of 100 patients undergoing a kidney biopsy.
32652955 2020. Ockham's razor defeated: about two atypical cases of hemolytic uremic syndrome.
27600725 2016. Collapsing glomerulopathy in a young woman with APOL1 risk alleles following acute parvovirus B19 infection: a case report investigation.
23343210 2013. Human parvovirus B19 infection in a renal transplant recipient: a case report.
8520401 1995. Parvovirus B19: an expanding spectrum of disease.
26811413 2016. Parvovirus leading to thrombotic microangiopathy in a healthy adult.
21686478 2009. Gastrointestinal lesions in parvovirus B19 infection.
22514477 1997. Parvovirus B19-induced constellation of acute renal failure, elevated aminotransferases and congestive heart failure.
22514456 1996. Seroprevalence of immunoglobulin G antibody to parvovirus B19 in Ontario.
28868104 2017. Parvovirus B19 Myocarditis of Fulminant Evolution.
24826236 2012. Acute heart failure caused by parvovirus B-19 myocarditis treated with human immunoglobulin.
23251163 2012. Guillain-Barre Syndrome Associated with Primary Parvovirus B19 Infection in an HIV-1-Infected Patient.
22611409 2012. Complete remission of human parvovirus b19 associated symptoms by loxoprofen in patients with atopic predispositions.
23304613 2012. A case report on parvovirus b19 associated myositis.
32621069 2020. Rapid progression to end-stage renal disease in a child with IgA-dominant infection-related glomerulonephritis associated with parvovirus B19.
31788255 2019. Parvovirus B19-induced hemophagocytic lymphohistiocytosis: Case report and review of the literature.
17302890 2007. Cytokine responses in acute and persistent human parvovirus B19 infection.
16542377 2006. Increased expression and secretion of interleukin-6 in human parvovirus B19 non-structural protein (NS1) transfected COS-7 epithelial cells.
16178856 2005. T helper cell-mediated interferon-gamma expression after human parvovirus B19 infection: persisting VP2-specific and transient VP1u-specific activity.
8625539 1996. Parvovirus infection and its treatment.
27797900 2017. Viral-Associated GN: Hepatitis B and Other Viral Infections.
17699510 2007. Parvovirus B19 and the kidney.
17699505 2007. Viral subversion mechanisms in chronic kidney disease pathogenesis.
23372939 2013. Viruses and collapsing glomerulopathy: a brief critical review.
11864255 1998. Kawasaki disease and parvovirus B19 infection in an adult HIV-1-infected patient.
27806994 2017. Human Parvoviruses.
12097253 2002. Human parvovirus B19.
11023960 2000. Passive immunity in prevention and treatment of infectious diseases.
32566445 2020. Treatment of parvovirus B19 viremia to facilitate kidney transplantation in a patient with collapsing glomerulopathy.
23979870 2013. Parvovirus infection mimicking systemic lupus erythematosus.
28018767 2016. A Rare Case of Hemophagocytic Lymphohistiocytosis Associated with Parvovirus B19 Infection.
32637161 2020. Prevalence of Human Parvovirus B19 in Neurological Patients: Findings from Region of Western Saudi Arabia.
8075461 1994. Henoch-Schonlein purpura and human parvovirus B19.
18198003 2008. Seroprevalence of parvovirus B19 in the German population.
17956642 2008. Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection.
17064457 2007. Current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of Germany.
27075795 2016. Parvovirus B19 induced lupus-like syndrome with nephritis.
10419244 1999. Role of parvovirus B19 infection in childhood idiopathic thrombocytopenic purpura.
7756792 1995. Parvovirus: the expanding spectrum of disease.
9821713 1998. Human parvovirus B19-associated thrombocytopenic purpura.
8775567 1995. Kawasaki disease and human parvovirus B19 antibody: role of immunoglobulin therapy.
25283854 2014. Human parvovirus B19: a review.
31202393 2019. Kidney Diseases Associated With Parvovirus B19, Hanta, Ebola, and Dengue Virus Infection: A Brief Review.
1558006 1992. Parvovirus B19 and human disease.
10645467 1999. Parvovirus infections in children and adults.
9544309 1997. Human parvovirus B19 infections in infants and children.
9412714 1997. Cutaneous vasculitis due to human parvovirus B19 in an HIV-infected patient: report of a case.
8466697 1993. Recurrent Kawasaki disease associated with co-infection with parvovirus B19 and HIV-1.
8042568 1994. Erythema infectiosum and other parvovirus B19 infections.
15487462 2004. Interstitial lung disease with cytomegalovirus and parvovirus B19 coinfection.
28700372 2018. Immunohistochemical Demonstration of Parvovirus B19 Viral Protein 2 in Periflexural Exanthema in an Adult, Supporting Antibody-Dependent Enhancement as Means of Endothelial Uptake of the Virus.
22024574 2011. Immunohistochemical detection of parvovirus B19 in "gloves and socks" papular purpuric syndrome: direct evidence for viral endothelial involvement. Report of three cases and review of the literature.
8362857 1993. Liver dysfunction caused by parvovirus B19.
1550103 1992. Parvovirus B19 for the hematologist.
26831272 2016. Outbreak of parvovirus B19 infection among anesthesiology and surgical fellows.
11007690 2000. Endocapillary proliferative glomerulonephritis in a patient with parvovirus B19 infection.
10845847 2000. Acute glomerulonephritis after human parvovirus B19 infection.
10845832 2000. Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis.
21854885 2011. Parvovirus B19-induced type II mixed cryoglobulinemia.
11184773 2000. Transient anticardiolipin antibody syndrome in a patient with parvovirus B19 infection.
7978048 1994. Childhood idiopathic thrombocytopenic purpura: association with human parvovirus B19 infection.
17375014 2007. Vasculite leucocytoclasique compliquee d'une atteinte renale grave au decours d'une primo-infection a Parvovirus B19.
9686060 1997. Acrosyndrome atypique a parvovirus B19.
3293516 1988. Le parvovirus B 19 en pathologie humaine.
28224193 2017. Massive erythrophagocytosis by peripheral monocytes and neutrophils in parvovirus-B19 autoimmune hemolytic anemia.
21538062 2012. Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphoma.
8766256 1996. Parvovirus B19 infection and idiopathic thrombocytopenic purpura.
1903312 1991. Spontaneous interferon-alpha antibodies in a patient with pure red cell aplasia and recurrent cutaneous carcinomas.
10766703 2000. Parvovirus B19 and glomerulonephritis in a healthy adult.
8849170 1996. Insulin-dependent diabetes mellitus associated with parvovirus B19 infection.
9137705 1997. Vascularite cutanee revelatrice d'une infection a parvovirus B19.
9092365 1996. Maladie de Still de l'adulte associee a une infection aigue par le parvovirus B 19, survenant au cours d'une grossesse.
17894022 2007. Are antiphospholipid antibodies an essential requirement for an effective immune response to infections?
1334393 1992. A propos de vingt-quatre observations d'infections a parvovirus humain B19 chez l'enfant.
9046945 1997. Parvovirus B19 in human disease.
2158761 1990. Human parvovirus infections.
31283445 2019. Emerging Human Parvoviruses: The Rocky Road to Fame.
20587861 2010. Parvovirus-B19-associated fulminant myocarditis successfully treated with immunosuppressive and antiviral therapy.
30529090 2019. Antiviral activity of brincidofovir on parvovirus B19.
25446336 2015. Antiviral effect of cidofovir on parvovirus B19 replication.
19775347 2009. Fulminant parvovirus B19-associated pancarditis with haemophagocytic lympho-histiocytosis in an immunocompetent adult.
9808410 1998. The 1994 human parvovirus B19 epidemic in Denmark: diagnostic and epidemiological experience.
17010169 2006. Human parvovirus B19 erythrovirus. Methods established for virological and diagnostic aspects.
16785792 2006. Autoimmune-like pulmonary disease in association with parvovirus B19: a clinical, morphologic, and molecular study of 12 cases.
10606079 1999. The spectrum of cutaneous eruptions in 22 patients with isolated serological evidence of infection by parvovirus B19.
2541666 1989. Clinical manifestations of human parvovirus B19 in adults.
2848470 1988. Transient rheumatoid factor positivity in acute human parvovirus B19 infection.
16294544 2005. Cardiomyopathies virales. A propos de 4 observations d'infection myocardique a parvovirus B-19 et revue de la litterature.
15734124 2005. Purpura thrombopenique a parvovirus B19 complique d'hemorragie cerebromeningee.
7951839 1994. Parvovirus B 19 et pathologie pediatrique.
21041600 2010. Picture of the month. Parvovirus-associated papular-purpuric "gloves and socks" eruption,with atypical unilateral facial involvement in locus minoris resistentiae.
9895006 1999. Picture of the month. Petechial eruption with parvovirus B19 infection.
10542021 1999. Human parvovirus B19 infection in acute fulminant liver failure.
9008606 1997. Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus.
8639187 1996. Prevalence of human parvovirus B19 infection in children with Henoch-Schonlein purpura.

956363 1976. Comparison of human fecal and serum parvo-like viruses.
17412871 2007. Persistent parvovirus b19 infection resulting in carpal tunnel syndrome.
17142576 2006. Parvovirus B19 detected in Rosai-Dorfman disease in nodal and extranodal manifestations.
16049292 2005. Parvovirus B19 infection associated with unilateral cervical lymphadenopathy, apoptotic sinus histiocytosis, and prolonged fatigue.
7629301 1995. Anticomplementary activity in serum samples from patients with acute parvovirus B19 infection.
1401175 1992. Non-isotopic in situ hybridisation and immunophenotyping of infected cells in the investigation of human fetal parvovirus infection.
25411609 2014. Case of fulminant type 1 diabetes mellitus associated with parvovirus B19 infection.
32533899 2020. Major cluster of paediatric 'true' primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown.
21195886 2010. Cluster of parvovirus infection among hospital staff working in coronary care units.
17384979 2007. Secondary symptomatic parvovirus B19 infection in a healthy adult.
27902343 2016. Frequency and significance of parvovirus B19 infection in patients with rheumatoid arthritis.
27902331 2016. The plasma virome of febrile adult Kenyans shows frequent parvovirus B19 infections and a novel arbovirus (Kadipiro virus).
15383603 2004. Human parvovirus B19 transgenic mice become susceptible to polyarthritis.
30346568 2019. Parvovirus B19V Nonstructural Protein NS1 Induces Double-Stranded Deoxyribonucleic Acid Autoantibodies and End-Organ Damage in Nonautoimmune Mice.
21921203 2011. Seroepidemiology of human bocaviruses 1-4.
19691429 2009. High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies.
18831690 2008. CD4+ T helper cell responses against human bocavirus viral protein 2 viruslike particles in healthy adults.
17397006 2007. Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus.
19549095 2009. Persistent parvovirus B19 infection detected by specific CD4+ T-cell responses in a patient with hepatitis and polyarthritis.
16961667 2006. Clinical aspects of parvovirus B19 infection.
9747749 1998. Acute lung injury due to parvovirus pneumonia.
31635495 2019. Hemophagocytic Lymphohistiocytosis Associated With Parvovirus B19 in a Patient With Acquired Immunodeficiency Syndrome.
25560323 2015. Persistent parvovirus B19 viremia with chronic arthralgia treated with ascorbic acid: a case report.
31257106 2019. Human parvovirus B19 infection in patients with or without underlying diseases.
12438480 2002. Evidence for the role of demyelination, HLA-DR alleles, and cytokines in the pathogenesis of parvovirus B19 meningoencephalitis and its sequelae.
8961710 1996. Various associations of human parvovirus B19 infection.
31341051 2019. Globoside Is Dispensable for Parvovirus B19 Entry but Essential at a Postentry Step for Productive Infection.
30787153 2019. Structure of Parvovirus B19 Decorated by Fabs from a Human Antibody.
30282717 2019. The 11-Kilodalton Nonstructural Protein of Human Parvovirus B19 Facilitates Viral DNA Replication by Interacting with Grb2 through Its Proline-Rich Motifs.
29237843 2018. Human Parvovirus B19 Utilizes Cellular DNA Replication Machinery for Viral DNA Replication.
29437973 2018. RNA Binding Protein RBM38 Regulates Expression of the 11-Kilodalton Protein of Parvovirus B19, Which Facilitates Viral DNA Replication.
24807719 2014. Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q.
24067971 2013. Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropism.
24049177 2013. Human parvovirus B19 infection causes cell cycle arrest of human erythroid progenitors at late S phase that favors viral DNA replication.
22718826 2012. Characterization of the early steps of human parvovirus B19 infection.
22855485 2012. Acute diarrhea in West African children: diverse enteric viruses and a novel parvovirus genus.
22837195 2012. Human parvovirus B19 DNA replication induces a DNA damage response that is dispensable for cell cycle arrest at phase G2/M.
22357277 2012. Roles of E4orf6 and VA I RNA in adenovirus-mediated stimulation of human parvovirus B19 DNA replication and structural gene expression.
21159861 2011. Inclusion of the central exon of parvovirus B19 precursor mRNA is determined by multiple splicing enhancers in both the exon and the downstream intron.
21680529 2011. Parvovirus B19 infection of human primary erythroid progenitor cells triggers ATR-Chk1 signaling, which promotes B19 virus replication.
20668071 2010. Widespread infection with homologues of human parvoviruses B19, PARV4, and human bocavirus of chimpanzees and gorillas in the wild.
20631151 2010. Advances in human B19 erythrovirus biology.
20826697 2010. The globoside receptor triggers structural changes in the B19 virus capsid that facilitate virus internalization.
20375175 2010. Human bocavirus capsid structure: insights into the structural repertoire of the parvoviridae.
20943969 2010. Codon optimization of human parvovirus B19 capsid genes greatly increases their expression in nonpermissive cells.
20861249 2010. Role of erythropoietin receptor signaling in parvovirus B19 replication in human erythroid progenitor cells.
19587029 2009. The genome of human parvovirus b19 can replicate in nonpermissive cells with the help of adenovirus genes and produces infectious virus.
19710152 2009. Analysis of nucleotide sequences of human parvovirus B19 genome reveals two different modes of evolution, a gradual alteration and a sudden replacement: a retrospective study in Sapporo, Japan, from 1980 to 2008.
18684834 2008. Block to the production of full-length B19 virus transcripts by internal polyadenylation is overcome by replication of the viral genome.
18160440 2008. Ex vivo-generated CD36+ erythroid progenitors are highly permissive to human parvovirus B19 replication.
18417586 2008. Rapid sequence change and geographical spread of human parvovirus B19: comparison of B19 virus evolution in acute and persistent infections.
18815302 2008. Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity.
18550668 2008. Human parvovirus B19 NS1 protein modulates inflammatory signaling by activation of STAT3/PIAS3 in human endothelial cells.
18508892 2008. Visualization of the externalized VP2 N termini of infectious human parvovirus B19.
17409158 2007. Biological and immunological relations among human parvovirus B19 genotypes 1 to 3.
16956939 2006. Phospholipase A2 activity-dependent stimulation of Ca2+ entry by human parvovirus B19 capsid protein VP1.
16943301 2006. Tracking of peptide-specific CD4+ T-cell responses after an acute resolving viral infection: a study of parvovirus B19.
16731932 2006. Molecular and functional analyses of a human parvovirus B19 infectious clone demonstrates essential roles for NS1, VP1, and the 11-kilodalton protein in virus replication and infectivity.
16775358 2006. A highly restricted T-cell receptor dominates the CD8+ T-cell response to parvovirus B19 infection in HLA-A2402-positive individuals.
16415037 2006. Identification and characterization of two internal cleavage and polyadenylation sites of parvovirus B19 RNA.
17020940 2006. Conformational changes in the VP1-unique region of native human parvovirus B19 lead to exposure of internal sequences that play a role in virus neutralization and infectivity.
16571827 2006. Apoptosis of liver-derived cells induced by parvovirus B19 nonstructural protein.
16537636 2006. Phylogenetic evidence for the rapid evolution of human B19 erythrovirus.
16140790 2005. Sustained CD8+ T-cell responses induced after acute parvovirus B19 infection in humans.
15220451 2004. Parvovirus B19-induced apoptosis of hepatocytes.
12584315 2003. Human parvovirus B19 nonstructural protein (NS1) induces cell cycle arrest at G(1) phase.
12186896 2002. Genetic diversity within human erythroviruses: identification of three genotypes.
11991968 2002. Regulation of tumor necrosis factor alpha promoter by human parvovirus B19 NS1 through activation of AP-1 and AP-2.
11799199 2002. The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity.
11287560 2001. Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells.
11222696 2001. Evolutionary relationships among parvoviruses: virus-host coevolution among autonomous primate parvoviruses and links between adeno-associated and avian parvoviruses.
11119624 2001. Direct ex vivo measurement of CD8(+) T-lymphocyte responses to human parvovirus B19.
11462027 2001. Human parvovirus B19 induces cell cycle arrest at G(2) phase with accumulation of mitotic cyclins.
11024117 2000. Impaired gamma interferon responses against parvovirus B19 by recently infected children.
15888184 2005. Prevalence of human parvovirus B19 component NS1 gene in patients with Henoch-Schonlein purpura and hypersensitivity vasculitis.
15888183 2005. Altered prevalence of human parvovirus B19 component genes in systemic sclerosis skin tissue.
15840133 2005. Parvovirus B19 and systemic sclerosis.
15214893 2004. Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin.
15270892 2004. The juvenile variant of papular-purpuric gloves and socks syndrome and its association with viral infections.
8915154 1996. Immunohistochemical and virological study of skin in the papular-purpuric gloves and socks syndrome.
32088927 2020. Numerous abnormal mitoses in parvovirus B19-infected proerythroblasts.
25920561 2015. Spectrum of adult Parvovirus B19 infection according to the underlying predisposing condition and proposals for clinical practice.
20064150 2010. Acute human parvovirus B19 infection and nephrotic syndrome in patients with sickle cell disease.
15606559 2005. Human parvovirus B19-induced acquired pure amegakaryocytic thrombocytopenia.
15257717 2004. Evidence of parvovirus B19 infection in patients of pre-eclampsia and eclampsia with dyserythropoietic anaemia.
12786811 2003. Risk of parvovirus infection by immunoglobulin.
12199806 2002. Life-threatening human parvovirus B19 infection transmitted by intravenous immune globulin.
9074434 1997. Parvovirus B19-associated haemophagocytic syndrome with lymphadenopathy resembling histiocytic necrotizing lymphadenitis (Kikuchi's disease).
7772537 1995. Parvovirus B19-associated haemophagocytic syndrome in healthy adults.
8199040 1994. Parvovirus B19-associated haemophagocytic syndrome with prominent neutrophilia.
7819097 1994. Haemophagocytic lymphohistiocytosis: experience at two U.K. centres.
7986722 1994. Parvovirus B19 as a cause of acquired chronic pure red cell aplasia.
8136290 1993. Parvovirus B19-related lymphadenopathy.
1536802 1992. Transient erythroblastopenia of childhood with megakaryocytopenia associated with human parvovirus B19 infection.
1550770 1992. Recurrent granulocytic aplasia as clinical presentation of a persistent parvovirus B19 infection.
1654995 1991. Productive infection of in vitro generated haemopoietic progenitor cells from normal human adult peripheral blood with parvovirus B19: studies by morphology, immunocytochemistry, flow-cytometry and DNA-hybridization.
1648374 1991. Congenital spherocytosis, B19 parvovirus infection and inherited interstitial deletion of the short arm of chromosome 8.
2553096 1989. Transient erythroblastopenia of childhood due to human parvovirus B19 infection.
8616129 1996. Fetal pathology in intrauterine death due to parvovirus B19 infection.
1525097 1992. Clinical and histopathological features of parvovirus B19 infection in the human fetus.
2548567 1989. Fetal pathology in human parvovirus B19 infection.
9117160 1997. Reactive arthritis in a patient with simultaneous parvovirus B19 infection and Clostridium difficile diarrhoea.
8428231 1993. Exacerbation of systemic lupus erythematosus during human parvovirus B19 infection.
20395090 2011. Acute autonomic sensory and motor neuropathy associated with parvovirus B19 infection.
9595838 1998. Parvovirus: a review.
11828445 2001. Scanning force microscopy study on a single-stranded DNA: the genome of parvovirus B19.
20177002 2010. Parvovirus b19-induced myocarditis mimicking acute myocardial infarction: clarification of diagnosis by cardiac magnetic resonance imaging.
17404165 2007. Images in cardiovascular medicine. Parvovirus-B19-associated active myocarditis with biventricular thrombi. Results of endomyocardial biopsy investigations and cardiac magnetic resonance imaging.
15505098 2004. Endothelium-dependent flow-mediated vasodilation of systemic arteries is impaired in patients with myocardial virus persistence.
12925460 2003. Parvovirus B19 infection mimicking acute myocardial infarction.
17434906 2007. Biosensor analysis of beta2-glycoprotein I-reactive autoantibodies: evidence for isotype-specific binding and differentiation of pathogenic from infection-induced antibodies.
7955387 1994. Increased prevalence of IgM antibodies to Epstein-Barr virus and parvovirus B19 in blood donations with above-normal neopterin.
24513539 2014. Parvovirus B19 (B19) and cytomegalovirus (CMV) infections and anti-erythropoietin (anti-EPO) antibodies in patients on dialysis hyporesponsive to erythropoietin therapy.
22309679 2012. Significant association of past parvovirus B19 infection with cytopenia in both adult-onset Still's disease and systemic lupus erythematosus patients.
10482630 1999. Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19.
10400786 1999. Three-dimensional structure of Aleutian mink disease parvovirus: implications for disease pathogenicity.
9420265 1998. Characterization of cis-acting and NS1 protein-responsive elements in the p6 promoter of parvovirus B19.
9525624 1998. Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells.
9151844 1997. Experimental infection of cynomolgus monkeys with simian parvovirus.
9371610 1997. The 3' untranslated region of the B19 parvovirus capsid protein mRNAs inhibits its own mRNA translation in nonpermissive cells.
8794392 1996. Lymphoproliferative responses after infection with human parvovirus B19.
8970971 1996. A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression.
8764053 1996. Identification of domains in canine parvovirus VP2 essential for the assembly of virus-like particles.
7666560 1995. Modest truncation of the major capsid protein abrogates B19 parvovirus capsid formation.
7745742 1995. Human parvovirus B19 can infect cynomolgus monkey marrow cells in tissue culture.
7494329 1995. Transcriptional transactivation of parvovirus B19 promoters in nonpermissive human cells by adenovirus type 2.
7933098 1994. The transcriptional regulator YY1 binds to the 5'-terminal region of B19 parvovirus and regulates P6 promoter activity.
8207846 1994. Formation of empty B19 parvovirus capsids by the truncated minor capsid protein.
7966641 1994. A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity.
7684458 1993. Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions.
1433504 1992. Localization of an immunodominant domain on baculovirus-produced parvovirus B19 capsids: correlation to a major surface region on the native virus particle.
1385833 1992. A block in full-length transcript maturation in cells nonpermissive for B19 parvovirus.
1716693 1991. Identification and mapping of neutralizing epitopes of human parvovirus B19 by using human antibodies.
1901917 1991. Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins.
1719240 1991. A second neutralizing epitope of B19 parvovirus implicates the spike region in the immune response.
1705987 1991. Identification of the region including the epitope for a monoclonal antibody which can neutralize human parvovirus B19.
2293668 1990. Nonstructural protein of parvoviruses B19 and minute virus of mice controls transcription.
2795719 1989. A GC-box motif upstream of the B19 parvovirus unique promoter is important for in vitro transcription.
2657097 1989. Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver.
3373576 1988. Functional mapping of the genome of the B19 (human) parvovirus by in vitro translation after negative hybrid selection.
3392774 1988. Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells from normal human bone marrow.
2969055 1988. The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells.
3599184 1987. Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures.
3599180 1987. Novel transcription map for the B19 (human) pathogenic parvovirus.
3021988 1986. Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments.
3701931 1986. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis.
3783814 1986. Complete nucleotide sequence and genome organization of bovine parvovirus.
31517001 2019. Extensive purpura as presenting sign of parvovirus B19 infection in a patient with paroxysmal nocturnal hemoglobinuria.
15973005 2005. Spontaneous resolution of hemophagocytic syndrome and disseminated intravascular coagulation associated with parvovirus b19 infection in a previously healthy child.
31290479 2019. An association between parvovirus B19 infection and the severity of coronary atherosclerosis.
12472788 2003. Familial collapsing glomerulopathy: clinical, pathological and immunogenetic features.
11380814 2001. Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy.
21116318 2010. Infection and chronic allograft dysfunction.
14563946 2003. PCR-based diagnosis of enterovirus and parvovirus B19 in paraffin-embedded heart tissue of children with suspected sudden infant death syndrome.
20385113 2010. The association of anti-parvovirus B19-VP1 unique region antibodies with antiphospholipid antibodies in patients with antiphospholipid syndrome.
19362081 2009. Anti-human parvovirus B19 nonstructural protein antibodies in patients with rheumatoid arthritis.
18538665 2008. Up-regulation of adhesion molecule expression and induction of TNF-alpha on vascular endothelial cells by antibody against human parvovirus B19 VP1 unique region protein.
17169353 2007. The association of VP1 unique region protein in acute parvovirus B19 infection and anti-phospholipid antibody production.
17451664 2007. Induction of antiphospholipid antibodies and antiphospholipid syndrome-like autoimmunity in naive mice with antibody against human parvovirus B19 VP1 unique region protein.
16765338 2006. Serologic and molecular detection of human Parvovirus B19 infection.
30981292 2019. The rash with maculopapules and fever in children.
30981291 2019. The rash with maculopapules and fever in adults.
17350501 2007. Viral exanthems in the tropics.
15566889 1996. IgG subclass response to human parvovirus B19 infection.
31400151 2020. An unusual cutaneous manifestation of parvovirus B19 infection: papular-purpuric gloves-and-socks syndrome and petechial bathing trunk eruption.
27900796 2017. Parvovirus B19 infection presenting concurrently as papular-purpuric gloves-and-socks syndrome and bathing-trunk eruption.
24164247 2014. Haemophagocytic syndrome with a fatal outcome triggered by parvovirus B19 infection in the skin.
19489851 2009. Melkersson-Rosenthal syndrome associated with parvovirus B19 viraemia and haemophagocytic lymphohistiocytosis.
18355355 2008. Acute heart failure associated with human parvovirus B19 infection.
17250756 2007. Detection of parvovirus B19 DNA in the lesional skin of patients with Behcet's disease.
16681615 2006. Acute urticaria and dry cough with interstitial pneumonia: a clue for the diagnosis of primary parvovirus B19 infection.
22468640 2012. Investigation of parvovirus B19 seroprevalence, endothelin-1 synthesis, and nitric oxide levels in the etiology of essential hypertension.
15971443 2005. Coexistence of non-specific and usual interstitial pneumonia in a patient with severe cystic scleroderma lung involvement and parvovirus B19 infection.
15301256 2004. Human Parvovirus B19 and juvenile systemic lupus erythematosus.
14611135 2003. Role of parvovirus B19 infection in juvenile chronic arthritis. Is more investigation needed?
11326495 2001. The historical record is consistent with the recent finding of parvovirus B19 infection of bone marrow in systemic sclerosis patients.
10949739 2000. Antinucleolar antibodies and parvovirus B19 arthritis.
10609071 1999. Parvovirus B19 infection of bone marrow in systemic sclerosis patients.
8697661 1996. Parvovirus B19 infection in Behcet's disease.
16169277 2005. Critical function of the CD40 pathway in parvovirus B19 infection revealed by a hypomorphic CD40 ligand mutation.
12921761 2003. Detection of IgE anti-parvovirus B19 and increased CD23+ B cells in parvovirus B19 infection: relation to Th2 cytokines.
30052873 2019. Infection Pressure in Men Who Have Sex With Men and Their Suitability to Donate Blood.
30304533 2019. An Outbreak of Human Parvovirus B19 Hidden by Dengue Fever.
20201675 2010. Mixed cryoglobulinemia: a role for parvovirus b19 infection.
19441978 2009. Neurologic manifestations associated with parvovirus B19 infection.
18558883 2008. Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman.
16758416 2006. Parvovirus B19 infection after transplantation: a review of 98 cases.
16163641 2005. Slow clearance of human parvovirus B19 viremia following acute infection.
16028146 2005. A case of persistent parvovirus B19 infection with bilateral cartilaginous and ligamentous damage to the wrists.
12715326 2003. Successful intravenous immunoglobulin therapy in 3 cases of parvovirus B19-associated chronic fatigue syndrome.
12715316 2003. Parvovirus B19 encephalitis presenting as immune restoration disease after highly active antiretroviral therapy for human immunodeficiency virus infection.
12384834 2002. Active, fulminant, lethal myocarditis associated with parvovirus B19 infection in an infant.
12471578 2002. Papular purpuric rash due to parvovirus B19 with distribution on the distal extremities and the face.
11170925 2001. A syndrome resembling thrombotic thrombocytopenic purpura associated with human parvovirus B19 infection.
11106317 2001. Renal involvement of human parvovirus B19 in an immunocompetent host.
10722434 2000. Raynaud's phenomenon as a manifestation of parvovirus B19 infection: case reports and review of parvovirus B19 rheumatic and vasculitic syndromes.
10913398 2000. Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review.
10451194 1999. Cardiorespiratory manifestations of parvovirus B19 infection.
10476760 1999. Prolonged fever caused by parvovirus B19-induced meningitis: case report and review.
9798055 1998. Parvovirus B19 infection associated with respiratory distress.
9675471 1998. Papular-purpuric gloves and socks syndrome associated with acute parvovirus B19 infection: case report and review.
9502455 1998. Life-threatening parvovirus B19-associated myocarditis and cardiac transplantation as possible therapy: two case reports.
9564490 1998. Still's disease, severe thrombocytopenia, and acute hepatitis associated with acute parvovirus B19 infection.
9564461 1998. Photo quiz II. Leukocytoclastic vasculitis secondary to parvovirus B19 infection.
9195056 1997. Chronic parvovirus B19 infection resulting in chronic fatigue syndrome: case history and review.
8783735 1996. Association of parvovirus B19 infection with giant cell arteritis.
8816166 1996. Myopericarditis due to parvovirus B19 in an adult.
8824988 1996. Acute bilateral carpal tunnel syndrome associated with human parvovirus B19 infection.
8645812 1995. Aseptic meningitis caused by parvovirus B19.
8749627 1995. Spectrum of parvovirus B19 infection: analysis of an outbreak of 43 cases in Cadiz, Spain.
8562756 1995. Juvenile dermatomyositis in a child infected with human parvovirus B19.
7948543 1994. Pure red cell aplasia, peripheral thrombocytopenic purpura, and parvovirus B19 infection in a women seropositive for human immunodeficiency virus.
1330011 1992. Chronic parvovirus infection in a presumably immunologically healthy woman.
16812953 2006. Prevention of iatrogenic transmission of B19 infection: different approaches to detect, remove or inactivate virus contamination.
11934222 2002. Humoral immune response to parvovirus B19 and serological diagnosis of B19 infection.
10792401 2000. Lupus anticoagulant in a patient with parvovirus B19 infection.
7955926 1994. Viral-associated haemophagocytosis and elevated serum TNF-alpha with parvovirus-B19-related pancytopenia in patients with hereditary spherocytosis.
26833301 2016. Postinfectious glomerulonephritis secondary to Erythrovirus B19 (Parvovirus B19): case report and review of the literature.
23442257 2014. Transition from endocapillary proliferative glomerulonephritis to membranoproliferative glomerulonephritis in a patient with a prolonged human parvovirus B19 infection.
16240895 2005. Characteristics of acute glomerulonephritis associated with human parvovirus B19 infection.
12708574 2003. Successful treatment of chronic parvovirus B19 infection by high-dose immunoglobulin.
11924757 2002. Acute endocapillary proliferative glomerulonephritis associated with human parvovirus B19 infection.
11837804 2002. Association of parvovirus B19 infection with acute glomerulonephritis in healthy adults: case report and review of the literature.
10749307 2000. Glomerulonephritis and Henoch-Schoenlein purpura associated with acute parvovirus B19 infection.
12140110 2002. Case report of meningoencephalitis during a concomitant mumps and parvovirus B19 infection.
23733615 2013. Chronic parvovirus infection in a pediatric cardiac transplant recipient: a case report.
19286620 2009. Successful treatment with high-dose intravenous immunoglobulin for parvovirus b19 infection associated with acute fulminant hepatitis in a chinese child.
18566354 2008. A case of catastrophic antiphospholipid syndrome in an adolescent girl with parvovirus B19 infection.
16708143 2006. Fever and petechial rash associated with parvovirus B19 infection.
8324977 1993. Parvovirus B19-induced chronic arthropathy in a child.
16085027 2005. Diagnosis and management of human parvovirus B19 infection.

15776413 2005. Fatal course of parvovirus B19-associated myocarditis in a female liver transplant recipient.
32156816 2020. RNA Binding Motif Protein RBM45 Regulates Expression of the 11-Kilodalton Protein of Parvovirus B19 through Binding to Novel Intron Splicing Enhancers.
30159289 2018. Frequency of human Parvovirus B19 among patients with respiratory infection in Iran.
17195827 2007. Papular purpuric gloves and socks syndrome. Presentation of a clinical case.
31490394 2019. Syphilis and parvovirus B19 co-infection imitating a lupus nephropathy: A case report.
31464949 2019. Parvovirus B19 infection presenting with neutropenia and thrombocytopenia: Three case reports.
30142866 2018. Clinical heterogeneity of human parvovirus B19 infection following adult liver transplantation.
19011502 2008. Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature.
29531655 2018. Parvovirus B19-triggered Acute Hemolytic Anemia and Thrombocytopenia in a Child with Evans Syndrome.
26517666 2015. Parvovirus B19 1A complete genome from a fatal case in Brazil.
24714965 2014. Clinical features and laboratory findings of human parvovirus B19 in human immunodeficiency virus-infected patients.
21739041 2011. Genotyping of human parvovirus B19 in clinical samples from Brazil and Paraguay using heteroduplex mobility assay, single-stranded conformation polymorphism and nucleotide sequencing.
16951812 2006. Erythrovirus B19 infection in acquired immunodeficiency syndrome: screening by histopathology, immunohistochemistry, and in situ hybridization.
1342709 1992. Human B19 parvovirus infection: an example of multiple pathogenic effects determined by differences in host susceptibility.
2549345 1989. Human parvovirus (HPV/B19) infection with purpura.
30533645 2018. Sequences of Seven Complete Genomes of Human Parvovirus B19.
16361103 2006. Application of transmission electron microscopy to the clinical study of viral and bacterial infections: present and future.
12920226 2003. Detection of parvovirus B19 capsid proteins in lymphocytic cells in synovial tissue of autoimmune chronic arthritis.
30875983 2019. Synthesis of 3-(Imidazo[2,1-b]thiazol-6-yl)-2H-chromen-2-one Derivatives and Study of Their Antiviral Activity against Parvovirus B19.
8139629 1994. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen).
30587876 2018. A pediatric case with parvovirus B19-associated uveitis without autoantibody formation.
16932438 2006. Viral nephropathy.
28374737 2017. Extinct type of human parvovirus B19 persists in tonsillar B cells.
22294016 2012. Reactive haemophagocytic syndrome associated with parvovirus B19 in a kidney-pancreas transplant patient.
8730455 1996. Parvovirus B19 and hemodialysis.
2762166 1989. Sequence of the right hand terminal palindrome of the human B19 parvovirus genome has the potential to form a 'stem plus arms' structure.
25013465 2014. Gene expression analysis of potential genes and pathways involved in the pathogenic mechanisms of parvovirus B19 in human colorectal cancer.
22740966 2012. High prevelance of human parvovirus infection in patients with malignant tumors.
32391400 2020. Hyaluronidase-Facilitated High-Dose Subcutaneous IgG Effectively Controls Parvovirus B19 Infection in a Pediatric Cardiac Transplant Patient With Severe T-Cell Lymphopenia.
32760751 2020. Parvovirus B19-Infected Tubulointerstitial Nephritis in Hereditary Spherocytosis.
8065702 1994. Conjunctivitis caused by human parvovirus B19 infection.
17207644 2007. Human parvovirus B19, varicella zoster virus, and human herpesvirus-6 in mesenchymal stem cells of patients with osteoarthritis: analysis with quantitative real-time polymerase chain reaction.
22254152 2012. Potential Infectious Etiology of Behcet's Disease.
19418550 2009. Simultaneous acute splenic sequestration and transient aplastic crisis in children with sickle cell disease.
26499513 2016. High Frequency of Detection by PCR of Viral Nucleic Acid in The Blood of Infants Presenting with Clinical Myocarditis.
16282940 2005. Acute respiratory distress syndrome in a child with human parvovirus B19 infection.
25669893 2014. Parvovirus B19 associated acute cholestatic hepatitis.
29853623 2018. Parvovirus B19: A Cause of Sepsislike Syndrome in an Infant.
16253012 2005. Prolonged activation of virus-specific CD8+T cells after acute B19 infection.
20436917 2010. Chloroquine and its derivatives exacerbate B19V-associated anemia by promoting viral replication.
31086415 2019. The effects of human parvovirus VP1 unique region in a mouse model of allergic asthma.
30114253 2018. The VP1 unique region of human parvovirus B19 and human bocavirus induce lung injury in naive Balb/c mice.
28531186 2017. Parvovirus B19-induced vascular damage in the heart is associated with elevated circulating endothelial microparticles.
26845771 2016. Parvovirus B19 Replication and Expression in Differentiating Erythroid Progenitor Cells.
25462010 2014. Th17-related cytokines in systemic lupus erythematosus patients with dilated cardiomyopathies: a possible linkage to parvovirus B19 infection.
25268969 2014. Effects of human Parvovirus B19 and Bocavirus VP1 unique region on tight junction of human airway epithelial A549 cells.
23840852 2013. Exacerbating effects of human parvovirus B19 NS1 on liver fibrosis in NZB/W F1 mice.
23776709 2013. Human parvovirus B19 induced apoptotic bodies contain altered self-antigens that are phagocytosed by antigen presenting cells.
23737981 2013. Prevalence of human parvovirus B19, bocavirus, and PARV4 in blood samples from the general population of China and lack of a correlation between parvovirus and hepatitis B co-infection.
23596524 2013. The determinants for the enzyme activity of human parvovirus B19 phospholipase A2 (PLA2) and its influence on cultured cells.
23555760 2013. Human parvovirus B19 NS1 protein aggravates liver injury in NZB/W F1 mice.
22912828 2012. Global co-existence of two evolutionary lineages of parvovirus B19 1a, different in genome-wide synonymous positions.
22438961 2012. Green fluorescent protein (GFP) color reporter gene visualizes parvovirus B19 non-structural segment 1 (NS1) transfected endothelial modification.
22413013 2012. Parvovirus b19 DNA CpG dinucleotide methylation and epigenetic regulation of viral expression.
22235298 2012. High prevalence of human parvovirus 4 infection in HBV and HCV infected individuals in shanghai.
18523634 2008. NS1 specific CD8+ T-cells with effector function and TRBV11 dominance in a patient with parvovirus B19 associated inflammatory cardiomyopathy.
28459842 2017. Phosphorylated STAT5 directly facilitates parvovirus B19 DNA replication in human erythroid progenitors through interaction with the MCM complex.
28328962 2017. The blood DNA virome in 8,000 humans.
28264028 2017. Parvovirus B19 NS1 protein induces cell cycle arrest at G2-phase by activating the ATR-CDC25C-CDK1 pathway.
21698228 2011. Productive parvovirus B19 infection of primary human erythroid progenitor cells at hypoxia is regulated by STAT5A and MEK signaling but not HIFalpha.
29904309 2018. Hemophagocytic lymphohistiocytosis.
22275777 2012. Focal segmental glomerulosclerosis and parvovirus B19.
29967156 2018. Ancient human parvovirus B19 in Eurasia reveals its long-term association with humans.
15289612 2004. The structure of human parvovirus B19.
8755503 1996. Cryo-electron microscopy studies of empty capsids of human parvovirus B19 complexed with its cellular receptor.
8618912 1995. Parvovirus B19 promoter at map unit 6 confers autonomous replication competence and erythroid specificity to adeno-associated virus 2 in primary human hematopoietic progenitor cells.
24878787 2014. Frequency of antiparvovirus B19 antibodies in rheumatoid arthritis and systemic lupus erythematosus.
30724999 2018. Parvovirus B19: Un virus ADN asociado a multiples manifestaciones cutaneas.
17505669 2007. Detection of parvovirus B19 infection in formalin-fixed and paraffin-embedded placenta and fetal tissues.
31448778 2019. TREATMENT STRATEGIES AND OUTCOME OF PARVOVIRUS B19 INFECTION IN KIDNEY TRANSPLANT RECIPIENTS: A CASE SERIES AND LITERATURE REVIEW OF 128 PATIENTS.
23559294 2012. Glomerulopatia colapsante.
24459081 2014. Neurological aspects of human parvovirus B19 infection: a systematic review.
19942964 2009. Acquired aplastic anemia: correlation between etiology, pathophysiology, bone marrow histology and prognosis factors.
21198754 2011. Comparison of Th-cell immunity against human bocavirus and parvovirus B19: proliferation and cytokine responses are similar in magnitude but more closely interrelated with human bocavirus.
30487523 2018. Increased seroprevalence of HAV and parvovirus B19 in children and of HEV in adults at diagnosis of autoimmune hepatitis.
27775080 2016. Substitution rate and natural selection in parvovirus B19.
26611279 2015. Bones hold the key to DNA virus history and epidemiology.
1652405 1991. Human parvovirus B19 and its associated diseases.
27112783 2016. Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-beta treatment in patients with chronic viral cardiomyopathy.
26133158 2016. Predictors of outcome in patients with parvovirus B19 positive endomyocardial biopsy.
31917176 2020. Parvovirus B19 infection: A challenging cause of fulminant hepatitis.
23886765 2014. Parvovirus B19 associated acute hepatitis and hepatosplenomegaly.
12794260 2003. Systemic lupus erythematosus and parvovirus B-19: casual coincidence or causative culprit?
19057847 2009. Seroprevalence of parvovirus B19 in fibromyalgia syndrome.
17851708 2008. Different patterns of disease manifestations of parvovirus B19-associated reactive juvenile arthritis and the induction of antiphospholipid-antibodies.
17622480 2008. Emerging lupus-like manifestations in acute parvovirus B19 infection.
16421644 2006. Multiple small pulmonary emboli associated with transient antiphospholipid syndrome in human Parvovirus B19 infection.
14749987 2004. Parvovirus B19-related chronic monoarthritis: immunohistochemical detection of virus-positive lymphocytes within the synovial tissue compartment: two reported cases.
15045641 2004. Parvovirus B19 infection and myofasciitis.
12189459 2002. Unusual localisation of chronic arthropathy in lumbar facet joints after parvovirus B19 infection.
11147771 2000. Parovirus B19-associated mono- and oligoarticular arthritis may evolve into a chronic inflammatory arthropathy fulfilling criteria for rheumatoid arthritis or spondylarthropathy.
10941809 2000. High incidence of parvovirus B19 DNA in synovial tissue of patients with undifferentiated mono- and oligoarthritis.
8894369 1996. A case of parvovirus-B19 adult acute arthritis with some allergic disease clinical features.
30973192 2019. Human parvovirus B19 in solid organ transplantation: Guidelines from the American society of transplantation infectious diseases community of practice.
16313320 2005. Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients.
10081630 1999. Human parvovirus B19 infection in organ transplant recipients.
8826660 1996. Parvovirus B19 infection in a liver transplant recipient: case report and review in organ transplant recipients.
22902951 2012. miRNA and tropism of human parvovirus B19.
8074799 1994. Molecular, cellular and clinical aspects of parvovirus B19 infection.
1651089 1991. The clinical spectrum of human parvovirus B19 infections.
11095799 1999. Infection with Parvovirus B19.
25703483 2015. Common childhood viral infections.
17531174 2007. Antiphospholipid antibodies in response to infection.
16568906 2006. Parvovirus variation for disease: a difference with RNA viruses?
8794248 1996. Adeno-associated virus 2-mediated transduction and erythroid lineage-specific expression in human hematopoietic progenitor cells.
24195090 2013. Pediatric parvovirus B19: spectrum of clinical manifestations.
28288327 2017. Parvovirus B19 infection modulates the levels of cytokines in the plasma of rheumatoid arthritis patients.
12120446 2002. Parvovirus B19: a review.
20110633 2010. Parvovirus b19 DNA is commonly harboured in human skin.
15645679 2004. Cell culture-based assay of parvovirus B19 and the relevance of animal model viruses.
15645675 2004. Variants of B19.
16401330 2005. Human parvovirus B19 infection in children with new onset Type 1 diabetes mellitus.
22395961 2012. Acute fulminant hepatic failure associated with parvovirus B19 infection in an immunocompetent adult.

22619569 2012. Parvovirus B19 infection and severe anemia in renal transplant recipients.
19013331 2008. Viruses and kidney disease: beyond HIV.
29587847 2018. High-sensitivity virus and mycoplasma screening test reveals high prevalence of parvovirus B19 infection in human synovial tissues and bone marrow.
8991535 1996. Parvoviruses and bone marrow failure.
28864597 2017. Parvovirus B19 Infection in Children With Arterial Ischemic Stroke.
30378400 2018. Akutt glomerulonefritt utlost av parvovirus B19.
21483465 2010. Parvovirus B19 - Revised.
22998193 2013. Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening.
21303368 2011. Distribution of parvovirus B19 DNA in blood compartments and persistence of virus in blood donors.
19144091 2009. Clinical implications of quantitative real time-polymerase chain reaction of parvovirus B19 in kidney transplant recipients - a prospective study.
16441366 2006. Parvovirus B19-induced anemia in renal transplantation: a role for rHuEPO in resistance to classical treatment.
29184906 2017. Parvovirus B19 in the Context of Hematopoietic Stem Cell Transplantation: Evaluating Cell Donors and Recipients.
8212203 1993. Parvovirus B19 infection in pediatric transplant patients.
8434395 1993. Parvovirus B19 infection causing pure red cell aplasia in a recipient of pediatric donor kidneys.
27511498 2016. Serological prevalence of human parvovirus B19 in diseases or disordersrelated to different human body systems.
21200105 2010. Acute pericarditis and transient erythroblastopenia associated with human parvovirus B19 infection.
29785793 2018. Outcome of fetuses with congenital parvovirus B19 infection: systematic review and meta-analysis.
24862083 2014. Cause of fetal demise in first-trimester parvovirus infection: anemia, placentitis or myocarditis?
22344957 2012. Polymicrogyria in a fetus with human parvovirus B19 infection: a case with radiologic-pathologic correlation.
21433169 2011. Congenital hypoplasia of the abdominal wall muscles following fetal ascites due to parvovirus B19 infection.
11555463 2001. Fetal parvovirus B19 infection.
8932634 1996. Spontaneous resolution of non-immune hydrops fetalis secondary to transplacental parvovirus B19 infection.
28410597 2017. The role of nuclear localization signal in parvovirus life cycle.
27639978 2016. Existence of various human parvovirus B19 genotypes in Chinese plasma pools: genotype 1, genotype 3, putative intergenotypic recombinant variants and new genotypes.
20950445 2010. Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V).
28806616 2017. Parvovirus B19 integration into human CD36+ erythroid progenitor cells.
28500881 2017. A Parvovirus B19 synthetic genome: sequence features and functional competence.
24889255 2014. Parvovirus B19 VLP recognizes globoside in supported lipid bilayers.
24418564 2014. The human parvovirus B19 non-structural protein 1 N-terminal domain specifically binds to the origin of replication in the viral DNA.
24074579 2013. Human parvovirus B19 infection leads to downregulation of thyroid, estrogen, and retinoid hormone receptor expression.
21236463 2011. Transactivation of human parvovirus B19 gene expression in endothelial cells by adenoviral helper functions.
20457462 2010. Characterization of the gene expression profile of human bocavirus.
19758675 2009. Molecular characterization of human parvovirus B19 genotypes 2 and 3.
19450862 2009. Antibody-mediated opsonization of red blood cells in parvovirus B19 infection.
18838151 2008. Functional analysis and quantitative determination of the expression profile of human parvovirus B19.
18252260 2008. VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones.
16643977 2006. Survival of parvovirus B19-infected cells by cellular autophagy.
16246390 2006. Human parvovirus B19 infection of monocytic cell line U937 and antibody-dependent enhancement.
16242744 2006. Parvovirus uncoating in vitro reveals a mechanism of DNA release without capsid disassembly and striking differences in encapsidated DNA stability.
16427674 2006. Parvovirus B19 genome as a single, two-state replicative and transcriptional unit.
15661151 2005. Parvovirus B19 does not bind to membrane-associated globoside in vitro.
15327892 2004. Hypoxia enhances human B19 erythrovirus gene expression in primary erythroid cells.
15518826 2004. Human Parvovirus B19 nonstructural protein transactivates the p21/WAF1 through Sp1.
14972543 2004. Construction and sequencing of an infectious clone of the human parvovirus B19.
12620794 2003. Identification of a nonconventional motif necessary for the nuclear import of the human parvovirus B19 major capsid protein (VP2).
12359439 2002. Identification and characterization of a second novel human erythrovirus variant, A6.
12441066 2002. A new parvovirus genotype persistent in human skin.
11853402 2002. NS1 protein of parvovirus B19 interacts directly with DNA sequences of the p6 promoter and with the cellular transcription factors Sp1/Sp3.
11878897 2001. The small 11-kDa protein from B19 parvovirus binds growth factor receptor-binding protein 2 in vitro in a Src homology 3 domain/ligand-dependent manner.
10964772 2000. Identification of a novel RNA splicing pattern as a basis of restricted cell tropism of erythrovirus B19.
11118359 2000. Different patterns of restriction to B19 parvovirus replication in human blast cell lines.
7571426 1995. Analysis of the complete nucleotide sequences of goose and muscovy duck parvoviruses indicates common ancestral origin with adeno-associated virus 2.
7530397 1995. Peptides derived from the unique region of B19 parvovirus minor capsid protein elicit neutralizing antibodies in rabbits.
7544049 1995. Most of the VP1 unique region of B19 parvovirus is on the capsid surface.
28960143 2018. Antigenicity analysis of human parvovirus B19-VP1u protein in the induction of anti-phospholipid syndrome.
26786960 2016. Hepatic inflammation resulting from localized, subcutaneous expression of Parvovirus VP1u capsid protein: Importance and implication.
26632342 2016. Human parvovirus B19 VP1u Protein as inflammatory mediators induces liver injury in naive mice.
31487941 2019. Establishment of a Parvovirus B19 NS1-Expressing Recombinant Adenoviral Vector for Killing Megakaryocytic Leukemia Cells.
31083301 2019. Parvovirus B19 Uncoating Occurs in the Cytoplasm without Capsid Disassembly and It Is Facilitated by Depletion of Capsid-Associated Divalent Cations.
30845701 2019. Telbivudine Reduces Parvovirus B19-Induced Apoptosis in Circulating Angiogenic Cells.
31216741 2019. Systematic Review of PCR Proof of Parvovirus B19 Genomes in Endomyocardial Biopsies of Patients Presenting with Myocarditis or Dilated Cardiomyopathy.
31323869 2019. Advances in the Development of Antiviral Strategies against Parvovirus B19.
30366357 2018. Evidence of Human Parvovirus B19 Infection in the Post-Mortem Brain Tissue of the Elderly.
28608818 2017. Impact of Parvovirus B19 Viremia in Liver Transplanted Children on Anemia: A Retrospective Study.
27690083 2016. The VP1u Receptor Restricts Parvovirus B19 Uptake to Permissive Erythroid Cells.
26927158 2016. The Receptor-Binding Domain in the VP1u Region of Parvovirus B19.
8553651 1995. Multiple organ dysfunction caused by parvovirus B19.
24772258 2014. Molecular phenotypes of human parvovirus B19 in patients with myocarditis.
26566485 2015. Acute encephalitis and encephalopathy associated with human parvovirus B19 infection in children.
19705505 2009. Parvovirus B19 induced hepatic failure in an adult requiring liver transplantation.
17461508 2007. Pure red cell aplasia due to parvovirus B19 infection after liver transplantation: a case report and review of the literature.
25616288 2015. [Clinical features of childhood hemophagocytic syndrome and its association with human parvovirus B19 infection].
20113609 2009. [Association of human parvovirus B19 infection and childhood idiopathic thrombocytopenic purpura: a meta analysis of Chinese literatures].
9424130 1997. Crioglobulinemia e infeccion por parvovirus B19.
32101607 2020. Parvovirus B19-induced angiogenesis in fulminant myocarditis.
24289269 2014. Parvovirus B19 at the culprit coronary stenosis predicts outcome after stenting.
11152317 2000. Quantitative evidence for persistence of human parvovirus B19 DNA in an immunocompetent individual.
10614957 1999. Occurrence and clinical role of active parvovirus B19 infection in transplant recipients.
8641299 1996. Parvovirus B19 infection.
9031882 1996. Detection of parvovirus B19 in skin biopsy, serum, and bone marrow of a patient with fever, rash, and polyarthritis followed by pneumonia, pericardial effusion, and hepatitis.
10210793 1999. Henoch-Schonlein syndrome associated with human Parvovirus B19 primary infection.
18691322 2008. Parvovirus B19 infection as trigger of graft vs. host disease.
7859882 1995. Pure red cell aplasia caused by parvovirus B19 infection in a renal transplant recipient.
31476088 2019. Immunosuppression in inflammatory cardiomyopathy and parvovirus B19 persistence.
18549931 2008. Parvovirus B19 infection and systemic lupus erythematosus: Activation of an aberrant pathway?
17693235 2007. Parvovirus B19 infection as a cause of cytopenia with a lupus-like presentation in the elderly: A case report.
17098597 2006. Parvovirus B19 reactivation presenting as neutropenia after rituximab treatment.
9481569 1998. Evaluation of Parvo B19, CMV and HPV viruses in human aborted material using the polymerase chain reaction technique.
20155703 2010. Acute ophthalmoparesis associated with human parvovirus B19 infection.
30467085 2018. Fetal stroke and cerebrovascular disease: Advances in understanding from lenticulostriate and venous imaging, alloimmune thrombocytopaenia and monochorionic twins.
18629535 2009. Prolonged anemia by superinfection of parvovirus B19 in a boy with enterohemorrhagic Escherichia coli O157-associated hemolytic uremic syndrome.
11277389 2001. Neuralgic amyotrophy associated with parvovirus B19 infection in a child.
10653351 2000. Myocarditis associated with parvovirus B19 infection in two siblings with merosin-deficient congenital muscular dystrophy.
7588963 1995. Kawasaki disease associated with parvovirus B19 infection.
1468455 1992. Different syndromes associated with B19 parvovirus viraemia in paediatric patients: report of four cases.
10394046 1999. Human parvovirus B19 infection in multiple sclerosis.
22428480 2012. Human parvovirus B 19 and Epstein-Barr virus co-infection in a child with hereditary spherocytosis.
30028234 2018. The clinical use of parvovirus B19 assays: recent advances.
19060481 2008. Disturbance of cerebral neuronal migration following congenital parvovirus B19 infection.
11125248 2001. Recombinant parvovirus B19 empty capsids inhibit fetal hematopoietic colony formation in vitro.
25313841 2015. Clinical features of 10 fetuses with prenatally diagnosed parvovirus b19 infection and fetal hydrops.
16216706 2005. Sudden cardiac death in a 5-year-old girl associated with parvovirus B19 infection.
32668397 2020. The landscape of persistent human DNA viruses in femoral bone.
32495258 2020. Sudden death of a young adult with coronary artery vasculitis, coronary aneurysms, parvovirus B19 infection and Kawasaki disease.
24781135 2014. The presence of enterovirus, adenovirus, and parvovirus B19 in myocardial tissue samples from autopsies: an evaluation of their frequencies in deceased individuals with myocarditis and in non-inflamed control hearts.
7498847 1995. Parvovirus B19--ein weitverbreitetes, wenig bekanntes Virus. Von Ringelroteln uber Arthropathie bis zur chronischen Anamie.
1778531 1991. Humanes Parvovirus B19--wirklich nur "Ringelroteln"? Aussergewohnliche Krankheitsverlaufe bei Kindern und Jugendlichen.
31605404 2020. Prevention of parvovirus B19-induced repetitive acute kidney failure by subcutaneous immunoglobulins.
32286103 2020. Persistence of Parvovirus B19 in liver from transplanted patients with acute liver failure.
25034095 2016. Gianotti-Crosti syndrome associated with Ebstein-Barr virus and Parvovirus B-19 coinfection in a male adult: case report and review of the literature.
12746805 2003. Glomerulonefriti post-infettive.
15906067 2005. Prevalence of parvovirus B19-specific antibodies and of viral DNA in patients with endogenous uveitis.
21051853 2010. Pregnancy loss ascribable to parvovirus B19/erythrovirus is associated with a high prevalence of trisomy.

16940737 2007. Prolonged parvovirus b19 viremia in spite of neutralizing antibodies after erythema infectiosum in pregnancy.
11114822 2000. Erythroblastopenia and Parvovirus B19 infection in a healthy child.
24365423 2014. Measles, mumps, rubella, and human parvovirus B19 infections and neurologic disease.
8707582 1996. Dermatologische Symptomatik bei Parvovirus B19-Infektionen.
8567265 1995. Das humane Parvovirus B19 und seine klinische Bedeutung.
2537803 1989. Die Parvovirus B19-Infektion: nicht nur das Exanthem der "Ringelroteln".
18230640 2008. Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis.
9352328 1997. Parvovirus [correction of Parovirus] B19-induced red cell aplasia in solid-organ transplant recipients. Two case reports and review of the literature.
17178665 2006. Parvovirus B19 infection in children with a variety of hematological disorders.
16019474 2005. Acquired red cell aplasia in association with the use of recombinant erythropoietin in chronic renal failure.
21969057 2012. Acute fulminant hepatitis with bone marrow failure in an adult due to parvovirus B19 infection.
7489971 1995. Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia.
22872003 2012. miRNA as activity markers in Parvo B19 associated heart disease.
7713756 1995. Combined immunocytochemistry and non-isotopic in situ hybridization for the ultrastructural investigation of human parvovirus B19 infection.
8360079 1993. Intracellular localization of parvovirus B19 nucleic acid at the ultrastructural level by in situ hybridization with digoxigenin-labelled probes.
8557804 1995. Viral arthritis: the lessons of parvovirus B19.
16972759 2006. Role of integrin cross-regulation in parvovirus B19 targeting.
16386644 2005. IgE, CD8(+)CD60+ T cells and IFN-alpha in human immunity to parvovirus B19 in selective IgA deficiency.
26475096 2015. PRDM1 expression via human parvovirus B19 infection plays a role in the pathogenesis of Hashimoto thyroiditis.
23683879 2013. Post-infectious acute glomerulonephritis and transient coagulation factor XIII deficiency associated with acute parvovirus B19 infection in a young woman--reply.
23683878 2013. Post-infectious acute glomerulonephritis and transient coagulation factor XIII deficiency associated with acute parvovirus B19 infection in a young woman.
22939574 2013. Kikuchi-Fujimoto lymphadenitis: role of parvovirus B-19, Epstein-Barr virus, human herpesvirus 6, and human herpesvirus 8.
22819999 2012. Proliferative glomerulonephritis with monoclonal immunoglobulin G3kappa deposits in association with parvovirus B19 infection.
12874772 2003. Acute parvovirus B19 infection associated with myocarditis in an immunocompetent adult.
12605372 2003. Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease.
11274646 2001. Fatal parvovirus myocarditis in a 5-year-old girl.
11112222 2000. Fatal intrauterine adenoviral endomyocarditis with aortic and pulmonary valve stenosis: diagnosis by polymerase chain reaction.
10685629 2000. Unusual bone marrow manifestations of parvovirus B19 infection in immunocompromised patients.
10821497 2000. The cutaneous manifestations of human parvovirus B19 infection.
10029458 1999. Parvovirus B19 in fetal hydrops.
9781644 1998. Polymerase chain reaction amplification of archival material for Epstein-Barr virus, cytomegalovirus, human herpesvirus 6, and parvovirus B19 in children with bone marrow hemophagocytosis.
9224741 1997. Human parvovirus B19 in bone marrows from adults with acquired immunodeficiency syndrome: a comparative study using in situ hybridization and immunohistochemistry.
20818959 2010. Pregnancy-associated parvovirus B19 infection causing postinfectious glomerulonephritis.
19064815 2009. Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study.
12880679 2003. Tumor necrosis factor (TNF)alpha and its soluble receptor (sTNFR) p75 during acute human parvovirus B19 infection in children.
16041107 2005. Acute liver failure and severe hemophagocytosis secondary to parvovirus B19 infection.
31741634 2019. Parvovirus B19 Infection in Human Bone Marrow Mesenchymal Stem Cells Affects Gene Expression of IL-6 and TNF-alpha and also Affects Hematopoietic Stem Cells Differentiation.
12452123 2000. Erythrovirus B19 infection in humans.
9529776 1998. Raised IgM antibodies to parvovirus B19 in juvenile rheumatoid arthritis.
32036592 2020. Acute Necrotizing Encephalopathy of Childhood Associated with Human Parvovirus B19 Infection.
22544695 2013. Immune thrombocytopenic purpura due to mixed viral infections.
19347671 2009. Red baby syndrome a new disease due to parvovirus B-19 observed in Kerala.
17978457 2007. Laryngitis and neutropenia from parvovirus-B19.
30940465 2019. Infections with DNA Viruses, Adenovirus, Polyomaviruses, and Parvovirus B19 in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies.
20466274 2010. Viral impact on long-term kidney graft function.
16297742 2005. Viral arthritis.
1315813 1992. Impact of child day care on infectious diseases in adults.
14556063 2003. Influenza B pneumonia with Staphylococcus aureus superinfection associated with parvovirus B19 and concomitant agranulocytosis.
10219641 1999. Human parvovirus B19-associated disease in bone marrow transplantation.
1917040 1991. Acute obstructive respiratory diseases in infants and children associated with parvovirus B19 infection.
2544532 1989. Human parvovirus B19 infection associated with vascular purpura and vasculitis.
2822582 1987. Human parvovirus B19 infection and juvenile chronic polyarthritis.
18280593 2009. Giant cell myocarditis triggered by a parvovirus B19 infection.
17098306 2007. Tako-Tsubo cardiomyopathy (apical ballooning) with parvovirus B19 genome in endomyocardial biopsy.
17010458 2006. Cardiac troponin I release in non-ischemic reversible myocardial injury from parvovirus B19 myocarditis.
26147127 2015. Remitting seronegative symmetrical synovitis with pitting edema associated with parvovirus B19 infection: two new cases and review of the comorbidities.
23113722 2013. Sweet's syndrome and acute parvovirus B19 infection.
15540900 2004. Successful treatment with cyclosporine and high-dose gamma immunoglobulin for persistent parvovirus B19 infection in a patient with refractory autoimmune hemolytic anemia.
15218970 2004. Successful bone marrow transplantation for severe aplastic anemia in a patient with persistent human parvovirus B19 infection.
15239401 2004. Fulminant hemophagocytic syndrome with a high interferon gamma level diagnosed as macrophage activation syndrome.
11594514 2001. Expression of p53 and Ki-67 antigen in bone marrow giant proerythroblasts associated with human parvovirus B19 infection.
9631589 1998. Increase of platelet-associated IgG (PA-IgG) and hemophagocytosis of neutrophils and platelets in parvovirus B19 infection.
18384396 2009. Promoter methylation of P15(INK4B) gene is possibly associated with parvovirus B19 infection in adult acute leukemias.
28573901 2017. A Case Report of Parvovirus B19 Infection in a Renal Allograft.
10036637 1998. Human parvovirus B19 in rheumatoid arthritis.
16503960 2006. Parvovirus encephalitis and pneumonia in an immunocompetent adult.
18536522 2008. Human bocavirus--a novel parvovirus to infect humans.
18431072 2008. Variants of parvovirus B19: bioinformatical evaluation of nested PCR assays.
25582535 2015. Viral infections in acute graft-versus-host disease: a review of diagnostic and therapeutic approaches.
24726401 2014. Different patterns of skin manifestations associated with parvovirus B19 primary infection in adults.
25454032 2014. Exanthems associated with parvovirus B19 infection in adults.
22980284 2012. Wells syndrome in a child triggered by parvovirus B19 infection?
19293017 2009. Bullous papular-purpuric gloves and socks syndrome in a 42-year-old female: molecular detection of parvovirus B19 DNA in lesional skin.
17224386 2007. Wells' syndrome after primoinfection by parvovirus B19 in a child.
16635678 2006. Presence of perineuritis in a case of papular purpuric gloves and socks syndrome associated with mononeuritis multiplex attributable to B19 parvovirus.
12399769 2002. Gloves and socks syndrome: early and late histopathologic features.
1401292 1992. Koplik spots and a purpuric eruption associated with parvovirus B19 infection.
26320984 2015. Non HCV-related infectious cryoglobulinemia vasculitis: Results from the French nationwide CryoVas survey and systematic review of the literature.
32127272 2020. Viral Myocarditis-Incidence, Diagnosis and Management.
8151074 1994. Human parvovirus B19 antibodies in infantile autism.
1654342 1991. Tonic pupils and human parvovirus (B19) infection.
26644521 2016. The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease.
17039168 2001. Pericardial effusion and cardiomyopathy following arthritis with parvovirus B19 infection: response to intravenous immunoglobulin.
17039152 2001. Can parvovirus B19 infection trigger adult Still's disease? Report of a case controlled with infliximab.
19078035 1996. Parvovirus b19 infection associated with acute hepatitis, arthralgias, and rash.
30897374 2019. The risk of maternal parvovirus B19 infection during pregnancy on fetal loss and fetal hydrops: A systematic review and meta-analysis.
27664778 2016. Detection of parvovirus B19 DNA in blood: Viruses or DNA remnants?
27130981 2016. Focal epilepsy as a long term sequela of Parvovirus B19 encephalitis.
26433772 2015. Human parvovirus B19 and autoimmune diseases. Review of the literature and pathophysiological hypotheses.
23916377 2013. Low-level DNAemia of parvovirus B19 (genotypes 1-3) in adult transplant recipients is not associated with anaemia.
23522566 2013. Increased IL-6 detection in adult and pediatric lymphoid tissue harboring parvovirus B19.
23182456 2013. Neurologic consequence of a parvovirus B19 infection.
22789138 2012. PVB19-associated purpuric-petechial eruption with Henoch Schonlein-like distribution.
19058999 2009. Placental endothelial cells can be productively infected by Parvovirus B19.
18313977 2008. Fulminant myocarditis associated with parvovirus B19 infection in a child.
17174596 2007. A possible parvovirus B19 encephalitis in an immunocompetent adult patient.
17337241 2007. Parvovirus B19-brain interactions: infection, autoimmunity, or both?
16569510 2006. Genetic variants of parvovirus B19 identified in the United Kingdom: implications for diagnostic testing.
15797368 2005. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
15288611 2004. Analysing myocardial tissue from explanted hearts of heart transplant recipients and multi-organ donors for the presence of parvovirus B19 DNA.
15288608 2004. Long-term parvovirus B19 viraemia associated with pure red cell aplasia after allogeneic bone marrow transplantation.
12927746 2003. B19 virus genome diversity: epidemiological and clinical correlations.
12637086 2003. B19 virus infection in renal transplant recipients.
12367657 2002. Presence of parvovirus B19 DNA in chronic urticaric and healthy human skin.
12367647 2002. Chronic human parvovirus B19 infection in rheumatic disease of childhood and adolescence.
11166667 2001. Chronic autoimmune thrombopenia/neutropenia in a boy with persistent parvovirus B19 infection.
10548133 1999. Acute parvovirus B19 infection in connection with a flare of systemic lupus erythematodes in a female patient.
10405890 1999. Parvovirus B19 infection in thoracic organ transplant recipients.
29185410 2017. Parvovirus B19: A Rare Cause of Post-renal Transplant Anemia.
19586495 2009. Fulminant and accelerated presentation of dermatomyositis in two previously healthy young adult males: a potential role for endotheliotropic viral infection.
18537856 2008. Parvovirus B19-associated catastrophic endothelialitis with a Degos-like presentation.
15268707 2004. Pityriasis lichenoides: a cytotoxic T-cell-mediated skin disorder. Evidence of human parvovirus B19 DNA in nine cases.
14675284 2004. Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma.
12453298 2002. Parvovirus B19 associated adult Henoch Schonlein purpura.

11168747 2001. The cutaneous pathology of lupus erythematosus: a review.
11100810 2000. A causal role for parvovirus B19 infection in adult dermatomyositis and other autoimmune syndromes.
9870672 1998. A distinctive cutaneous reaction pattern indicative of infection by reactive arthropathy-associated microbial pathogens: the superantigen ID reaction.
7560352 1995. Human parvovirus B19 infection: immunohistochemical and electron microscopic studies of skin lesions.
27238731 2017. Hypocomplementemia is a diagnostic clue for parvovirus B19 infection in adults.
18808380 2009. Viral exanthems in childhood--infectious (direct) exanthems. Part 2: Other viral exanthems.
16684303 2006. Parvovirus B19 primary infection with vasculitis: DNA identification in cutaneous lesions and sera.
15857474 2005. Cutaneous necrosis during paroxysmal nocturnal haemoglobinuria: role of parvovirus B19?
24931854 2014. Sudden cardiac death from parvovirus B19 myocarditis in a young man with Brugada syndrome.
12570225 2003. Fatal parvovirus B19 myocarditis in an 8-year-old boy.
30924765 2019. Secondary structure of DNA released from purified capsids of human parvovirus B19 under moderate denaturing conditions.
20007355 2010. Antibody to parvovirus B19 nonstructural protein is associated with chronic arthralgia in patients with chronic fatigue syndrome/myalgic encephalomyelitis.
18753240 2008. A third genotype of the human parvovirus PARV4 in sub-Saharan Africa.
18089740 2008. Simultaneous persistence of multiple genome variants of human parvovirus B19.
17251559 2007. Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes.
16963753 2006. Phylogenetic analysis of human parvovirus B19, indicating two subgroups of genotype 1 in Vietnamese patients.
17098972 2006. Short regions of sequence identity between the genomes of human and rodent parvoviruses and their respective hosts occur within host genes for the cytoskeleton, cell adhesion and Wnt signalling.
11807219 2002. A transgenic mouse model for non-immune hydrops fetalis induced by the NS1 gene of human parvovirus B19.
11369893 2001. Cellular transcription factors that interact with p6 promoter elements of parvovirus B19.
11125172 2001. The VP1-unique region of parvovirus B19: amino acid variability and antigenic stability.
11714978 2001. Circulating tumour necrosis factor-alpha and interferon-gamma are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue.
10725428 2000. Integrity and full coding sequence of B19 virus DNA persisting in human synovial tissue.
10092001 1999. Infection of apheresis cells by parvovirus B19.
9519836 1998. Persistence of parvovirus B19 DNA in testis of patients with testicular germ cell tumours.
9010306 1997. Establishment of a cell line expressing human parvovirus B19 non-structural protein from an inducible promoter.
8922470 1996. Genetic diversity of human parvovirus B19: sequence analysis of the VP1/VP2 gene from multiple isolates.
8683195 1996. Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: human megakaryocytic leukaemia cells are non-permissive for AAV infection.
8760426 1996. Sequence variability among different parvovirus B19 isolates.
7595371 1995. A new genome type of human parvovirus B19 present in sera of patients with encephalopathy.
7730807 1995. Morphology and antigenicity of recombinant B19 parvovirus capsids expressed in transfected COS-7 cells.
7534811 1995. Antibodies to parvovirus B19 NS-1 protein in infected individuals.
8207413 1994. Differential transcription, without replication, of non-structural and structural genes of human parvovirus B19 in the UT7/EPO cell as demonstrated by in situ hybridization.
8376975 1993. Trans-activation of the long terminal repeat of human immunodeficiency virus type 1 by the parvovirus B19 NS1 gene product.
1645153 1992. Haemagglutination by parvovirus B19.
2824662 1987. Structure and mapping of the DNA of human parvovirus B19.
3819702 1987. Structural and functional homology of parvovirus and papovavirus polypeptides.
18342755 2008. Myocardial pro-inflammatory cytokine expression and cellular rejection in pediatric heart transplant recipients.
18582815 2008. Unexplained chronic anemia and leukopenia in lung transplant recipients secondary to parvovirus B19 infection.
16210141 2005. High prevalence of cardiotropic viruses in myocardial tissue from explanted hearts of heart transplant recipients and heart donors: a 3-year retrospective study from a German patients' pool.
11448804 2001. Association of parvovirus B19 with plasma cell-rich myocardial infiltrates after heart transplantation.
8878766 1996. Transient aplastic anemia caused by parvovirus B19 infection in a heart transplant recipient.
8031818 1994. Severe pneumonia after heart transplantation as a result of human parvovirus B19.
10645765 1999. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted expression from parvovirus B19p6 promoter in primary human hematopoietic progenitor cells.
12586308 2003. Parvovirus B19 and "cryptogenic" chronic hepatitis.
12076880 2002. Acute viral hepatitis A and parvovirus B19 infections complicated by pure red cell aplasia and autoimmune hemolytic anemia.
9382984 1997. Human parvovirus B19 infection associated with idiopathic thrombocytopenic purpura in a child following liver transplantation.
27050929 2016. ANA testing in the presence of acute and chronic infections.
17582502 2007. Intrathyroidal persistence of human parvovirus B19 DNA in a patient with Hashimoto's thyroiditis.
16313965 2006. Immune reconstitution syndrome associated with parvovirus B19-induced pure red cell aplasia during highly active antiretroviral therapy.
10468132 1999. Parvovirus B19 infection induces apoptosis of erythroid cells in vitro and in vivo.
9661947 1998. A case of Guillain-Barre syndrome associated with human parvovirus B19 infection.
8852550 1996. Autoantibodies following parvovirus B19 infection.
20799048 2011. Immune reconstitution to parvovirus B19 and resolution of anemia in a patient treated with highly active antiretroviral therapy.
18936893 2008. Intravenous immunoglobulin therapy for severe arthritis associated with human parvovirus B19 infection.
11810534 2000. Hepatic dysfunction due to parvovirus B19 infection.
28961998 2018. Human Parvovirus B19 (B19V) Up-regulates CXCR4 Surface Expression of Circulating Angiogenic Cells: Implications for Cardiac Ischemia in B19V Cardiomyopathy.
27789725 2017. The Chemokine CXCL-10 Is a Marker of Infection Stage in Individuals With DNAemia Due to Parvovirus B19.
25805750 2015. Impaired Endothelial Regeneration Through Human Parvovirus B19-Infected Circulating Angiogenic Cells in Patients With Cardiomyopathy.
20158391 2010. Interferon beta modulates endothelial damage in patients with cardiac persistence of human parvovirus b19 infection.
19099488 2009. Investigation of intrarenal viral infections in kidney transplant recipients unveils an association between parvovirus B19 and chronic allograft injury.
18491974 2008. Seroepidemiology of human bocavirus defined using recombinant virus-like particles.
16779720 2006. The immune response to parvovirus B19 exposure in previously seronegative and seropositive individuals.
16425138 2006. Activation of synoviocytes by the secreted phospholipase A2 motif in the VP1-unique region of parvovirus B19 minor capsid protein.
15962222 2005. Single-nucleotide polymorphisms associated with symptomatic infection and differential human gene expression in healthy seropositive persons each implicate the cytoskeleton, integrin signaling, and oncosuppression in the pathogenesis of human parvovirus B19 infection.
15122524 2004. B cell memory is directed toward conformational epitopes of parvovirus B19 capsid proteins and the unique region of VP1.
14976602 2004. Persistent parvovirus B19 infection without the development of chronic anemia in HIV-infected and -uninfected children: the Women and Infants Transmission Study.
12404168 2002. Human parvovirus Bb19 detection in asymptomatic blood donors: association with increased neopterin concentrations.
12195370 2002. Association of symptomatic acute human parvovirus B19 infection with human leukocyte antigen class I and II alleles.
9952368 1999. Quantitative analysis of neutralizing immune responses to human parvovirus B19 using a novel reverse transcriptase-polymerase chain reaction-based assay.
10395869 1999. Prevalence of antibodies to human parvovirus B19 nonstructural protein in persons with various clinical outcomes following B19 infection.
7594678 1995. Parvovirus B19 clearance from peripheral blood after acute infection.
7594677 1995. Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: implications for pathogenesis.
7594654 1995. Multiple glycosphingolipids determine the tissue tropism of parvovirus B19.
7876624 1995. Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity.
8440942 1993. Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence.
2172397 1990. Immunoglobulins in the prophylaxis of parvovirus B19 infection.
2153742 1990. Numbness and tingling of fingers associated with parvovirus B19 infection.
2156940 1990. Human parvoviruses.
2760505 1989. B19 parvovirus replicates in erythroid leukemic cells in vitro.
30978354 2019. Effects of Parvovirus B19 In Vitro Infection on Monocytes from Patients with Systemic Sclerosis: Enhanced Inflammatory Pathways by Caspase-1 Activation and Cytokine Production.
28060552 2017. The Root Extract of Gentiana macrophylla Pall. Alleviates B19-NS1-Exacerbated Liver Injuries in NZB/W F1 Mice.
22977072 2013. The lack of routine surveillance of Parvovirus B19 infection in pregnancy prevents an accurate understanding of this regular cause of fetal loss and the risks posed by occupational exposure.
15150324 2004. Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19.
11444773 2001. Lymphocyte recognition of human parvovirus B19 non-structural (NS1) protein: associations with occurrence of acute and chronic arthropathy?
32603480 2020. Intratonsillar detection of 27 distinct viruses: A cross-sectional study.
30011073 2018. Identification of potential pathogenic viruses in patients with acute myocarditis using next-generation sequencing.
26705119 2016. Epidemiologic study of human parvovirus B19 infection in East China.
26241406 2016. Serum level of C-reactive protein is not a parameter to determine the difference between viral and atypical bacterial infections.
26756922 2016. Identification of recombination in the NS1 and VPs genes of parvovirus B19.
25965702 2015. Atypical exanthems associated with Parvovirus B19 (B19V) infection in children and adults.
24760746 2015. Erythrovirus B19 and autoimmune thyroid diseases. Review of the literature and pathophysiological hypotheses.
25946433 2015. Large-scale multiplex polymerase chain reaction assay for diagnosis of viral reactivations after allogeneic hematopoietic stem cell transplantation.
24037981 2014. Serology indicates cytomegalovirus infection is associated with varicella-zoster virus reactivation.
23983182 2013. Selective reactivation of human herpesvirus 6 in patients with autoimmune connective tissue diseases.
23588740 2013. Frequent occurrence of parvovirus B19 DNAemia in the first year after kidney transplantation.
22711355 2012. Occurrence of human bocaviruses and parvovirus 4 in solid tissues.
21837800 2011. Genotype-specific effects on left ventricular function in parvovirus B19-positive patients with dilated cardiomyopathy.
21108352 2011. Identification and characterization of acute infection with parvovirus B19 genotype 2 in immunocompromised patients in Poland.
20572082 2010. Low level myocardial parvovirus B19 persistence is a frequent finding in patients with heart disease but unrelated to ongoing myocardial injury.
19774687 2009. Prevalence of persistent and latent viruses in untreated patients infected with HIV-1 from Ghana, West Africa.
19856479 2009. Intrahepatic long-term persistence of parvovirus B19 and its role in chronic viral hepatitis.
18712818 2008. Detection of cytomegalovirus, parvovirus B19 and herpes simplex viruses in cases of intrauterine fetal death: association with pathological findings.
18814251 2008. Tissue persistence of parvovirus B19 genotypes in asymptomatic persons.
18461615 2008. Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy.
17607784 2007. Dose-by-dose virological and hematological responses to intravenous immunoglobulin in an immunocompromised patient with persistent parvovirus B19 infection.
17935173 2007. Parvovirus B19 infection in Chile: markers of infection and immunity in patients with clinical symptoms.
16998895 2006. Genetic drift of parvovirus B19 is found in AIDS patients with persistent B19 infection.
16998885 2006. Concurrent detection of human herpesvirus type 6 and measles-specific IgMs during acute exanthematic human parvovirus B19 infection.
16299723 2006. Establishment of functional B cell memory against parvovirus B19 capsid proteins may be associated with resolution of persistent infection.
16299714 2006. Aberrant cellular immune responses in humans infected persistently with parvovirus B19.
15543592 2005. Association between enterovirus endomyocardial infection and late severe cardiac events in some adult patients receiving heart transplants.
15543575 2005. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.
15258981 2004. Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis.
12767014 2003. Ex vivo cytokine responses against parvovirus B19 antigens in previously infected pregnant women.
11992589 2002. Parvovirus B19 nonstructural (NS1) protein as a transactivator of interleukin-6 synthesis: common pathway in inflammatory sequelae of human parvovirus infections?

11782935 2002. Baculovirus expression of erythrovirus V9 capsids and screening by ELISA: serologic cross-reactivity with erythrovirus B19.
11536251 2001. Persistence of parvovirus B19 DNA in synovium of patients with haemophilic arthritis.
11536250 2001. Evidence for persistence of parvovirus B19 DNA in livers of adults.
10935990 2000. Four putative subtypes of human parvovirus B19 based on amino acid polymorphism in the C-terminal region of non-structural protein.
9783686 1998. Analysis of genetic diversity in the VP1 unique region gene of human parvovirus B19 using the mismatch detection method and direct nucleotide sequencing.
9783685 1998. Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin.
9365887 1997. Evidence for persistence of human parvovirus B19 DNA in bone marrow.
8825713 1996. Follow-up study of clinical and immunological findings in patients presenting with acute parvovirus B19 infection.
7636495 1995. Persistent B19 parvovirus infections in haemophilic HIV-1 infected patients.
8083666 1994. Case report: detection of parvovirus B19 in a skin biopsy of a patient with erythema infectiosum.
1583466 1992. Replication and cytopathology of human parvovirus B19 in human umbilical cord blood erythroid progenitor cells.
1722505 1991. Detection of B19 parvovirus in human fetal tissues by electron microscopy.
1646854 1991. Detection of B19 parvovirus in human fetal tissues by in situ hybridisation.
2164559 1990. Electron microscopic detection of human parvovirus (B19) in a patient with HIV infection.
2828533 1988. Intrauterine infection with human parvovirus B19: a light and electron microscopy study.
3694180 1987. Detection of parvovirus B19 DNA, antigen, and particles in the human fetus.
3973569 1985. Detection of human parvovirus using a molecularly cloned probe.
25487255 2015. Down-regulation of inwardly rectifying Kir2.1 K+ channels by human parvovirus B19 capsid protein VP1.
12455712 2002. Virus-related glomerular diseases: histological and clinical aspects.
9238623 1997. Aplastic anemia due to B19 parvovirus infection in cadaveric renal transplant recipients: an underestimated infectious disease in the immunocompromised host.
21287183 2011. Mononeuropathy multiplex associated with acute parvovirus B19 infection: characteristics, treatment and outcome.
21327846 2011. Parvovirus B19 infection antedating Guillain-Barre' syndrome variant with prominent facial diplegia.
20339862 2010. Parainfectious myelitis associated with parvovirus B19 infection.
32779109 2020. Acute viral encephalitis associated with human parvovirus B19 infection: unexpectedly diagnosed by metagenomic next-generation sequencing.
28831691 2017. Parvovirus B19 infection associated with hemolytic anemia and cranial polyneuropathy.
28895082 2017. Clinical manifestations and treatment outcomes of parvovirus B19 encephalitis in immunocompetent adults.
16877300 2006. Detection of adeno-associated virus 2 and parvovirus B19 in the human dorsolateral prefrontal cortex.
14982731 2004. Middle cerebral artery thrombosis in course of parvovirus B19 infection in a young adult: A new risk factor for stroke?
11031695 2000. Chronic parvovirus B-19 meningoencephalitis with additional detection of Epstein-Barr virus DNA in the cerebrospinal fluid of an immunocompetent patient.
30634881 2019. Trisomy 21 and hydrops fetalis: parvovirus B19 or transient abnormal myelopoiesis?
12173996 2002. Parvovirus B19 in the acute arthropathies and juvenile rheumatoid arthritis.
8445486 1993. Ultrastructural features of fetal erythroid precursors infected with parvovirus B19 in vitro: evidence of cell death by apoptosis.
1313862 1992. Immunohistological detection of human parvovirus B19 in formalin-fixed, paraffin-embedded tissues.
23919909 2013. Anti-N-methyl-D-aspartate receptor encephalitis and parvovirus B19: A possible link?
22316626 2012. Parvovirus B19 and necrotizing enterocolitis in neonates.
11562626 2001. Cerebrovascular complications and parvovirus infection in homozygous sickle cell disease.
7699536 1995. Life-threatening infection in two children with hemoglobin S-beta-thalassemia.
8429430 1993. Human parvovirus B19-associated arthritis in children.
8463907 1993. Acute splenic sequestration together with aplastic crisis caused by human parvovirus B19 in patients with sickle cell disease.
1689774 1990. Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients.
2550601 1989. Hepatic disease associated with intrauterine parvovirus B19 infection in a newborn premature infant.
29432306 2018. Parvovirus B19-associated Hemophagocytic Lymphohistiocytosis in a Patient With Glucose-6-phosphate Dehydrogenase Deficiency.
24390447 2015. Myeloid leukemia of Down syndrome: relation to parvovirus B19 infection and wilms tumor gene (WT1) expression.
24072236 2014. Long-term parvovirus B19 infections with genetic drift after cord blood transplantation complicated by persistent CD4+ lymphocytopenia.
21617562 2011. Parvovirus B19-associated hemophagocytic lymphohistiocytosis in a child with precursor B-cell acute lymphoblastic leukemia under maintenance chemotherapy.
15956889 2005. Classic transient erythroblastopenia of childhood with human parvovirus B19 genome detection in the blood and bone marrow.
11972099 2002. Transient erythroblastopenia of childhood: prospective study of 10 patients with special reference to viral infections.
8556383 1996. Transient erythroblastopenia in a child with Kawasaki syndrome: probable parvovirus B19 infection?
16318623 2005. Intrauterine therapy for parvovirus B19 infected symptomatic fetus using B19 IgG-rich high titer gammaglobulin.
11249292 2000. Dermatologic manifestations of infectious diseases in pregnancy.
17150255 2007. Is parvovirus B19 the cause for autoimmunity against the angiotensin II type receptor?
21632693 2011. Association of parvovirus B19 infection with systemic lupus erythematosus: role of Th1 predominance.
21041264 2010. Parvovirus B19-associated systemic lupus erythematosus: clinical mimicry or autoimmune induction?
18484700 2008. Incidence and clinical significance of parvovirus B19 infection in patients with rheumatoid arthritis.
17477467 2007. Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis.
16511938 2006. Parvovirus B19 infection in patients with rheumatoid arthritis in Taiwan.
15693107 2005. Parvovirus B19: another agent associated with remitting seronegative symmetrical synovitis with pitting edema.
12610801 2003. Infections preceding early arthritis in southern Sweden: a prospective population-based study.
11911112 2002. Chronic fatigue syndrome and arthralgia following parvovirus B19 infection.
11669178 2001. Antibodies to beta 2-glycoprotein I and cardiolipin with symptoms suggestive of systemic lupus erythematosus in parvovirus B19 infection.
11036842 2000. Parvovirus arthropathy outbreak in southwestern United States.
10555914 1999. Remission of juvenile rheumatoid arthritis after infection with parvovirus B19.
9150091 1997. Postpartum lupus erythematosus associated with parvovirus B19 infection.
8823689 1996. Human parvovirus infection: rheumatic manifestations, angioedema, C1 esterase inhibitor deficiency, ANA positivity, and possible onset of systemic lupus erythematosus.
7791179 1995. Parvovirus B19 associated monoarthritis in a 5-year-old boy.
7932438 1994. Chronic modulation of the autoimmune response following parvovirus B19 infection.
8308782 1993. Established fibromyalgia syndrome and parvovirus B19 infection.
8371233 1993. Lupus-like presentation of human parvovirus B19 infection.
1556683 1992. Lupus-like presentation of human parvovirus B19 infection.
2159072 1990. Autoantibodies in sera from patients with parvovirus B19 infection.
2550630 1989. Anti-DNA and antilymphocyte antibodies during acute infection with human parvovirus B19.
22971793 1993. Brachial neuritis after human parvovirus B19 infection.
28941869 2017. Transcription-associated mutational pressure in the Parvovirus B19 genome: Reactivated genomes contribute to the variability of viral populations.
1648152 1991. The evolution of defective and autonomous parvoviruses.
19203989 2009. Parvovirus B19-induced thrombocytopenia and anemia in a child with fatal fulminant hepatic failure coinfected with hepatitis A and E viruses.
16316402 2005. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection.
16316401 2005. CD4(+) T-cell responses against the VP1-unique region in individuals with recent and persistent parvovirus B19 infection.
16316400 2005. Human parvovirus B19 infection and antiphospholipid-syndrome: the two sides of one medal?
16316398 2005. Pathophysiology and aetiological diagnosis of inflammatory myocardial diseases with a special focus on parvovirus B19.
16316397 2005. Human parvovirus B19: a new emerging pathogen of inflammatory cardiomyopathy.
16316396 2005. Pathogenesis of parvovirus B19 infection: host gene variability, and possible means and effects of virus persistence.
16316395 2005. Pathogenesis of aleutian mink disease parvovirus and similarities to b19 infection.
16316388 2005. Proceedings of International Parvovirus Meeting 2005. July 15-16, 2005. Leipzig, Germany.
23764418 2013. Impaired genome encapsidation restricts the in vitro propagation of human parvovirus B19.
15381351 2004. Hypoxia enables B19 erythrovirus to yield abundant infectious progeny in a pluripotent erythroid cell line.
12445941 2003. Evaluation of anti-parvovirus B19 activity in sera by assay using quantitative polymerase chain reaction.
16264157 2005. Parvovirus B19 and onset of juvenile dermatomyositis.
2157074 1990. Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum.
32335625 2020. Adult-onset Still's Disease: A Case Report.
23478734 2012. Pure red cell aplasia caused by Parvo B19 virus in a kidney transplant recipient.
28062379 2018. Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection.
12639611 2003. Parvovirus B19 and autoimmune diseases.
10680086 1999. Role of human parvovirus B19 in the pathogenesis of rheumatoid arthritis.
24483023 2013. [An adult case of acute pericarditis and glomerulonephritis associated with human parvovirus B19 infection].
1405390 1992. Nierenaffektion bei Parvovirus B 19-Infektion eines Kindes.
1745035 1991. Obstruktive Respirationstrakterkrankungen bei Kindern und Parvovirus B19-Infektion.
1660551 1991. Blutbildbefunde bei Kindern mit Parvovirus B19-Infektion (Ringelroteln/Erythema infectiosum).
2164118 1990. Seropravalenz von Antikorpern gegen das humane Parvovirus B 19 (Ringelroteln/Erythema infectiosum) in der DDR-Bevolkerung.
2544763 1989. Vaskulare Purpura und andere Gefass- und Kreislaufalterationen bei Kindern mit akuter Parvovirus B19-Infektion. Bericht uber 3 eigene Beobachtungen.
29660757 2018. Spektrum von klinischen Prasentationen der Parvovirus B19 Infektion in Kindern mit Hamato-Onkologische Erkrankungen: Eine Fallserie.
22052631 2011. Stem cell transplantation in 6 children with parvovirus B19- induced severe aplastic anaemia or myelodysplastic syndrome.
17405071 2007. Renal complications associated with human parvovirus B19 infection in early childhood.
16125597 2005. Rheumatoid arthritis, type 1 diabetes, and Graves' disease after acute parvovirus B19 infection.
15064032 2004. Rubella.
11551584 2001. Association of human parvovirus B19 infection with acute meningoencephalitis.
11009166 2000. Digital arterial occlusive disease.
11071192 2000. Severe digital arterial occlusive disease and acute parvovirus B19 infection.
10501383 1999. Parvovirus B19 and the pathogenesis of rheumatoid arthritis: a case for historical reasoning.
10073544 1999. Parvovirus B19 infection and fulminant hepatitis.
9820308 1998. Detection of an erythrovirus sequence distinct from B19 in a child with acute anaemia.
9848349 1998. Acute parvovirus B19 infection associated with fulminant hepatitis of favourable prognosis in young children.
9734945 1998. Parvovirus B19 and acute hepatitis in adults.
9107245 1997. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy.
8622394 1996. Human parvovirus B19 infection associated with acute hepatitis.
8684141 1996. Human parvovirus B19 infection and hepatitis.
7674787 1995. Persistent infection of human parvovirus B19 in a normal subject.
7605434 1995. Life-threatening human parvovirus B19 infection in immunocompetent haemophilia.

7799719 1995. Is Still's disease associated with parvovirus B19 infection?
7637482 1995. Glomerulonephritis after human parvovirus infection in homozygous sickle-cell disease.
7715366 1995. Persistent parvovirus B19 infection.
7910278 1994. Active or recent parvovirus B19 infection in children with Kawasaki disease.
7910276 1994. Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent?
7913176 1994. Polyarteritis nodosa and parvovirus B19.
7912323 1994. Human parvovirus B19 infection in Kawasaki disease.
7912322 1994. Human parvovirus B19 infection in Kawasaki disease.
7905974 1994. Parvovirus B19 and erosive polyarthritis.
7914998 1994. Transient disturbance of consciousness and hepatic dysfunction associated with human parvovirus B19 infection.
8098810 1993. Heart failure after parvovirus B19 infection.
8098420 1993. Adult Still's disease associated with acute human parvovirus B19 infection.
8098419 1993. Human parvovirus B19 and arthritis.
8094512 1993. Persistent arthritis after human parvovirus B19 infection.
8102466 1993. Neuralgic amyotrophy after parvovirus B19 infection.
1349370 1992. Viral-associated haemophagocytosis with parvovirus-B19-related pancytopenia.
1351981 1992. Parvovirus-B19-related pancytopenia in children with HIV infection.
1346840 1992. Polyarteritis nodosa and parvovirus B19 infection.
1671156 1991. Parvovirus B19-infected erythroblasts in fetal cord blood.
2893953 1988. B19 parvovirus infection of myocardial cells.
2895293 1988. Fetal cell tropism of human parvovirus B19.
6140462 1984. Nakatani antigen and human parvovirus (B19)
6134886 1983. Aplastic crisis due to parvovirus infection in pyruvate kinase deficiency.
6117755 1981. Parvovirus B19 finds a disease.
7934594 1994. Immune-mediated inner ear disease and parvovirus B19.
8401184 1993. Electron microscopic identification of parvovirus virions in erythroid and granulocytic-line cells in a patient with human parvovirus B19 induced pancytopenia.
28945149 2018. Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis.
27060064 2016. Systematic review of case reports of antiphospholipid syndrome following infection.
24285096 2014. Collapsing glomerulopathy in collagen vascular-like disease.
20511275 2010. Clinical and molecular evidence for association of SLE with parvovirus B19.
11035424 2000. Parvovirus B19 infection associated with the production of anti-neutrophil cytoplasmic antibody (ANCA) and anticardiolipin antibody (aCL).
1845362 1991. Parvovirus B19 infection can induce histiocytic necrotizing lymphadenitis (Kikuchi's disease) associated with systemic lupus erythematosus.
1304627 1992. In situ hybridisation: principles and applications.
7861814 1995. Systemic monocyte and T-cell activation in a patient with human parvovirus B19 infection.
16987488 2006. Neuralgia amiotrofica bilateral precipitada por infeccion por el parvovirus B19.
10996879 2000. Presencia de anticuerpos anticardiolipina en el curso de un proceso de poliartritis por Parvovirus B19.
17196758 2007. Parvovirus B19 infection of brain: possible role of gender in determining mental illness and autoimmune thyroid disorders.
16850174 2006. Seltene Ursache einer Anamie bei einer nierentransplantierten Patientin.
21546176 2011. Cryoglobulinemie grave secondaire a une primo-infection au Parvovirus B19.
14689308 2004. Frequent detection of parvovirus B19 genome in the myocardium of adult patients with idiopathic dilated cardiomyopathy.
12920583 2004. Molecular pathology of inflammatory cardiomyopathy.
9574901 1998. Persistent parvovirus B19 infections in immunocompromised children.
9680929 1998. Persistent B19 parvovirus infection in pediatric malignancies.
18509278 2008. Immunohistological detection of Parvovirus B19 capsid proteins in endomyocardial biopsies from dilated cardiomyopathy patients.
19043365 2008. Parvovirus B19 profiles in patients presenting with acute myocarditis and chronic dilated cardiomyopathy.
16193712 2005. Nefritis tubulo intersticial asociada a parvovirus B19.
21116804 2011. The detection of parvoviruses.
9664388 1998. Immunogold probes in electron microscopy.
29428424 2018. Parvovirus B19 and in situ immune response in eczema and psoriasis skin lesions of patients from the Brazilian Amazon region.
2560110 1989. Persistent parvovirus B19 infections in humans.
27337440 2016. Parvovirus B19.
1375519 1992. A combined pseudoreplica-immunochemical technique for research and diagnostic virology.
20680378 2011. Clinical findings in parvovirus B19 infection in 30 adult patients in Kyoto.
20607339 2010. Pericarditis and pleuritis associated with human parvovirus B19 infection in a systemic lupus erythematosus patient.
24383775 2001. Human parvovirus B19 infection mimicking systemic lupus erythematosus.
26878856 2016. Possible involvement of miRNAs in tropism of Parvovirus B19.
21555155 2011. Increased cardiac injury in NZB/W F1 mice received antibody against human parvovirus B19 VP1 unique region protein.
31922220 2020. Effects of antibodies against human parvovirus B19 on angiogenic signaling.
30106148 2018. Selective activation of inflammation factors by human parvovirus B19 and human bocavirus VP1 unique region on H9c2 cardiomyocyte.
29257322 2018. Human parvovirus B19 nonstructural protein NS1 activates NLRP3 inflammasome signaling in adultonset Still's disease.
27748859 2016. Human parvovirus B19 antibodies induce altered membrane protein expression and apoptosis of BeWo trophoblasts.
20357294 2010. Human parvovirus B19-associated myocarditis.
16641410 2006. Elevated sFlt1 level and preeclampsia with parvovirus-induced hydrops.
14762186 2004. Parvovirus B19.
11357850 2001. Treatment of parvovirus B19-associated polyarteritis nodosa with intravenous immune globulin.
7990901 1995. Expression of P antigen in parvovirus B19-infected bone marrow.
1846224 1991. Parvovirus B19 as the cause of a syndrome resembling Lyme arthritis in adults.
2548099 1989. Human parvovirus B19.
2548098 1989. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy.
2548096 1989. Human parvovirus B19 infection among hospital staff members after contact with infected patients.
3037373 1987. Chronic bone marrow failure due to persistent B19 parvovirus infection.
16265461 2005. A rare case of acute 'infective' myocardial infarction triggered by acute parvovirus B19 myocarditis.
17895931 2007. Parvovirus-B19-associated complications in renal transplant recipients.
6835376 1983. A human parvovirus-like virus inhibits haematopoietic colony formation in vitro.
17403701 2007. Acute nephritis induced by human parvovirus B 19 infection.
17890751 2007. Relapsing severe anaemia due to primary parvovirus B19 infection after renal transplantation: a case report and review of the literature.
16705026 2006. Collapsing and non-collapsing focal segmental glomerulosclerosis in kidney transplants.
15827056 2005. What is antibody-mediated pure red cell aplasia (PRCA)?
12270996 2002. Eradication of parvovirus B19 infection after renal transplantation requires reduction of immunosuppression and high-dose immunoglobulin therapy.
11733638 2001. Fibrosing cholestatic hepatitis possibly related to persistent parvovirus B19 infection in a renal transplant recipient.
10978424 2000. Parvovirus B19-related acute hepatitis in an immunosuppressed kidney transplant.
10069217 1999. Concomitant parvovirus B19 and cytomegalovirus infections after living-related renal transplantation.
9550669 1998. Parvovirus B19 infection and unresponsiveness to erythropoietin therapy in haemodialysis patients.
8672044 1996. Chronic parvovirus B19 infection-associated pure red cell anaemia in a kidney transplant recipient.
8538947 1995. Severe aplastic anaemia due to B19 parvovirus infection in renal transplant recipient.
22177600 2012. Purpura febrile et proteinurie chez une patiente de 71 ans.
21757415 2012. Infection par le Parvovirus B19 apres transplantation renale.
14584298 2003. Infection a parvovirus B19 et transplantation renale.
1641054 1992. Infection a parvovirus B19 revelee par une insuffisance renale aigue.
11598390 2001. Renal involvement induced by human parvovirus B19 infection.
10364707 1999. Correlation between cytomegalovirus infection and Raynaud's phenomenon in lupus nephritis.
10516501 1999. Parvovirus B19 and Schonlein-Henoch purpura in adults.
10809628 2000. Human parvovirus B19 and renal disease?
10399450 1999. Human parvovirus B19: relevance in internal medicine.
9050335 1997. Life-threatening anaemia caused by B19 parvovirus infection in a non-immunocompromised patient.
20567990 2010. Bilateral Holmes-Adie syndrome as an early manifestation of the HIV neuropathy.
11591864 2001. Status epilepticus due to human parvovirus B19 encephalitis in an immunocompetent adult.
16608124 2006. Erythema infectiosum following generalized petechial eruption induced by human parvovirus B19.
17240885 2006. [Tsutsugamushi disease with hemophagocytosis complicated by Parvovirus B19 infection].
15500141 2004. [Secondary nephrotic syndrome induced by infection].
11155595 1998. [A case of systemic lupus erythematosus with pure red cell aplasia possibly caused by persistent infection of human parvovirus B 19].
8437795 1993. Detection of human parvovirus B19 in early spontaneous abortuses using serology, histology, electron microscopy, in situ hybridization, and the polymerase chain reaction.
14996283 2004. Oral manifestations of papular-purpuric 'gloves and socks' syndrome due to parvovirus B19 infection: the first case presented in Greece and review of the literature.
18243574 2009. Detection of the human Parvovirus B19 in nonimmune hydrops fetalis using immunohistochemistry and nested-PCR in formalin-fixed and paraffin-embedded placenta and fetal tissues.
12116850 2002. T lymphocyte responses against human parvovirus B19: small virus, big response.
12116849 2002. Persistence of human parvovirus B19 in human tissues.
12116846 2002. The human parvovirus B19 and its interactions in vivo.
10214619 1999. Traitement des vascularites virales.
29457859 2018. Post-infectious acute glomerulonephritis with podocytopathy induced by parvovirus B19 infection.
1946224 1991. Pathomorphologie der fetalen Parvovirus-B19-Infektion.
28834316 2018. History of parvovirus B19 infection is associated with silent cerebral infarcts.
22872019 2013. Parvovirus B19 myocarditis causes significant morbidity and mortality in children.
23864223 2013. Severe constrictive pericarditis after parvovirus B19 and human herpes virus 6 infection in a 9-year-old girl.
8649911 1996. Diverse hematologic effects of parvovirus B19 infection.
1321971 1992. Congenital infections and the nervous system.
30230024 2018. Unusual skin manifestations associated with parvovirus B19 primary infection in children.
22150362 2012. Wells' syndrome associated with parvovirus in a 5-year old boy.

9496814 1998. Testing for parvovirus B19 in Henoch-Schonlein syndrome?
31335286 2020. Parvovirus B19 Myocarditis: Looking Beyond the Heart.
25361230 2015. Parvovirus infection: an immunohistochemical study using fetal and placental tissue.
15022071 2004. Collapsing glomerulopathy in a 16-year-old girl with pulmonary tuberculosis: the role of systemic inflammatory mediators.
14708734 2003. Parvovirus infects cardiac myocytes in hydrops fetalis.
10347273 1999. Parvovirus B19: twenty-five years in perspective.
16020122 2005. Human parvovirus B19 associated with idiopathic thrombocytopenic purpura.
15205085 2004. Human parvovirus B19 associated with idiopathic thrombocytopenic purpura.
8940744 1996. Erythrocyte P antigen in beta thalassemia major patients with human parvovirus-B19 infection.
8940740 1996. Severe Shwachman-Diamond syndrome and invasive parvovirus B19 infection.
8721035 1996. A case of severe thrombocytopenia due to parvovirus B19 virus.
8721028 1996. Infection-associated hemophagocytic syndrome complicated by infectious lymphoproliferation: a case report.
26756268 2016. Steroid-responsive Status Epilepticus Caused by Human Parvovirus B19 Encephalitis.
23429554 2013. Successful immunotherapy in life-threatening parvovirus B19 infection in a child.
22217972 2012. Acute liver failure as the initial manifestation of Wilson disease triggered by human parvovirus b19 infection.
22418658 2012. Acute cerebellitis and concurrent encephalitis associated with parvovirus B19 infection.
22173134 2012. Fatal parvovirus B19 myocarditis in children and possible dysimmune mechanism.
19483661 2009. Coinfection of parvovirus b19 with other hepatitis viruses leading to fulminant hepatitis of unfavorable outcome in children.
19238110 2009. Absence of parvoviral genomes in endothelial cells of Kawasaki disease patients with coronary artery lesions.
18520445 2008. Acute encephalopathy with human parvovirus B19 infection in hereditary spherocytosis.
14872194 2004. Autoimmune hemolytic anemia and autoimmune hepatitis associated with parvovirus B19 infection.
11791095 2002. Parvovirus B19 and parvovirus V9 are not associated with Henoch-Schonlein purpura in children.
10819350 2000. Lack of association between Kawasaki syndrome and infection with parvovirus B19, human herpesvirus 8, TT virus, GB virus C/hepatitis G virus or Chlamydia pneumoniae.
10223704 1999. Chronic parvovirus B19 meningitis in a child with acute lymphocytic leukemia.
9076823 1997. Detection of human parvovirus B19 DNA in cerebrospinal fluid.
7845728 1994. Parvovirus B19 infection in a hypogammaglobulinemic infant with neurologic disorders and anemia: successful immunoglobulin therapy.
28745457 2017. Discrimination of Diamond-Blackfan anemia from parvovirus B19 infection by RBC glutathione.
19500282 2009. Self-limited lupus-like presentation of human parvovirus B19 infection in a 1-year-old girl.
10703246 2000. Henoch-Schonlein purpura nephritis associated with human parvovirus B19 infection.
11192536 2000. Childhood idiopathic thrombocytopenic purpura associated with human parvovirus B19 infection.
10530073 1999. Pancytopenia with hemophagocytosis secondary to parvovirus B19 infection in a family with hereditary spherocytosis.
20526852 2010. Resolution of Henoch-Schonlein purpura nephritis after acquired IgA deficiency.
15747163 2005. Central nervous system vasculitis secondary to parvovirus B19 infection in a pediatric renal transplant patient.
12883967 2003. Renal involvement in human parvovirus B19 infection.
12644924 2003. Nephrotic syndrome associated with human parvovirus B19 infection.
10454787 1999. Parvovirus glomerulonephritis in a patient with sickle cell disease.
9203192 1997. Chronic anemia as a complication of parvovirus B19 infection in a pediatric kidney transplant patient.
7917866 1994. Dual infection with human herpesvirus type 6 and parvovirus B19 in a renal transplant recipient.
25035141 2014. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion caused by human parvovirus b19 infection: a case of two brothers with hereditary spherocytosis.
18054695 2008. Hemolytic anemia presenting with idiopathic intracranial hypertension.
12657425 2003. Case of stroke in a 7-year-old male after parvovirus B19 infection.
10513695 1999. Fetal brain infection with human parvovirus B19.
8390649 1993. Diagnosis and incidence of fetal parvovirus infection in an autopsy series: II. DNA amplification.
8390648 1993. Diagnosis and incidence of fetal parvovirus infection in an autopsy series: I. Histology.
1448397 1992. Histopathologic variability of finding erythroid inclusions with intrauterine parvovirus B19 infection.
2842740 1988. Electron microscopic identification of parvovirus virions in erythroid-line cells in fatal hydrops fetalis.
9566279 1998. Detection of parvovirus B19 infection in first and second trimester fetal loss.
9353830 1997. Congenital parvovirus infection.
9025846 1996. Polymerase chain reaction amplification of archival material for parvovirus B19 in children with transient erythroblastopenia of childhood.
8963632 1996. Fatal fat embolism syndrome in a child with undiagnosed hemoglobin S/beta+ thalassemia: a complication of acute parvovirus B19 infection.
9859908 1998. Parvovirus B19-associated interstitial lung disease, hepatitis, and myositis.
20136725 2011. Long-term remission of recurrent severe anemia as a result of parvovirus B19 infection in a pediatric renal transplant recipient.
17096771 2006. Severe parvovirus B19 encephalitis after renal transplantation.
16269055 2005. Acute renal failure in a pediatric kidney allograft recipient treated with intravenous immunoglobulin for parvovirus B19 induced pure red cell aplasia.
12890002 2003. Anemia in children after transplantation: etiology and the effect of immunosuppressive therapy on erythropoiesis.
11560750 2001. Parvovirus B19 infection in pediatric solid-organ and bone marrow transplantation.
23129076 2012. Common variable immunodeficiency presenting with persistent parvovirus B19 infection.
12175970 2002. Apoptotic activity in villous trophoblast cells during B19 infection correlates with clinical outcome: assessment by the caspase-related M30 Cytodeath antibody.
9950151 1999. Globoside expression within the human placenta.
8668619 1996. Parvovirus B19 infection. Associated diseases, common and uncommon.
29211607 1994. Acute polyarthritis.
8202421 1994. Acute polyarthritis. Fifth disease passed from child to adult.
2847129 1988. Parvovirus infections. From benign to life-threatening.
10327150 1999. Fetal parvovirus B19 infection associated with myocardial necrosis.
8750289 1995. Prevalence and clinical significance of anticardiolipin antibodies in pregnancies complicated by parvovirus B19 infection.
10189908 1999. Ptosis revelant une primo-infection a Parvovirus B19.
8949610 1996. Manifestations cutanees de l'infection a parvovirus B19.
7899371 1995. Les manifestations rhumatologiques de l'infection a parvovirus B19.
8493234 1993. Vascularite avec cryoglobuline mixte au cours d'une infection par le parvovirus humain B19.
23113616 2013. Human parvovirus B19-induced acute glomerulonephritis: a case report.
20446792 2010. Parvovirus B19-induced multisystemic vasculitis and acute endocapillary proliferative glomerulonephritis in a child.
20662703 2010. Endocapillary glomerulonephritis secondary to human parvovirus B19 presenting with nephrotic syndrome: a report of two cases and a review of the literature.
16526324 2006. Glomerulonephritis associating parvovirus B19 infection.
10783955 2000. Presumed parvovirus B19-associated retinal pigment epitheliopathy.
22112282 2012. Sindrome del tunel carpiano bilateral e infeccion por parvovirus B19.
27220938 2016. The role of human parvovirus B19 and hepatitis C virus in the development of thyroid disorders.
2847280 1988. Human parvovirus B19: historical and clinical review.
9830727 1998. Feto-placentary pathology in human parvovirus B19 infection.
25060808 2015. OEdeme facial matinal, insuffisance renale et anemie : petite cause, grands effets.
18926604 2009. Anticorps antiphospholipide, syndrome des anticorps antiphospholipides et infections virales.
15471600 2004. Manifestations systemiques des infections a Parvovirus B19.
12763177 2003. Placards pseudocellulitiques multiples et signe de Koplick: une forme originale de primo-infection a parvovirus B19 de l'adulte.
7901884 1993. Periarterite noueuse et infection par le parvovirus B19.
32720461 2020. An overview of the immune mechanisms of viral myocarditis.
25855476 2015. The role of parvovirus B19 and the immune response in the pathogenesis of acute leukemia.
25962796 2015. A review of blood diseases and cytopenias associated with human parvovirus B19 infection.
20586082 2010. The expanding range of parvoviruses which infect humans.
14625883 2003. Parvovirus B19 and the pathogenesis of anaemia.
12740833 2003. Neurological manifestations of human parvovirus B19 infection.
10398485 1997. The Simian Parvoviruses.
9476277 1997. Lupus syndrome after parvovirus B19 infection.
9010974 1996. Rheumatic manifestations due to human parvovirus B19. A report of four cases.
9010973 1996. Parvovirus B19 infection and rheumatic diseases.
19480999 2009. Parvovirus B19: its role in chronic arthritis.
9606764 1998. Rheumatic manifestations of parvovirus B19 infection.
8502782 1993. Parvovirus B19 infection.
1662820 1991. Infectious etiology of rheumatoid arthritis.
20012869 2010. Gender differences in the relationship of anti-parvovirus B19 IgG with antinuclear antibody and C-reactive protein in clinical adult serum samples.
18807045 2009. Anasarca as the presenting manifestation of parvovirus B19 associated juvenile dermatomyositis.
17028860 2007. A case of pure red cell aplasia and systemic lupus erythematosus caused by human parvovirus B19 infection.
15322815 2005. The relationship between arthritis and human parvovirus B19 infection.
15088118 2005. Parvovirus B19-induced multisystem disease simulating systemic vasculitis in a young child.
7839075 1994. Prevalence of antihuman parvovirus B19 IgG antibodies in patients with refractory rheumatoid arthritis and polyarticular juvenile rheumatoid arthritis.
1439481 1992. Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis.
32556240 2020. Parvovirus B19 activates in vitro normal human dermal fibroblasts: a possible implication in skin fibrosis and systemic sclerosis.
22157685 2012. Antibodies to common infectious agents in coronary artery disease patients with and without rheumatic conditions.
12364654 2002. Parvovirus B19 infection associated with myelosuppression and cutaneous polyarteritis nodosa.
12096244 2002. High mutation rate in the NS1 gene of parvovirus B19 DNA amplified from skeletal muscle of a case of mixed connective tissue disease.
11709613 2001. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients.
11257151 2001. Human parvovirus B19 infection in patients with systemic lupus erythematosus.
10986312 2000. Dermatomyositis associated with the presence of parvovirus B19 DNA in muscle.
10952747 2000. Antibodies to parvovirus B19 non-structural protein are associated with chronic but not acute arthritis following B19 infection.
11002730 2000. [A case of Guillain-Barre syndrome (GBS) following human parvovirus B19 infection].
1300262 1992. [An adult case of transverse myelitis with erythema infectiosum].
9311285 1997. [Human parvovirus B19 infection mimicking systemic lupus erythematosus: case report].
21284565 2011. Association of parvovirus B19 infection with acute icteric hepatitis in adults.

19883162 2010. The VP1-unique region of parvovirus B19 induces myocardial injury in mice.
19922076 2009. Association of parvovirus B19 infection with glomerulonephritis in an immunocompetent host: a case report.
16138433 2005. Effusive-constrictive pericarditis associated with human parvovirus B19 infection.
15370668 2004. Human parvovirus B19 non-structural protein (NS1) induces apoptosis through mitochondria cell death pathway in COS-7 cells.
15307588 2004. Parvovirus B19-related anaemia after renal transplantation.
11874173 2002. A case of persistent anemia in a renal transplant recipient: association with parvovirus B19 infection.
10225391 1998. Parvovirus B19 infection associated with myocarditis following adult cardiac transplantation.
8685646 1995. Parvovirus B19 infection associated with encephalitis in a patient suffering from malignant lymphoma.
22043904 2012. Severe glomerulonephritis and encephalopathy associated with parvovirus B19 infection mimicking systemic lupus erythematosus.
7777831 1995. The variable clinical picture of arthritis induced by human parvovirus B19. Report of seven adult cases and review of the literature.
8211117 1993. Erythrocyte P antigen: cellular receptor for B19 parvovirus.
3738514 1986. Replication of the B19 parvovirus in human bone marrow cell cultures.
15692957 2005. Lupus-like presentation of parvovirus B19 infection.
10342389 1999. Human parvovirus B19 infection: its relationship with systemic lupus erythematosus.
10342388 1999. Parvovirus infection mimicking systemic lupus erythematosus in a pediatric population.
9572708 1998. Autoantibodies and common viral illnesses.
7604297 1995. Parvovirus infection mimicking systemic lupus erythematosus.
1561488 1992. Parvovirus infection of the human fetus and newborn.
2838911 1988. Hematologic and hematopoietic consequences of B19 parvovirus infection.
27772627 2016. Not the Usual Viral Suspects: Parvovirus B19, West Nile Virus, and Human T-Cell Lymphotrophic Virus Infections After Kidney Transplantation.
12704581 2003. Collapsing glomerulopathy.
24195363 2013. [Regulatory effect of 11 kDa protein of parvovirus B19 on NF-kappaB pathway in Hela cells].
12503064 2002. Human parvovirus B19-induced cell cycle arrest and apoptosis.
24432604 2013. [The course of parvovirus B19 infection during pregnancy after kidney transplantation].
10227760 1998. The efficacy of therapeutic plasmapheresis for the treatment of fatal hemophagocytic syndrome: two case reports.
21190433 2011. Parvovirus B19 infection in Hashimoto's thyroiditis, papillary thyroid carcinoma, and anaplastic thyroid carcinoma.
26778837 2016. Update of the human parvovirus B19 biology.
17900278 2008. Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins.
17880601 2007. Molecular mechanism underlying B19 virus inactivation and comparison to other parvoviruses.
17524097 2007. Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals.
11896304 2002. Transfusion medicine illustrated. Giant pronormoblasts due to parvovirus B19 infection.
30586222 2019. Atraumatic splenic rupture following IVIg for parvovirus B19 pure red cell aplasia post renal transplant.
28741797 2017. Risk factors and long-term outcomes of parvovirus B19 infection in kidney transplant patients.
22931551 2012. How many times can parvovirus B19-related anemia recur in solid organ transplant recipients?
19594866 2009. Pancreas allograft thrombosis following intravenous immunoglobulin administration to treat parvovirus B19 infection.
15984946 2005. Long-term remission of recurrent parvovirus-B associated anemia in a renal transplant recipient induced by treatment with immunoglobulin and positive seroconversion.
12421463 2002. Donor-transmitted parvovirus infection in a kidney transplant recipient presenting as pancytopenia and allograft dysfunction.
32591136 2020. Pure Red Cell Aplasia Related to Parvovirus B19 Infection in Simultaneous Pancreas and Kidney Recipient: A Case Report.
32389489 2020. Successful Treatment of Anemia With Anaplastic and Microangiopathic Characteristics in a Kidney Transplant Recipient With Parvovirus B19 Infection: A Case Report.
32276841 2020. Pure Red Cell Aplasia and Antibody-Mediated Rejection: Double Trouble in 1 Kidney Transplant Recipient Solved by Intravenous Immunoglobulin Infusion: A Case Report.
31351772 2019. Parvovirus B19-Associated Anemia in Kidney Transplant Recipients: A Single-Center Experience.
31101193 2019. Parvovirus B19 Infection as a Rare Cause of Fulminant Liver Failure: A Case Report.
23726627 2013. Clinical investigation of human parvovirus B19 infection after renal transplantation in China.
19010248 2008. Severe anemia from parvovirus b19 infection in pediatric renal transplant recipients: two case reports.
16980079 2006. Recurrent anemia in kidney transplant recipients with parvovirus B19 infection.
16387138 2005. Parvovirus B19 infection in an isolated pancreas transplant recipient.
16387104 2005. Renal anemia aggravated by long-term parvovirus B19 and cytomegalovirus infection in a renal transplant patient: case report and evaluation of B19 seroprevalence in dialysis patients.
12493423 2002. Parvovirus B19 infection and IGF system components in relation to erythropoiesis in dialyzed patients and kidney transplant recipients.
11377483 2001. Monoclonal anti-CD52 antibodies: a potential mode of therapy for parvovirus B(19) hepatitis.
11120023 2000. Discontinuation of immunosuppressive antimetabolite for parvovirus B19-associated anemia in kidney transplant patients.
11120017 2000. Pure red cell aplasia due to parvovirus B19 infection in a renal transplant patient: a case report.
10456000 1999. Acute parvovirus infection in a heart transplant recipient.
9123540 1997. Unusual incidence of aplastic anaemia due to B-19 parvovirus infection in renal transplant recipients.
29762456 2018. Parvovirus B19 Induced Red Cell Aplasia in a Heart Transplant Patient Diagnosed on Pleural Fluid.
15785387 2005. Pure red cell aplasia associated with parvovirus B19 infection in renal transplantation: the first case report in Mexico.
14743003 2004. Parvovirus B19 infection-associated red-cell aplasia in renal-transplant recipients: clues from the bone marrow.
12042652 2002. A role for chronic parvovirus B19 infection in liver dysfunction in renal transplant recipients?
11889431 2002. Chronic parvovirus B19 infection in a pediatric lung transplanted patient.
11211196 2001. Nosocomial outbreak of parvovirus B19 infection in a renal transplant unit.
10852625 2000. Parvovirus B19 in kidney transplant patients.
10910292 2000. Human parvovirus B19 infection presenting as persistent anemia in renal transplant recipients.
10949207 2000. Splenectomy for idiopathic thrombocytopenic purpura after living-related liver transplantation.
9422430 1997. Parvovirus B19 infection-related complications in renal transplant recipients: treatment with intravenous immunoglobulin.
15552021 2004. Manifestations rhumatologiques de l'infection a parvovirus B19.
18078665 2007. Neurologiske symptomer og akut hepatitis associeret til parvovirus B19.
1509571 1992. Akut vasculitis og arthritis forarsaget af Parvovirus B 19 infektion.
7941039 1994. Immunoelectron microscopic identification of human parvovirus B19.
9569471 1998. Nucleic acid immunization protects dogs against challenge with virulent canine parvovirus.
12510554 2002. Digital arterial occlusive disease and parvovirus B19 infection.
32412895 2020. New Insights of Human Parvovirus B19 in Modulating Erythroid Progenitor Cell Differentiation.
17931112 2007. An association between parvovirus B19 and Kikuchi-Fujimoto disease.
12536309 2003. Parvovirus B19: a pathogen responsible for more than hematologic disorders.
1980555 1990. In situ hybridization for the detection of human parvovirus B19 nucleic acid sequences in paraffin-embedded specimens.
8030266 1994. The structure of human parvovirus B19 at 8 A resolution.
8517014 1993. Identification and characterization of a family of 11-kDa proteins encoded by the human parvovirus B19.
8337823 1993. A novel protein encoded by small RNAs of parvovirus B19.
1641977 1992. Parvovirus B19 replication in human umbilical cord blood cells.
1871964 1991. Preliminary X-ray crystallographic investigation of human parvovirus B19.
1926783 1991. Upstream sequences within the terminal hairpin positively regulate the P6 promoter of B19 parvovirus.
2024472 1991. Indiscriminate activity from the B19 parvovirus p6 promoter in nonpermissive cells.
2053277 1991. Analysis of splice junctions and in vitro and in vivo translation potential of the small, abundant B19 parvovirus RNAs.
2408228 1990. Cloning of the human parvovirus B19 genome and structural analysis of its palindromic termini.
3824910 1987. A transcriptional promoter of the human parvovirus B19 active in vitro and in vivo.
3824909 1987. In vitro identification of a B19 parvovirus promoter.
23114653 2013. The effects of the 11 kDa protein and the putative X protein on the p6 promoter activity of Parvovirus B19 in Hela cells.
27071853 2016. Enhanced inhibition of parvovirus B19 replication by cidofovir in extendedly exposed erythroid progenitor cells.
27270128 2016. Nonstructural protein (NS1) of human parvovirus B19 stimulates host innate immunity and blunts the exogenous type I interferon signaling in vitro.
24998884 2014. Persistent parvovirus B19 infection in non-erythroid tissues: possible role in the inflammatory and disease process.
23770153 2013. Adenovirus vector-mediated RNA interference for the inhibition of human parvovirus B19 replication.
24100233 2013. Single-cell chemiluminescence imaging of parvovirus B19 life cycle.
15990190 2005. Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures.
9620213 1998. Typing of European strains of parvovirus B19 by restriction endonuclease analyses and sequencing: identification of evolutionary lineages and evidence of recombination of markers from different lineages.
11816291 2001. Stezenia interleukin 6 oraz 12 u kobiet ciezarnych zakazonych ludzkim parwowirusem B19 i niezakazonych.
1964320 1990. Infektion mit Parvovirus B19: Typischer Verlauf der Ringelroteln (Erythema infectiosum) und die Komplikationen.
27761646 2016. Virale Arthritiden und Vaskulitiden.
21128048 2010. Virale Arthritiden.
8023586 1994. Humanes Parvovirus B19 (HPV-B19), eine klinische Ubersicht mit Betonung der rheumatologischen Manifestationen.
20388386 2010. [Viral nephropathy].

red cell items

-neglected-

Parvovirus B19

Aktuelle Version vom 1. September 2020, 08:08 Uhr

of utmost importance

top rated

red cell items

Meine Werkzeuge

Namensräume

Varianten

Ansichten

Aktionen

Suche

Navigation

Werkzeuge

@@ Zeile 2: / Zeile 2: @@
 Got the idea when I realized that most non-covid causes of collapsing glomerulopathy are hiv, parvovirus, other virus, high interferon states, hlh, sle and some other connective tissue diseases.
 Parvo b19 makes some overlapping multisystem signs so its worth consideration.
-Bib shows selection from item1 1-500/1-500 out of 1100/3100
-===normal rated===
+Bib shows selection from 'parvovirus b19 OR parvovirus b19' pubmed on 08/21/2020
-will follow in a couple of days
+http://www.moremed.org/SiteSearch.php?S1=parvovirus+b19+OR+parvovirus-b19&S2=&S3=&submit=submit&px1=proxy.nationallizenzen.de&px2=&px3=&px4=&R=all&Y0=1500&Y1=2025
+===of utmost importance===
+{{ttp|p=20436917|t=2010. Chloroquine and its derivatives exacerbate B19V-associated anemia by promoting viral replication |pdf=|usr=}}
+*'''[[Parvovirus B19(2) normal rated papers]]'''
 ===top rated===
-further items will follow in a couple of days
 {{tp|p=15816155|t=2005. Seroprevalence of parvovirus B19 infection in daycare educators.|pdf=|usr=}}
@@ Zeile 192: / Zeile 197: @@
 {{tp|p=9008606|t=1997. Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus.|pdf=|usr=}}
 {{tp|p=8639187|t=1996. Prevalence of human parvovirus B19 infection in children with Henoch-Schonlein purpura.|pdf=|usr=}}
+{{tp|p=956363|t=1976. Comparison of human fecal and serum parvo-like viruses.|pdf=|usr=}}
+{{tp|p=17412871|t=2007. Persistent parvovirus b19 infection resulting in carpal tunnel syndrome.|pdf=|usr=}}
+{{tp|p=17142576|t=2006. Parvovirus B19 detected in Rosai-Dorfman disease in nodal and extranodal manifestations.|pdf=|usr=}}
+{{tp|p=16049292|t=2005. Parvovirus B19 infection associated with unilateral cervical lymphadenopathy, apoptotic sinus histiocytosis, and prolonged fatigue.|pdf=|usr=}}
+{{tp|p=7629301|t=1995. Anticomplementary activity in serum samples from patients with acute parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=1401175|t=1992. Non-isotopic in situ hybridisation and immunophenotyping of infected cells in the investigation of human fetal parvovirus infection.|pdf=|usr=}}
+{{tp|p=25411609|t=2014. Case of fulminant type 1 diabetes mellitus associated with parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=32533899|t=2020. Major cluster of paediatric 'true' primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown.|pdf=|usr=}}
+{{tp|p=21195886|t=2010. Cluster of parvovirus infection among hospital staff working in coronary care units.|pdf=|usr=}}
+{{tp|p=17384979|t=2007. Secondary symptomatic parvovirus B19 infection in a healthy adult.|pdf=|usr=}}
+{{tp|p=27902343|t=2016. Frequency and significance of parvovirus B19 infection in patients with rheumatoid arthritis.|pdf=|usr=}}
+{{tp|p=27902331|t=2016. The plasma virome of febrile adult Kenyans shows frequent parvovirus B19 infections and a novel arbovirus (Kadipiro virus).|pdf=|usr=}}
+{{tp|p=15383603|t=2004. Human parvovirus B19 transgenic mice become susceptible to polyarthritis.|pdf=|usr=}}
+{{tp|p=30346568|t=2019. Parvovirus B19V Nonstructural Protein NS1 Induces Double-Stranded Deoxyribonucleic Acid Autoantibodies and End-Organ Damage in Nonautoimmune Mice.|pdf=|usr=}}
+{{tp|p=21921203|t=2011. Seroepidemiology of human bocaviruses 1-4.|pdf=|usr=}}
+{{tp|p=19691429|t=2009. High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies.|pdf=|usr=}}
+{{tp|p=18831690|t=2008. CD4+ T helper cell responses against human bocavirus viral protein 2 viruslike particles in healthy adults.|pdf=|usr=}}
+{{tp|p=17397006|t=2007. Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus.|pdf=|usr=}}
+{{tp|p=19549095|t=2009. Persistent parvovirus B19 infection detected by specific CD4+ T-cell responses in a patient with hepatitis and polyarthritis.|pdf=|usr=}}
+{{tp|p=16961667|t=2006. Clinical aspects of parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=9747749|t=1998. Acute lung injury due to parvovirus pneumonia.|pdf=|usr=}}
+{{tp|p=31635495|t=2019. Hemophagocytic Lymphohistiocytosis Associated With Parvovirus B19 in a Patient With Acquired Immunodeficiency Syndrome.|pdf=|usr=}}
+{{tp|p=25560323|t=2015. Persistent parvovirus B19 viremia with chronic arthralgia treated with ascorbic acid: a case report.|pdf=|usr=}}
+{{tp|p=31257106|t=2019. Human parvovirus B19 infection in patients with or without underlying diseases.|pdf=|usr=}}
+{{tp|p=12438480|t=2002. Evidence for the role of demyelination, HLA-DR alleles, and cytokines in the pathogenesis of parvovirus B19 meningoencephalitis and its sequelae.|pdf=|usr=}}
+{{tp|p=8961710|t=1996. Various associations of human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=31341051|t=2019. Globoside Is Dispensable for Parvovirus B19 Entry but Essential at a Postentry Step for Productive Infection.|pdf=|usr=}}
+{{tp|p=30787153|t=2019. Structure of Parvovirus B19 Decorated by Fabs from a Human Antibody.|pdf=|usr=}}
+{{tp|p=30282717|t=2019. The 11-Kilodalton Nonstructural Protein of Human Parvovirus B19 Facilitates Viral DNA Replication by Interacting with Grb2 through Its Proline-Rich Motifs.|pdf=|usr=}}
+{{tp|p=29237843|t=2018. Human Parvovirus B19 Utilizes Cellular DNA Replication Machinery for Viral DNA Replication.|pdf=|usr=}}
+{{tp|p=29437973|t=2018. RNA Binding Protein RBM38 Regulates Expression of the 11-Kilodalton Protein of Parvovirus B19, Which Facilitates Viral DNA Replication.|pdf=|usr=}}
+{{tp|p=24807719|t=2014. Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q.|pdf=|usr=}}
+{{tp|p=24067971|t=2013. Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropism.|pdf=|usr=}}
+{{tp|p=24049177|t=2013. Human parvovirus B19 infection causes cell cycle arrest of human erythroid progenitors at late S phase that favors viral DNA replication.|pdf=|usr=}}
+{{tp|p=22718826|t=2012. Characterization of the early steps of human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=22855485|t=2012. Acute diarrhea in West African children: diverse enteric viruses and a novel parvovirus genus.|pdf=|usr=}}
+{{tp|p=22837195|t=2012. Human parvovirus B19 DNA replication induces a DNA damage response that is dispensable for cell cycle arrest at phase G2/M.|pdf=|usr=}}
+{{tp|p=22357277|t=2012. Roles of E4orf6 and VA I RNA in adenovirus-mediated stimulation of human parvovirus B19 DNA replication and structural gene expression.|pdf=|usr=}}
+{{tp|p=21159861|t=2011. Inclusion of the central exon of parvovirus B19 precursor mRNA is determined by multiple splicing enhancers in both the exon and the downstream intron.|pdf=|usr=}}
+{{tp|p=21680529|t=2011. Parvovirus B19 infection of human primary erythroid progenitor cells triggers ATR-Chk1 signaling, which promotes B19 virus replication.|pdf=|usr=}}
+{{tp|p=20668071|t=2010. Widespread infection with homologues of human parvoviruses B19, PARV4, and human bocavirus of chimpanzees and gorillas in the wild.|pdf=|usr=}}
+{{tp|p=20631151|t=2010. Advances in human B19 erythrovirus biology.|pdf=|usr=}}
+{{tp|p=20826697|t=2010. The globoside receptor triggers structural changes in the B19 virus capsid that facilitate virus internalization.|pdf=|usr=}}
+{{tp|p=20375175|t=2010. Human bocavirus capsid structure: insights into the structural repertoire of the parvoviridae.|pdf=|usr=}}
+{{tp|p=20943969|t=2010. Codon optimization of human parvovirus B19 capsid genes greatly increases their expression in nonpermissive cells.|pdf=|usr=}}
+{{tp|p=20861249|t=2010. Role of erythropoietin receptor signaling in parvovirus B19 replication in human erythroid progenitor cells.|pdf=|usr=}}
+{{tp|p=19587029|t=2009. The genome of human parvovirus b19 can replicate in nonpermissive cells with the help of adenovirus genes and produces infectious virus.|pdf=|usr=}}
+{{tp|p=19710152|t=2009. Analysis of nucleotide sequences of human parvovirus B19 genome reveals two different modes of evolution, a gradual alteration and a sudden replacement: a retrospective study in Sapporo, Japan, from 1980 to 2008.|pdf=|usr=}}
+{{tp|p=18684834|t=2008. Block to the production of full-length B19 virus transcripts by internal polyadenylation is overcome by replication of the viral genome.|pdf=|usr=}}
+{{tp|p=18160440|t=2008. Ex vivo-generated CD36+ erythroid progenitors are highly permissive to human parvovirus B19 replication.|pdf=|usr=}}
+{{tp|p=18417586|t=2008. Rapid sequence change and geographical spread of human parvovirus B19: comparison of B19 virus evolution in acute and persistent infections.|pdf=|usr=}}
+{{tp|p=18815302|t=2008. Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity.|pdf=|usr=}}
+{{tp|p=18550668|t=2008. Human parvovirus B19 NS1 protein modulates inflammatory signaling by activation of STAT3/PIAS3 in human endothelial cells.|pdf=|usr=}}
+{{tp|p=18508892|t=2008. Visualization of the externalized VP2 N termini of infectious human parvovirus B19.|pdf=|usr=}}
+{{tp|p=17409158|t=2007. Biological and immunological relations among human parvovirus B19 genotypes 1 to 3.|pdf=|usr=}}
+{{tp|p=16956939|t=2006. Phospholipase A2 activity-dependent stimulation of Ca2+ entry by human parvovirus B19 capsid protein VP1.|pdf=|usr=}}
+{{tp|p=16943301|t=2006. Tracking of peptide-specific CD4+ T-cell responses after an acute resolving viral infection: a study of parvovirus B19.|pdf=|usr=}}
+{{tp|p=16731932|t=2006. Molecular and functional analyses of a human parvovirus B19 infectious clone demonstrates essential roles for NS1, VP1, and the 11-kilodalton protein in virus replication and infectivity.|pdf=|usr=}}
+{{tp|p=16775358|t=2006. A highly restricted T-cell receptor dominates the CD8+ T-cell response to parvovirus B19 infection in HLA-A2402-positive individuals.|pdf=|usr=}}
+{{tp|p=16415037|t=2006. Identification and characterization of two internal cleavage and polyadenylation sites of parvovirus B19 RNA.|pdf=|usr=}}
+{{tp|p=17020940|t=2006. Conformational changes in the VP1-unique region of native human parvovirus B19 lead to exposure of internal sequences that play a role in virus neutralization and infectivity.|pdf=|usr=}}
+{{tp|p=16571827|t=2006. Apoptosis of liver-derived cells induced by parvovirus B19 nonstructural protein.|pdf=|usr=}}
+{{tp|p=16537636|t=2006. Phylogenetic evidence for the rapid evolution of human B19 erythrovirus.|pdf=|usr=}}
+{{tp|p=16140790|t=2005. Sustained CD8+ T-cell responses induced after acute parvovirus B19 infection in humans.|pdf=|usr=}}
+{{tp|p=15220451|t=2004. Parvovirus B19-induced apoptosis of hepatocytes.|pdf=|usr=}}
+{{tp|p=12584315|t=2003. Human parvovirus B19 nonstructural protein (NS1) induces cell cycle arrest at G(1) phase.|pdf=|usr=}}
+{{tp|p=12186896|t=2002. Genetic diversity within human erythroviruses: identification of three genotypes.|pdf=|usr=}}
+{{tp|p=11991968|t=2002. Regulation of tumor necrosis factor alpha promoter by human parvovirus B19 NS1 through activation of AP-1 and AP-2.|pdf=|usr=}}
+{{tp|p=11799199|t=2002. The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity.|pdf=|usr=}}
+{{tp|p=11287560|t=2001. Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells.|pdf=|usr=}}
+{{tp|p=11222696|t=2001. Evolutionary relationships among parvoviruses: virus-host coevolution among autonomous primate parvoviruses and links between adeno-associated and avian parvoviruses.|pdf=|usr=}}
+{{tp|p=11119624|t=2001. Direct ex vivo measurement of CD8(+) T-lymphocyte responses to human parvovirus B19.|pdf=|usr=}}
+{{tp|p=11462027|t=2001. Human parvovirus B19 induces cell cycle arrest at G(2) phase with accumulation of mitotic cyclins.|pdf=|usr=}}
+{{tp|p=11024117|t=2000. Impaired gamma interferon responses against parvovirus B19 by recently infected children.|pdf=|usr=}}
+{{tp|p=15888184|t=2005. Prevalence of human parvovirus B19 component NS1 gene in patients with Henoch-Schonlein purpura and hypersensitivity vasculitis.|pdf=|usr=}}
+{{tp|p=15888183|t=2005. Altered prevalence of human parvovirus B19 component genes in systemic sclerosis skin tissue.|pdf=|usr=}}
+{{tp|p=15840133|t=2005. Parvovirus B19 and systemic sclerosis.|pdf=|usr=}}
+{{tp|p=15214893|t=2004. Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin.|pdf=|usr=}}
+{{tp|p=15270892|t=2004. The juvenile variant of papular-purpuric gloves and socks syndrome and its association with viral infections.|pdf=|usr=}}
+{{tp|p=8915154|t=1996. Immunohistochemical and virological study of skin in the papular-purpuric gloves and socks syndrome.|pdf=|usr=}}
+{{tp|p=32088927|t=2020. Numerous abnormal mitoses in parvovirus B19-infected proerythroblasts.|pdf=|usr=}}
+{{tp|p=25920561|t=2015. Spectrum of adult Parvovirus B19 infection according to the underlying predisposing condition and proposals for clinical practice.|pdf=|usr=}}
+{{tp|p=20064150|t=2010. Acute human parvovirus B19 infection and nephrotic syndrome in patients with sickle cell disease.|pdf=|usr=}}
+{{tp|p=15606559|t=2005. Human parvovirus B19-induced acquired pure amegakaryocytic thrombocytopenia.|pdf=|usr=}}
+{{tp|p=15257717|t=2004. Evidence of parvovirus B19 infection in patients of pre-eclampsia and eclampsia with dyserythropoietic anaemia.|pdf=|usr=}}
+{{tp|p=12786811|t=2003. Risk of parvovirus infection by immunoglobulin.|pdf=|usr=}}
+{{tp|p=12199806|t=2002. Life-threatening human parvovirus B19 infection transmitted by intravenous immune globulin.|pdf=|usr=}}
+{{tp|p=9074434|t=1997. Parvovirus B19-associated haemophagocytic syndrome with lymphadenopathy resembling histiocytic necrotizing lymphadenitis (Kikuchi's disease).|pdf=|usr=}}
+{{tp|p=7772537|t=1995. Parvovirus B19-associated haemophagocytic syndrome in healthy adults.|pdf=|usr=}}
+{{tp|p=8199040|t=1994. Parvovirus B19-associated haemophagocytic syndrome with prominent neutrophilia.|pdf=|usr=}}
+{{tp|p=7819097|t=1994. Haemophagocytic lymphohistiocytosis: experience at two U.K. centres.|pdf=|usr=}}
+{{tp|p=7986722|t=1994. Parvovirus B19 as a cause of acquired chronic pure red cell aplasia.|pdf=|usr=}}
+{{tp|p=8136290|t=1993. Parvovirus B19-related lymphadenopathy.|pdf=|usr=}}
+{{tp|p=1536802|t=1992. Transient erythroblastopenia of childhood with megakaryocytopenia associated with human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=1550770|t=1992. Recurrent granulocytic aplasia as clinical presentation of a persistent parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=1654995|t=1991. Productive infection of in vitro generated haemopoietic progenitor cells from normal human adult peripheral blood with parvovirus B19: studies by morphology, immunocytochemistry, flow-cytometry and DNA-hybridization.|pdf=|usr=}}
+{{tp|p=1648374|t=1991. Congenital spherocytosis, B19 parvovirus infection and inherited interstitial deletion of the short arm of chromosome 8.|pdf=|usr=}}
+{{tp|p=2553096|t=1989. Transient erythroblastopenia of childhood due to human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=8616129|t=1996. Fetal pathology in intrauterine death due to parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=1525097|t=1992. Clinical and histopathological features of parvovirus B19 infection in the human fetus.|pdf=|usr=}}
+{{tp|p=2548567|t=1989. Fetal pathology in human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=9117160|t=1997. Reactive arthritis in a patient with simultaneous parvovirus B19 infection and Clostridium difficile diarrhoea.|pdf=|usr=}}
+{{tp|p=8428231|t=1993. Exacerbation of systemic lupus erythematosus during human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=20395090|t=2011. Acute autonomic sensory and motor neuropathy associated with parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=9595838|t=1998. Parvovirus: a review.|pdf=|usr=}}
+{{tp|p=11828445|t=2001. Scanning force microscopy study on a single-stranded DNA: the genome of parvovirus B19.|pdf=|usr=}}
+{{tp|p=20177002|t=2010. Parvovirus b19-induced myocarditis mimicking acute myocardial infarction: clarification of diagnosis by cardiac magnetic resonance imaging.|pdf=|usr=}}
+{{tp|p=17404165|t=2007. Images in cardiovascular medicine. Parvovirus-B19-associated active myocarditis with biventricular thrombi. Results of endomyocardial biopsy investigations and cardiac magnetic resonance imaging.|pdf=|usr=}}
+{{tp|p=15505098|t=2004. Endothelium-dependent flow-mediated vasodilation of systemic arteries is impaired in patients with myocardial virus persistence.|pdf=|usr=}}
+{{tp|p=12925460|t=2003. Parvovirus B19 infection mimicking acute myocardial infarction.|pdf=|usr=}}
+{{tp|p=17434906|t=2007. Biosensor analysis of beta2-glycoprotein I-reactive autoantibodies: evidence for isotype-specific binding and differentiation of pathogenic from infection-induced antibodies.|pdf=|usr=}}
+{{tp|p=7955387|t=1994. Increased prevalence of IgM antibodies to Epstein-Barr virus and parvovirus B19 in blood donations with above-normal neopterin.|pdf=|usr=}}
+{{tp|p=24513539|t=2014. Parvovirus B19 (B19) and cytomegalovirus (CMV) infections and anti-erythropoietin (anti-EPO) antibodies in patients on dialysis hyporesponsive to erythropoietin therapy.|pdf=|usr=}}
+{{tp|p=22309679|t=2012. Significant association of past parvovirus B19 infection with cytopenia in both adult-onset Still's disease and systemic lupus erythematosus patients.|pdf=|usr=}}
+{{tp|p=10482630|t=1999. Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19.|pdf=|usr=}}
+{{tp|p=10400786|t=1999. Three-dimensional structure of Aleutian mink disease parvovirus: implications for disease pathogenicity.|pdf=|usr=}}
+{{tp|p=9420265|t=1998. Characterization of cis-acting and NS1 protein-responsive elements in the p6 promoter of parvovirus B19.|pdf=|usr=}}
+{{tp|p=9525624|t=1998. Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells.|pdf=|usr=}}
+{{tp|p=9151844|t=1997. Experimental infection of cynomolgus monkeys with simian parvovirus.|pdf=|usr=}}
+{{tp|p=9371610|t=1997. The 3' untranslated region of the B19 parvovirus capsid protein mRNAs inhibits its own mRNA translation in nonpermissive cells.|pdf=|usr=}}
+{{tp|p=8794392|t=1996. Lymphoproliferative responses after infection with human parvovirus B19.|pdf=|usr=}}
+{{tp|p=8970971|t=1996. A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression.|pdf=|usr=}}
+{{tp|p=8764053|t=1996. Identification of domains in canine parvovirus VP2 essential for the assembly of virus-like particles.|pdf=|usr=}}
+{{tp|p=7666560|t=1995. Modest truncation of the major capsid protein abrogates B19 parvovirus capsid formation.|pdf=|usr=}}
+{{tp|p=7745742|t=1995. Human parvovirus B19 can infect cynomolgus monkey marrow cells in tissue culture.|pdf=|usr=}}
+{{tp|p=7494329|t=1995. Transcriptional transactivation of parvovirus B19 promoters in nonpermissive human cells by adenovirus type 2.|pdf=|usr=}}
+{{tp|p=7933098|t=1994. The transcriptional regulator YY1 binds to the 5'-terminal region of B19 parvovirus and regulates P6 promoter activity.|pdf=|usr=}}
+{{tp|p=8207846|t=1994. Formation of empty B19 parvovirus capsids by the truncated minor capsid protein.|pdf=|usr=}}
+{{tp|p=7966641|t=1994. A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity.|pdf=|usr=}}
+{{tp|p=7684458|t=1993. Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions.|pdf=|usr=}}
+{{tp|p=1433504|t=1992. Localization of an immunodominant domain on baculovirus-produced parvovirus B19 capsids: correlation to a major surface region on the native virus particle.|pdf=|usr=}}
+{{tp|p=1385833|t=1992. A block in full-length transcript maturation in cells nonpermissive for B19 parvovirus.|pdf=|usr=}}
+{{tp|p=1716693|t=1991. Identification and mapping of neutralizing epitopes of human parvovirus B19 by using human antibodies.|pdf=|usr=}}
+{{tp|p=1901917|t=1991. Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins.|pdf=|usr=}}
+{{tp|p=1719240|t=1991. A second neutralizing epitope of B19 parvovirus implicates the spike region in the immune response.|pdf=|usr=}}
+{{tp|p=1705987|t=1991. Identification of the region including the epitope for a monoclonal antibody which can neutralize human parvovirus B19.|pdf=|usr=}}
+{{tp|p=2293668|t=1990. Nonstructural protein of parvoviruses B19 and minute virus of mice controls transcription.|pdf=|usr=}}
+{{tp|p=2795719|t=1989. A GC-box motif upstream of the B19 parvovirus unique promoter is important for in vitro transcription.|pdf=|usr=}}
+{{tp|p=2657097|t=1989. Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver.|pdf=|usr=}}
+{{tp|p=3373576|t=1988. Functional mapping of the genome of the B19 (human) parvovirus by in vitro translation after negative hybrid selection.|pdf=|usr=}}
+{{tp|p=3392774|t=1988. Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells from normal human bone marrow.|pdf=|usr=}}
+{{tp|p=2969055|t=1988. The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells.|pdf=|usr=}}
+{{tp|p=3599184|t=1987. Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures.|pdf=|usr=}}
+{{tp|p=3599180|t=1987. Novel transcription map for the B19 (human) pathogenic parvovirus.|pdf=|usr=}}
+{{tp|p=3021988|t=1986. Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments.|pdf=|usr=}}
+{{tp|p=3701931|t=1986. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis.|pdf=|usr=}}
+{{tp|p=3783814|t=1986. Complete nucleotide sequence and genome organization of bovine parvovirus.|pdf=|usr=}}
+{{tp|p=31517001|t=2019. Extensive purpura as presenting sign of parvovirus B19 infection in a patient with paroxysmal nocturnal hemoglobinuria.|pdf=|usr=}}
+{{tp|p=15973005|t=2005. Spontaneous resolution of hemophagocytic syndrome and disseminated intravascular coagulation associated with parvovirus b19 infection in a previously healthy child.|pdf=|usr=}}
+{{tp|p=31290479|t=2019. An association between parvovirus B19 infection and the severity of coronary atherosclerosis.|pdf=|usr=}}
+{{tp|p=12472788|t=2003. Familial collapsing glomerulopathy: clinical, pathological and immunogenetic features.|pdf=|usr=}}
+{{tp|p=11380814|t=2001. Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy.|pdf=|usr=}}
+{{tp|p=21116318|t=2010. Infection and chronic allograft dysfunction.|pdf=|usr=}}
+{{tp|p=14563946|t=2003. PCR-based diagnosis of enterovirus and parvovirus B19 in paraffin-embedded heart tissue of children with suspected sudden infant death syndrome.|pdf=|usr=}}
+{{tp|p=20385113|t=2010. The association of anti-parvovirus B19-VP1 unique region antibodies with antiphospholipid antibodies in patients with antiphospholipid syndrome.|pdf=|usr=}}
+{{tp|p=19362081|t=2009. Anti-human parvovirus B19 nonstructural protein antibodies in patients with rheumatoid arthritis.|pdf=|usr=}}
+{{tp|p=18538665|t=2008. Up-regulation of adhesion molecule expression and induction of TNF-alpha on vascular endothelial cells by antibody against human parvovirus B19 VP1 unique region protein.|pdf=|usr=}}
+{{tp|p=17169353|t=2007. The association of VP1 unique region protein in acute parvovirus B19 infection and anti-phospholipid antibody production.|pdf=|usr=}}
+{{tp|p=17451664|t=2007. Induction of antiphospholipid antibodies and antiphospholipid syndrome-like autoimmunity in naive mice with antibody against human parvovirus B19 VP1 unique region protein.|pdf=|usr=}}
+{{tp|p=16765338|t=2006. Serologic and molecular detection of human Parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=30981292|t=2019. The rash with maculopapules and fever in children.|pdf=|usr=}}
+{{tp|p=30981291|t=2019. The rash with maculopapules and fever in adults.|pdf=|usr=}}
+{{tp|p=17350501|t=2007. Viral exanthems in the tropics.|pdf=|usr=}}
+{{tp|p=15566889|t=1996. IgG subclass response to human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=31400151|t=2020. An unusual cutaneous manifestation of parvovirus B19 infection: papular-purpuric gloves-and-socks syndrome and petechial bathing trunk eruption.|pdf=|usr=}}
+{{tp|p=27900796|t=2017. Parvovirus B19 infection presenting concurrently as papular-purpuric gloves-and-socks syndrome and bathing-trunk eruption.|pdf=|usr=}}
+{{tp|p=24164247|t=2014. Haemophagocytic syndrome with a fatal outcome triggered by parvovirus B19 infection in the skin.|pdf=|usr=}}
+{{tp|p=19489851|t=2009. Melkersson-Rosenthal syndrome associated with parvovirus B19 viraemia and haemophagocytic lymphohistiocytosis.|pdf=|usr=}}
+{{tp|p=18355355|t=2008. Acute heart failure associated with human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=17250756|t=2007. Detection of parvovirus B19 DNA in the lesional skin of patients with Behcet's disease.|pdf=|usr=}}
+{{tp|p=16681615|t=2006. Acute urticaria and dry cough with interstitial pneumonia: a clue for the diagnosis of primary parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=22468640|t=2012. Investigation of parvovirus B19 seroprevalence, endothelin-1 synthesis, and nitric oxide levels in the etiology of essential hypertension.|pdf=|usr=}}
+{{tp|p=15971443|t=2005. Coexistence of non-specific and usual interstitial pneumonia in a patient with severe cystic scleroderma lung involvement and parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=15301256|t=2004. Human Parvovirus B19 and juvenile systemic lupus erythematosus.|pdf=|usr=}}
+{{tp|p=14611135|t=2003. Role of parvovirus B19 infection in juvenile chronic arthritis. Is more investigation needed?|pdf=|usr=}}
+{{tp|p=11326495|t=2001. The historical record is consistent with the recent finding of parvovirus B19 infection of bone marrow in systemic sclerosis patients.|pdf=|usr=}}
+{{tp|p=10949739|t=2000. Antinucleolar antibodies and parvovirus B19 arthritis.|pdf=|usr=}}
+{{tp|p=10609071|t=1999. Parvovirus B19 infection of bone marrow in systemic sclerosis patients.|pdf=|usr=}}
+{{tp|p=8697661|t=1996. Parvovirus B19 infection in Behcet's disease.|pdf=|usr=}}
+{{tp|p=16169277|t=2005. Critical function of the CD40 pathway in parvovirus B19 infection revealed by a hypomorphic CD40 ligand mutation.|pdf=|usr=}}
+{{tp|p=12921761|t=2003. Detection of IgE anti-parvovirus B19 and increased CD23+ B cells in parvovirus B19 infection: relation to Th2 cytokines.|pdf=|usr=}}
+{{tp|p=30052873|t=2019. Infection Pressure in Men Who Have Sex With Men and Their Suitability to Donate Blood.|pdf=|usr=}}
+{{tp|p=30304533|t=2019. An Outbreak of Human Parvovirus B19 Hidden by Dengue Fever.|pdf=|usr=}}
+{{tp|p=20201675|t=2010. Mixed cryoglobulinemia: a role for parvovirus b19 infection.|pdf=|usr=}}
+{{tp|p=19441978|t=2009. Neurologic manifestations associated with parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=18558883|t=2008. Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman.|pdf=|usr=}}
+{{tp|p=16758416|t=2006. Parvovirus B19 infection after transplantation: a review of 98 cases.|pdf=|usr=}}
+{{tp|p=16163641|t=2005. Slow clearance of human parvovirus B19 viremia following acute infection.|pdf=|usr=}}
+{{tp|p=16028146|t=2005. A case of persistent parvovirus B19 infection with bilateral cartilaginous and ligamentous damage to the wrists.|pdf=|usr=}}
+{{tp|p=12715326|t=2003. Successful intravenous immunoglobulin therapy in 3 cases of parvovirus B19-associated chronic fatigue syndrome.|pdf=|usr=}}
+{{tp|p=12715316|t=2003. Parvovirus B19 encephalitis presenting as immune restoration disease after highly active antiretroviral therapy for human immunodeficiency virus infection.|pdf=|usr=}}
+{{tp|p=12384834|t=2002. Active, fulminant, lethal myocarditis associated with parvovirus B19 infection in an infant.|pdf=|usr=}}
+{{tp|p=12471578|t=2002. Papular purpuric rash due to parvovirus B19 with distribution on the distal extremities and the face.|pdf=|usr=}}
+{{tp|p=11170925|t=2001. A syndrome resembling thrombotic thrombocytopenic purpura associated with human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=11106317|t=2001. Renal involvement of human parvovirus B19 in an immunocompetent host.|pdf=|usr=}}
+{{tp|p=10722434|t=2000. Raynaud's phenomenon as a manifestation of parvovirus B19 infection: case reports and review of parvovirus B19 rheumatic and vasculitic syndromes.|pdf=|usr=}}
+{{tp|p=10913398|t=2000. Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review.|pdf=|usr=}}
+{{tp|p=10451194|t=1999. Cardiorespiratory manifestations of parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=10476760|t=1999. Prolonged fever caused by parvovirus B19-induced meningitis: case report and review.|pdf=|usr=}}
+{{tp|p=9798055|t=1998. Parvovirus B19 infection associated with respiratory distress.|pdf=|usr=}}
+{{tp|p=9675471|t=1998. Papular-purpuric gloves and socks syndrome associated with acute parvovirus B19 infection: case report and review.|pdf=|usr=}}
+{{tp|p=9502455|t=1998. Life-threatening parvovirus B19-associated myocarditis and cardiac transplantation as possible therapy: two case reports.|pdf=|usr=}}
+{{tp|p=9564490|t=1998. Still's disease, severe thrombocytopenia, and acute hepatitis associated with acute parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=9564461|t=1998. Photo quiz II. Leukocytoclastic vasculitis secondary to parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=9195056|t=1997. Chronic parvovirus B19 infection resulting in chronic fatigue syndrome: case history and review.|pdf=|usr=}}
+{{tp|p=8783735|t=1996. Association of parvovirus B19 infection with giant cell arteritis.|pdf=|usr=}}
+{{tp|p=8816166|t=1996. Myopericarditis due to parvovirus B19 in an adult.|pdf=|usr=}}
+{{tp|p=8824988|t=1996. Acute bilateral carpal tunnel syndrome associated with human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=8645812|t=1995. Aseptic meningitis caused by parvovirus B19.|pdf=|usr=}}
+{{tp|p=8749627|t=1995. Spectrum of parvovirus B19 infection: analysis of an outbreak of 43 cases in Cadiz, Spain.|pdf=|usr=}}
+{{tp|p=8562756|t=1995. Juvenile dermatomyositis in a child infected with human parvovirus B19.|pdf=|usr=}}
+{{tp|p=7948543|t=1994. Pure red cell aplasia, peripheral thrombocytopenic purpura, and parvovirus B19 infection in a women seropositive for human immunodeficiency virus.|pdf=|usr=}}
+{{tp|p=1330011|t=1992. Chronic parvovirus infection in a presumably immunologically healthy woman.|pdf=|usr=}}
+{{tp|p=16812953|t=2006. Prevention of iatrogenic transmission of B19 infection: different approaches to detect, remove or inactivate virus contamination.|pdf=|usr=}}
+{{tp|p=11934222|t=2002. Humoral immune response to parvovirus B19 and serological diagnosis of B19 infection.|pdf=|usr=}}
+{{tp|p=10792401|t=2000. Lupus anticoagulant in a patient with parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=7955926|t=1994. Viral-associated haemophagocytosis and elevated serum TNF-alpha with parvovirus-B19-related pancytopenia in patients with hereditary spherocytosis.|pdf=|usr=}}
+{{tp|p=26833301|t=2016. Postinfectious glomerulonephritis secondary to Erythrovirus B19 (Parvovirus B19): case report and review of the literature.|pdf=|usr=}}
+{{tp|p=23442257|t=2014. Transition from endocapillary proliferative glomerulonephritis to membranoproliferative glomerulonephritis in a patient with a prolonged human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=16240895|t=2005. Characteristics of acute glomerulonephritis associated with human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=12708574|t=2003. Successful treatment of chronic parvovirus B19 infection by high-dose immunoglobulin.|pdf=|usr=}}
+{{tp|p=11924757|t=2002. Acute endocapillary proliferative glomerulonephritis associated with human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=11837804|t=2002. Association of parvovirus B19 infection with acute glomerulonephritis in healthy adults: case report and review of the literature.|pdf=|usr=}}
+{{tp|p=10749307|t=2000. Glomerulonephritis and Henoch-Schoenlein purpura associated with acute parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=12140110|t=2002. Case report of meningoencephalitis during a concomitant mumps and parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=23733615|t=2013. Chronic parvovirus infection in a pediatric cardiac transplant recipient: a case report.|pdf=|usr=}}
+{{tp|p=19286620|t=2009. Successful treatment with high-dose intravenous immunoglobulin for parvovirus b19 infection associated with acute fulminant hepatitis in a chinese child.|pdf=|usr=}}
+{{tp|p=18566354|t=2008. A case of catastrophic antiphospholipid syndrome in an adolescent girl with parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=16708143|t=2006. Fever and petechial rash associated with parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=8324977|t=1993. Parvovirus B19-induced chronic arthropathy in a child.|pdf=|usr=}}
+{{tp|p=16085027|t=2005. Diagnosis and management of human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=15776413|t=2005. Fatal course of parvovirus B19-associated myocarditis in a female liver transplant recipient.|pdf=|usr=}}
+{{tp|p=32156816|t=2020. RNA Binding Motif Protein RBM45 Regulates Expression of the 11-Kilodalton Protein of Parvovirus B19 through Binding to Novel Intron Splicing Enhancers.|pdf=|usr=}}
+{{tp|p=30159289|t=2018. Frequency of human Parvovirus B19 among patients with respiratory infection in Iran.|pdf=|usr=}}
+{{tp|p=17195827|t=2007. Papular purpuric gloves and socks syndrome. Presentation of a clinical case.|pdf=|usr=}}
+{{tp|p=31490394|t=2019. Syphilis and parvovirus B19 co-infection imitating a lupus nephropathy: A case report.|pdf=|usr=}}
+{{tp|p=31464949|t=2019. Parvovirus B19 infection presenting with neutropenia and thrombocytopenia: Three case reports.|pdf=|usr=}}
+{{tp|p=30142866|t=2018. Clinical heterogeneity of human parvovirus B19 infection following adult liver transplantation.|pdf=|usr=}}
+{{tp|p=19011502|t=2008. Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature.|pdf=|usr=}}
+{{tp|p=29531655|t=2018. Parvovirus B19-triggered Acute Hemolytic Anemia and Thrombocytopenia in a Child with Evans Syndrome.|pdf=|usr=}}
+{{tp|p=26517666|t=2015. Parvovirus B19 1A complete genome from a fatal case in Brazil.|pdf=|usr=}}
+{{tp|p=24714965|t=2014. Clinical features and laboratory findings of human parvovirus B19 in human immunodeficiency virus-infected patients.|pdf=|usr=}}
+{{tp|p=21739041|t=2011. Genotyping of human parvovirus B19 in clinical samples from Brazil and Paraguay using heteroduplex mobility assay, single-stranded conformation polymorphism and nucleotide sequencing.|pdf=|usr=}}
+{{tp|p=16951812|t=2006. Erythrovirus B19 infection in acquired immunodeficiency syndrome: screening by histopathology, immunohistochemistry, and in situ hybridization.|pdf=|usr=}}
+{{tp|p=1342709|t=1992. Human B19 parvovirus infection: an example of multiple pathogenic effects determined by differences in host susceptibility.|pdf=|usr=}}
+{{tp|p=2549345|t=1989. Human parvovirus (HPV/B19) infection with purpura.|pdf=|usr=}}
+{{tp|p=30533645|t=2018. Sequences of Seven Complete Genomes of Human Parvovirus B19.|pdf=|usr=}}
+{{tp|p=16361103|t=2006. Application of transmission electron microscopy to the clinical study of viral and bacterial infections: present and future.|pdf=|usr=}}
+{{tp|p=12920226|t=2003. Detection of parvovirus B19 capsid proteins in lymphocytic cells in synovial tissue of autoimmune chronic arthritis.|pdf=|usr=}}
+{{tp|p=30875983|t=2019. Synthesis of 3-(Imidazo[2,1-b]thiazol-6-yl)-2H-chromen-2-one Derivatives and Study of Their Antiviral Activity against Parvovirus B19.|pdf=|usr=}}
+{{tp|p=8139629|t=1994. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen).|pdf=|usr=}}
+{{tp|p=30587876|t=2018. A pediatric case with parvovirus B19-associated uveitis without autoantibody formation.|pdf=|usr=}}
+{{tp|p=16932438|t=2006. Viral nephropathy.|pdf=|usr=}}
+{{tp|p=28374737|t=2017. Extinct type of human parvovirus B19 persists in tonsillar B cells.|pdf=|usr=}}
+{{tp|p=22294016|t=2012. Reactive haemophagocytic syndrome associated with parvovirus B19 in a kidney-pancreas transplant patient.|pdf=|usr=}}
+{{tp|p=8730455|t=1996. Parvovirus B19 and hemodialysis.|pdf=|usr=}}
+{{tp|p=2762166|t=1989. Sequence of the right hand terminal palindrome of the human B19 parvovirus genome has the potential to form a 'stem plus arms' structure.|pdf=|usr=}}
+{{tp|p=25013465|t=2014. Gene expression analysis of potential genes and pathways involved in the pathogenic mechanisms of parvovirus B19 in human colorectal cancer.|pdf=|usr=}}
+{{tp|p=22740966|t=2012. High prevelance of human parvovirus infection in patients with malignant tumors.|pdf=|usr=}}
+{{tp|p=32391400|t=2020. Hyaluronidase-Facilitated High-Dose Subcutaneous IgG Effectively Controls Parvovirus B19 Infection in a Pediatric Cardiac Transplant Patient With Severe T-Cell Lymphopenia.|pdf=|usr=}}
+{{tp|p=32760751|t=2020. Parvovirus B19-Infected Tubulointerstitial Nephritis in Hereditary Spherocytosis.|pdf=|usr=}}
+{{tp|p=8065702|t=1994. Conjunctivitis caused by human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=17207644|t=2007. Human parvovirus B19, varicella zoster virus, and human herpesvirus-6 in mesenchymal stem cells of patients with osteoarthritis: analysis with quantitative real-time polymerase chain reaction.|pdf=|usr=}}
+{{tp|p=22254152|t=2012. Potential Infectious Etiology of Behcet's Disease.|pdf=|usr=}}
+{{tp|p=19418550|t=2009. Simultaneous acute splenic sequestration and transient aplastic crisis in children with sickle cell disease.|pdf=|usr=}}
+{{tp|p=26499513|t=2016. High Frequency of Detection by PCR of Viral Nucleic Acid in The Blood of Infants Presenting with Clinical Myocarditis.|pdf=|usr=}}
+{{tp|p=16282940|t=2005. Acute respiratory distress syndrome in a child with human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=25669893|t=2014. Parvovirus B19 associated acute cholestatic hepatitis.|pdf=|usr=}}
+{{tp|p=29853623|t=2018. Parvovirus B19: A Cause of Sepsislike Syndrome in an Infant.|pdf=|usr=}}
+{{tp|p=16253012|t=2005. Prolonged activation of virus-specific CD8+T cells after acute B19 infection.|pdf=|usr=}}
+{{tp|p=20436917|t=2010. Chloroquine and its derivatives exacerbate B19V-associated anemia by promoting viral replication.|pdf=|usr=}}
+{{tp|p=31086415|t=2019. The effects of human parvovirus VP1 unique region in a mouse model of allergic asthma.|pdf=|usr=}}
+{{tp|p=30114253|t=2018. The VP1 unique region of human parvovirus B19 and human bocavirus induce lung injury in naive Balb/c mice.|pdf=|usr=}}
+{{tp|p=28531186|t=2017. Parvovirus B19-induced vascular damage in the heart is associated with elevated circulating endothelial microparticles.|pdf=|usr=}}
+{{tp|p=26845771|t=2016. Parvovirus B19 Replication and Expression in Differentiating Erythroid Progenitor Cells.|pdf=|usr=}}
+{{tp|p=25462010|t=2014. Th17-related cytokines in systemic lupus erythematosus patients with dilated cardiomyopathies: a possible linkage to parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=25268969|t=2014. Effects of human Parvovirus B19 and Bocavirus VP1 unique region on tight junction of human airway epithelial A549 cells.|pdf=|usr=}}
+{{tp|p=23840852|t=2013. Exacerbating effects of human parvovirus B19 NS1 on liver fibrosis in NZB/W F1 mice.|pdf=|usr=}}
+{{tp|p=23776709|t=2013. Human parvovirus B19 induced apoptotic bodies contain altered self-antigens that are phagocytosed by antigen presenting cells.|pdf=|usr=}}
+{{tp|p=23737981|t=2013. Prevalence of human parvovirus B19, bocavirus, and PARV4 in blood samples from the general population of China and lack of a correlation between parvovirus and hepatitis B co-infection.|pdf=|usr=}}
+{{tp|p=23596524|t=2013. The determinants for the enzyme activity of human parvovirus B19 phospholipase A2 (PLA2) and its influence on cultured cells.|pdf=|usr=}}
+{{tp|p=23555760|t=2013. Human parvovirus B19 NS1 protein aggravates liver injury in NZB/W F1 mice.|pdf=|usr=}}
+{{tp|p=22912828|t=2012. Global co-existence of two evolutionary lineages of parvovirus B19 1a, different in genome-wide synonymous positions.|pdf=|usr=}}
+{{tp|p=22438961|t=2012. Green fluorescent protein (GFP) color reporter gene visualizes parvovirus B19 non-structural segment 1 (NS1) transfected endothelial modification.|pdf=|usr=}}
+{{tp|p=22413013|t=2012. Parvovirus b19 DNA CpG dinucleotide methylation and epigenetic regulation of viral expression.|pdf=|usr=}}
+{{tp|p=22235298|t=2012. High prevalence of human parvovirus 4 infection in HBV and HCV infected individuals in shanghai.|pdf=|usr=}}
+{{tp|p=18523634|t=2008. NS1 specific CD8+ T-cells with effector function and TRBV11 dominance in a patient with parvovirus B19 associated inflammatory cardiomyopathy.|pdf=|usr=}}
+{{tp|p=28459842|t=2017. Phosphorylated STAT5 directly facilitates parvovirus B19 DNA replication in human erythroid progenitors through interaction with the MCM complex.|pdf=|usr=}}
+{{tp|p=28328962|t=2017. The blood DNA virome in 8,000 humans.|pdf=|usr=}}
+{{tp|p=28264028|t=2017. Parvovirus B19 NS1 protein induces cell cycle arrest at G2-phase by activating the ATR-CDC25C-CDK1 pathway.|pdf=|usr=}}
+{{tp|p=21698228|t=2011. Productive parvovirus B19 infection of primary human erythroid progenitor cells at hypoxia is regulated by STAT5A and MEK signaling but not HIFalpha.|pdf=|usr=}}
+{{tp|p=29904309|t=2018. Hemophagocytic lymphohistiocytosis.|pdf=|usr=}}
+{{tp|p=22275777|t=2012. Focal segmental glomerulosclerosis and parvovirus B19.|pdf=|usr=}}
+{{tp|p=29967156|t=2018. Ancient human parvovirus B19 in Eurasia reveals its long-term association with humans.|pdf=|usr=}}
+{{tp|p=15289612|t=2004. The structure of human parvovirus B19.|pdf=|usr=}}
+{{tp|p=8755503|t=1996. Cryo-electron microscopy studies of empty capsids of human parvovirus B19 complexed with its cellular receptor.|pdf=|usr=}}
+{{tp|p=8618912|t=1995. Parvovirus B19 promoter at map unit 6 confers autonomous replication competence and erythroid specificity to adeno-associated virus 2 in primary human hematopoietic progenitor cells.|pdf=|usr=}}
+{{tp|p=24878787|t=2014. Frequency of antiparvovirus B19 antibodies in rheumatoid arthritis and systemic lupus erythematosus.|pdf=|usr=}}
+{{tp|p=30724999|t=2018. Parvovirus B19: Un virus ADN asociado a multiples manifestaciones cutaneas.|pdf=|usr=}}
+{{tp|p=17505669|t=2007. Detection of parvovirus B19 infection in formalin-fixed and paraffin-embedded placenta and fetal tissues.|pdf=|usr=}}
+{{tp|p=31448778|t=2019. TREATMENT STRATEGIES AND OUTCOME OF PARVOVIRUS B19 INFECTION IN KIDNEY TRANSPLANT RECIPIENTS: A CASE SERIES AND LITERATURE REVIEW OF 128 PATIENTS.|pdf=|usr=}}
+{{tp|p=23559294|t=2012. Glomerulopatia colapsante.|pdf=|usr=}}
+{{tp|p=24459081|t=2014. Neurological aspects of human parvovirus B19 infection: a systematic review.|pdf=|usr=}}
+{{tp|p=19942964|t=2009. Acquired aplastic anemia: correlation between etiology, pathophysiology, bone marrow histology and prognosis factors.|pdf=|usr=}}
+{{tp|p=21198754|t=2011. Comparison of Th-cell immunity against human bocavirus and parvovirus B19: proliferation and cytokine responses are similar in magnitude but more closely interrelated with human bocavirus.|pdf=|usr=}}
+{{tp|p=30487523|t=2018. Increased seroprevalence of HAV and parvovirus B19 in children and of HEV in adults at diagnosis of autoimmune hepatitis.|pdf=|usr=}}
+{{tp|p=27775080|t=2016. Substitution rate and natural selection in parvovirus B19.|pdf=|usr=}}
+{{tp|p=26611279|t=2015. Bones hold the key to DNA virus history and epidemiology.|pdf=|usr=}}
+{{tp|p=1652405|t=1991. Human parvovirus B19 and its associated diseases.|pdf=|usr=}}
+{{tp|p=27112783|t=2016. Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-beta treatment in patients with chronic viral cardiomyopathy.|pdf=|usr=}}
+{{tp|p=26133158|t=2016. Predictors of outcome in patients with parvovirus B19 positive endomyocardial biopsy.|pdf=|usr=}}
+{{tp|p=31917176|t=2020. Parvovirus B19 infection: A challenging cause of fulminant hepatitis.|pdf=|usr=}}
+{{tp|p=23886765|t=2014. Parvovirus B19 associated acute hepatitis and hepatosplenomegaly.|pdf=|usr=}}
+{{tp|p=12794260|t=2003. Systemic lupus erythematosus and parvovirus B-19: casual coincidence or causative culprit?|pdf=|usr=}}
+{{tp|p=19057847|t=2009. Seroprevalence of parvovirus B19 in fibromyalgia syndrome.|pdf=|usr=}}
+{{tp|p=17851708|t=2008. Different patterns of disease manifestations of parvovirus B19-associated reactive juvenile arthritis and the induction of antiphospholipid-antibodies.|pdf=|usr=}}
+{{tp|p=17622480|t=2008. Emerging lupus-like manifestations in acute parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=16421644|t=2006. Multiple small pulmonary emboli associated with transient antiphospholipid syndrome in human Parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=14749987|t=2004. Parvovirus B19-related chronic monoarthritis: immunohistochemical detection of virus-positive lymphocytes within the synovial tissue compartment: two reported cases.|pdf=|usr=}}
+{{tp|p=15045641|t=2004. Parvovirus B19 infection and myofasciitis.|pdf=|usr=}}
+{{tp|p=12189459|t=2002. Unusual localisation of chronic arthropathy in lumbar facet joints after parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=11147771|t=2000. Parovirus B19-associated mono- and oligoarticular arthritis may evolve into a chronic inflammatory arthropathy fulfilling criteria for rheumatoid arthritis or spondylarthropathy.|pdf=|usr=}}
+{{tp|p=10941809|t=2000. High incidence of parvovirus B19 DNA in synovial tissue of patients with undifferentiated mono- and oligoarthritis.|pdf=|usr=}}
+{{tp|p=8894369|t=1996. A case of parvovirus-B19 adult acute arthritis with some allergic disease clinical features.|pdf=|usr=}}
+{{tp|p=30973192|t=2019. Human parvovirus B19 in solid organ transplantation: Guidelines from the American society of transplantation infectious diseases community of practice.|pdf=|usr=}}
+{{tp|p=16313320|t=2005. Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients.|pdf=|usr=}}
+{{tp|p=10081630|t=1999. Human parvovirus B19 infection in organ transplant recipients.|pdf=|usr=}}
+{{tp|p=8826660|t=1996. Parvovirus B19 infection in a liver transplant recipient: case report and review in organ transplant recipients.|pdf=|usr=}}
+{{tp|p=22902951|t=2012. miRNA and tropism of human parvovirus B19.|pdf=|usr=}}
+{{tp|p=8074799|t=1994. Molecular, cellular and clinical aspects of parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=1651089|t=1991. The clinical spectrum of human parvovirus B19 infections.|pdf=|usr=}}
+{{tp|p=11095799|t=1999. Infection with Parvovirus B19.|pdf=|usr=}}
+{{tp|p=25703483|t=2015. Common childhood viral infections.|pdf=|usr=}}
+{{tp|p=17531174|t=2007. Antiphospholipid antibodies in response to infection.|pdf=|usr=}}
+{{tp|p=16568906|t=2006. Parvovirus variation for disease: a difference with RNA viruses?|pdf=|usr=}}
+{{tp|p=8794248|t=1996. Adeno-associated virus 2-mediated transduction and erythroid lineage-specific expression in human hematopoietic progenitor cells.|pdf=|usr=}}
+{{tp|p=24195090|t=2013. Pediatric parvovirus B19: spectrum of clinical manifestations.|pdf=|usr=}}
+{{tp|p=28288327|t=2017. Parvovirus B19 infection modulates the levels of cytokines in the plasma of rheumatoid arthritis patients.|pdf=|usr=}}
+{{tp|p=12120446|t=2002. Parvovirus B19: a review.|pdf=|usr=}}
+{{tp|p=20110633|t=2010. Parvovirus b19 DNA is commonly harboured in human skin.|pdf=|usr=}}
+{{tp|p=15645679|t=2004. Cell culture-based assay of parvovirus B19 and the relevance of animal model viruses.|pdf=|usr=}}
+{{tp|p=15645675|t=2004. Variants of B19.|pdf=|usr=}}
+{{tp|p=16401330|t=2005. Human parvovirus B19 infection in children with new onset Type 1 diabetes mellitus.|pdf=|usr=}}
+{{tp|p=22395961|t=2012. Acute fulminant hepatic failure associated with parvovirus B19 infection in an immunocompetent adult.|pdf=|usr=}}
+{{tp|p=22619569|t=2012. Parvovirus B19 infection and severe anemia in renal transplant recipients.|pdf=|usr=}}
+{{tp|p=19013331|t=2008. Viruses and kidney disease: beyond HIV.|pdf=|usr=}}
+{{tp|p=29587847|t=2018. High-sensitivity virus and mycoplasma screening test reveals high prevalence of parvovirus B19 infection in human synovial tissues and bone marrow.|pdf=|usr=}}
+{{tp|p=8991535|t=1996. Parvoviruses and bone marrow failure.|pdf=|usr=}}
+{{tp|p=28864597|t=2017. Parvovirus B19 Infection in Children With Arterial Ischemic Stroke.|pdf=|usr=}}
+{{tp|p=30378400|t=2018. Akutt glomerulonefritt utlost av parvovirus B19.|pdf=|usr=}}
+{{tp|p=21483465|t=2010. Parvovirus B19 - Revised.|pdf=|usr=}}
+{{tp|p=22998193|t=2013. Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening.|pdf=|usr=}}
+{{tp|p=21303368|t=2011. Distribution of parvovirus B19 DNA in blood compartments and persistence of virus in blood donors.|pdf=|usr=}}
+{{tp|p=19144091|t=2009. Clinical implications of quantitative real time-polymerase chain reaction of parvovirus B19 in kidney transplant recipients - a prospective study.|pdf=|usr=}}
+{{tp|p=16441366|t=2006. Parvovirus B19-induced anemia in renal transplantation: a role for rHuEPO in resistance to classical treatment.|pdf=|usr=}}
+{{tp|p=29184906|t=2017. Parvovirus B19 in the Context of Hematopoietic Stem Cell Transplantation: Evaluating Cell Donors and Recipients.|pdf=|usr=}}
+{{tp|p=8212203|t=1993. Parvovirus B19 infection in pediatric transplant patients.|pdf=|usr=}}
+{{tp|p=8434395|t=1993. Parvovirus B19 infection causing pure red cell aplasia in a recipient of pediatric donor kidneys.|pdf=|usr=}}
+{{tp|p=27511498|t=2016. Serological prevalence of human parvovirus B19 in diseases or disordersrelated to different human body systems.|pdf=|usr=}}
+{{tp|p=21200105|t=2010. Acute pericarditis and transient erythroblastopenia associated with human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=29785793|t=2018. Outcome of fetuses with congenital parvovirus B19 infection: systematic review and meta-analysis.|pdf=|usr=}}
+{{tp|p=24862083|t=2014. Cause of fetal demise in first-trimester parvovirus infection: anemia, placentitis or myocarditis?|pdf=|usr=}}
+{{tp|p=22344957|t=2012. Polymicrogyria in a fetus with human parvovirus B19 infection: a case with radiologic-pathologic correlation.|pdf=|usr=}}
+{{tp|p=21433169|t=2011. Congenital hypoplasia of the abdominal wall muscles following fetal ascites due to parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=11555463|t=2001. Fetal parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=8932634|t=1996. Spontaneous resolution of non-immune hydrops fetalis secondary to transplacental parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=28410597|t=2017. The role of nuclear localization signal in parvovirus life cycle.|pdf=|usr=}}
+{{tp|p=27639978|t=2016. Existence of various human parvovirus B19 genotypes in Chinese plasma pools: genotype 1, genotype 3, putative intergenotypic recombinant variants and new genotypes.|pdf=|usr=}}
+{{tp|p=20950445|t=2010. Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V).|pdf=|usr=}}
+{{tp|p=28806616|t=2017. Parvovirus B19 integration into human CD36+ erythroid progenitor cells.|pdf=|usr=}}
+{{tp|p=28500881|t=2017. A Parvovirus B19 synthetic genome: sequence features and functional competence.|pdf=|usr=}}
+{{tp|p=24889255|t=2014. Parvovirus B19 VLP recognizes globoside in supported lipid bilayers.|pdf=|usr=}}
+{{tp|p=24418564|t=2014. The human parvovirus B19 non-structural protein 1 N-terminal domain specifically binds to the origin of replication in the viral DNA.|pdf=|usr=}}
+{{tp|p=24074579|t=2013. Human parvovirus B19 infection leads to downregulation of thyroid, estrogen, and retinoid hormone receptor expression.|pdf=|usr=}}
+{{tp|p=21236463|t=2011. Transactivation of human parvovirus B19 gene expression in endothelial cells by adenoviral helper functions.|pdf=|usr=}}
+{{tp|p=20457462|t=2010. Characterization of the gene expression profile of human bocavirus.|pdf=|usr=}}
+{{tp|p=19758675|t=2009. Molecular characterization of human parvovirus B19 genotypes 2 and 3.|pdf=|usr=}}
+{{tp|p=19450862|t=2009. Antibody-mediated opsonization of red blood cells in parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=18838151|t=2008. Functional analysis and quantitative determination of the expression profile of human parvovirus B19.|pdf=|usr=}}
+{{tp|p=18252260|t=2008. VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones.|pdf=|usr=}}
+{{tp|p=16643977|t=2006. Survival of parvovirus B19-infected cells by cellular autophagy.|pdf=|usr=}}
+{{tp|p=16246390|t=2006. Human parvovirus B19 infection of monocytic cell line U937 and antibody-dependent enhancement.|pdf=|usr=}}
+{{tp|p=16242744|t=2006. Parvovirus uncoating in vitro reveals a mechanism of DNA release without capsid disassembly and striking differences in encapsidated DNA stability.|pdf=|usr=}}
+{{tp|p=16427674|t=2006. Parvovirus B19 genome as a single, two-state replicative and transcriptional unit.|pdf=|usr=}}
+{{tp|p=15661151|t=2005. Parvovirus B19 does not bind to membrane-associated globoside in vitro.|pdf=|usr=}}
+{{tp|p=15327892|t=2004. Hypoxia enhances human B19 erythrovirus gene expression in primary erythroid cells.|pdf=|usr=}}
+{{tp|p=15518826|t=2004. Human Parvovirus B19 nonstructural protein transactivates the p21/WAF1 through Sp1.|pdf=|usr=}}
+{{tp|p=14972543|t=2004. Construction and sequencing of an infectious clone of the human parvovirus B19.|pdf=|usr=}}
+{{tp|p=12620794|t=2003. Identification of a nonconventional motif necessary for the nuclear import of the human parvovirus B19 major capsid protein (VP2).|pdf=|usr=}}
+{{tp|p=12359439|t=2002. Identification and characterization of a second novel human erythrovirus variant, A6.|pdf=|usr=}}
+{{tp|p=12441066|t=2002. A new parvovirus genotype persistent in human skin.|pdf=|usr=}}
+{{tp|p=11853402|t=2002. NS1 protein of parvovirus B19 interacts directly with DNA sequences of the p6 promoter and with the cellular transcription factors Sp1/Sp3.|pdf=|usr=}}
+{{tp|p=11878897|t=2001. The small 11-kDa protein from B19 parvovirus binds growth factor receptor-binding protein 2 in vitro in a Src homology 3 domain/ligand-dependent manner.|pdf=|usr=}}
+{{tp|p=10964772|t=2000. Identification of a novel RNA splicing pattern as a basis of restricted cell tropism of erythrovirus B19.|pdf=|usr=}}
+{{tp|p=11118359|t=2000. Different patterns of restriction to B19 parvovirus replication in human blast cell lines.|pdf=|usr=}}
+{{tp|p=7571426|t=1995. Analysis of the complete nucleotide sequences of goose and muscovy duck parvoviruses indicates common ancestral origin with adeno-associated virus 2.|pdf=|usr=}}
+{{tp|p=7530397|t=1995. Peptides derived from the unique region of B19 parvovirus minor capsid protein elicit neutralizing antibodies in rabbits.|pdf=|usr=}}
+{{tp|p=7544049|t=1995. Most of the VP1 unique region of B19 parvovirus is on the capsid surface.|pdf=|usr=}}
+{{tp|p=28960143|t=2018. Antigenicity analysis of human parvovirus B19-VP1u protein in the induction of anti-phospholipid syndrome.|pdf=|usr=}}
+{{tp|p=26786960|t=2016. Hepatic inflammation resulting from localized, subcutaneous expression of Parvovirus VP1u capsid protein: Importance and implication.|pdf=|usr=}}
+{{tp|p=26632342|t=2016. Human parvovirus B19 VP1u Protein as inflammatory mediators induces liver injury in naive mice.|pdf=|usr=}}
+{{tp|p=31487941|t=2019. Establishment of a Parvovirus B19 NS1-Expressing Recombinant Adenoviral Vector for Killing Megakaryocytic Leukemia Cells.|pdf=|usr=}}
+{{tp|p=31083301|t=2019. Parvovirus B19 Uncoating Occurs in the Cytoplasm without Capsid Disassembly and It Is Facilitated by Depletion of Capsid-Associated Divalent Cations.|pdf=|usr=}}
+{{tp|p=30845701|t=2019. Telbivudine Reduces Parvovirus B19-Induced Apoptosis in Circulating Angiogenic Cells.|pdf=|usr=}}
+{{tp|p=31216741|t=2019. Systematic Review of PCR Proof of Parvovirus B19 Genomes in Endomyocardial Biopsies of Patients Presenting with Myocarditis or Dilated Cardiomyopathy.|pdf=|usr=}}
+{{tp|p=31323869|t=2019. Advances in the Development of Antiviral Strategies against Parvovirus B19.|pdf=|usr=}}
+{{tp|p=30366357|t=2018. Evidence of Human Parvovirus B19 Infection in the Post-Mortem Brain Tissue of the Elderly.|pdf=|usr=}}
+{{tp|p=28608818|t=2017. Impact of Parvovirus B19 Viremia in Liver Transplanted Children on Anemia: A Retrospective Study.|pdf=|usr=}}
+{{tp|p=27690083|t=2016. The VP1u Receptor Restricts Parvovirus B19 Uptake to Permissive Erythroid Cells.|pdf=|usr=}}
+{{tp|p=26927158|t=2016. The Receptor-Binding Domain in the VP1u Region of Parvovirus B19.|pdf=|usr=}}
+{{tp|p=8553651|t=1995. Multiple organ dysfunction caused by parvovirus B19.|pdf=|usr=}}
+{{tp|p=24772258|t=2014. Molecular phenotypes of human parvovirus B19 in patients with myocarditis.|pdf=|usr=}}
+{{tp|p=26566485|t=2015. Acute encephalitis and encephalopathy associated with human parvovirus B19 infection in children.|pdf=|usr=}}
+{{tp|p=19705505|t=2009. Parvovirus B19 induced hepatic failure in an adult requiring liver transplantation.|pdf=|usr=}}
+{{tp|p=17461508|t=2007. Pure red cell aplasia due to parvovirus B19 infection after liver transplantation: a case report and review of the literature.|pdf=|usr=}}
+{{tp|p=25616288|t=2015. [Clinical features of childhood hemophagocytic syndrome and its association with human parvovirus B19 infection].|pdf=|usr=}}
+{{tp|p=20113609|t=2009. [Association of human parvovirus B19 infection and childhood idiopathic thrombocytopenic purpura: a meta analysis of Chinese literatures].|pdf=|usr=}}
+{{tp|p=9424130|t=1997. Crioglobulinemia e infeccion por parvovirus B19.|pdf=|usr=}}
+{{tp|p=32101607|t=2020. Parvovirus B19-induced angiogenesis in fulminant myocarditis.|pdf=|usr=}}
+{{tp|p=24289269|t=2014. Parvovirus B19 at the culprit coronary stenosis predicts outcome after stenting.|pdf=|usr=}}
+{{tp|p=11152317|t=2000. Quantitative evidence for persistence of human parvovirus B19 DNA in an immunocompetent individual.|pdf=|usr=}}
+{{tp|p=10614957|t=1999. Occurrence and clinical role of active parvovirus B19 infection in transplant recipients.|pdf=|usr=}}
+{{tp|p=8641299|t=1996. Parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=9031882|t=1996. Detection of parvovirus B19 in skin biopsy, serum, and bone marrow of a patient with fever, rash, and polyarthritis followed by pneumonia, pericardial effusion, and hepatitis.|pdf=|usr=}}
+{{tp|p=10210793|t=1999. Henoch-Schonlein syndrome associated with human Parvovirus B19 primary infection.|pdf=|usr=}}
+{{tp|p=18691322|t=2008. Parvovirus B19 infection as trigger of graft vs. host disease.|pdf=|usr=}}
+{{tp|p=7859882|t=1995. Pure red cell aplasia caused by parvovirus B19 infection in a renal transplant recipient.|pdf=|usr=}}
+{{tp|p=31476088|t=2019. Immunosuppression in inflammatory cardiomyopathy and parvovirus B19 persistence.|pdf=|usr=}}
+{{tp|p=18549931|t=2008. Parvovirus B19 infection and systemic lupus erythematosus: Activation of an aberrant pathway?|pdf=|usr=}}
+{{tp|p=17693235|t=2007. Parvovirus B19 infection as a cause of cytopenia with a lupus-like presentation in the elderly: A case report.|pdf=|usr=}}
+{{tp|p=17098597|t=2006. Parvovirus B19 reactivation presenting as neutropenia after rituximab treatment.|pdf=|usr=}}
+{{tp|p=9481569|t=1998. Evaluation of Parvo B19, CMV and HPV viruses in human aborted material using the polymerase chain reaction technique.|pdf=|usr=}}
+{{tp|p=20155703|t=2010. Acute ophthalmoparesis associated with human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=30467085|t=2018. Fetal stroke and cerebrovascular disease: Advances in understanding from lenticulostriate and venous imaging, alloimmune thrombocytopaenia and monochorionic twins.|pdf=|usr=}}
+{{tp|p=18629535|t=2009. Prolonged anemia by superinfection of parvovirus B19 in a boy with enterohemorrhagic Escherichia coli O157-associated hemolytic uremic syndrome.|pdf=|usr=}}
+{{tp|p=11277389|t=2001. Neuralgic amyotrophy associated with parvovirus B19 infection in a child.|pdf=|usr=}}
+{{tp|p=10653351|t=2000. Myocarditis associated with parvovirus B19 infection in two siblings with merosin-deficient congenital muscular dystrophy.|pdf=|usr=}}
+{{tp|p=7588963|t=1995. Kawasaki disease associated with parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=1468455|t=1992. Different syndromes associated with B19 parvovirus viraemia in paediatric patients: report of four cases.|pdf=|usr=}}
+{{tp|p=10394046|t=1999. Human parvovirus B19 infection in multiple sclerosis.|pdf=|usr=}}
+{{tp|p=22428480|t=2012. Human parvovirus B 19 and Epstein-Barr virus co-infection in a child with hereditary spherocytosis.|pdf=|usr=}}
+{{tp|p=30028234|t=2018. The clinical use of parvovirus B19 assays: recent advances.|pdf=|usr=}}
+{{tp|p=19060481|t=2008. Disturbance of cerebral neuronal migration following congenital parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=11125248|t=2001. Recombinant parvovirus B19 empty capsids inhibit fetal hematopoietic colony formation in vitro.|pdf=|usr=}}
+{{tp|p=25313841|t=2015. Clinical features of 10 fetuses with prenatally diagnosed parvovirus b19 infection and fetal hydrops.|pdf=|usr=}}
+{{tp|p=16216706|t=2005. Sudden cardiac death in a 5-year-old girl associated with parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=32668397|t=2020. The landscape of persistent human DNA viruses in femoral bone.|pdf=|usr=}}
+{{tp|p=32495258|t=2020. Sudden death of a young adult with coronary artery vasculitis, coronary aneurysms, parvovirus B19 infection and Kawasaki disease.|pdf=|usr=}}
+{{tp|p=24781135|t=2014. The presence of enterovirus, adenovirus, and parvovirus B19 in myocardial tissue samples from autopsies: an evaluation of their frequencies in deceased individuals with myocarditis and in non-inflamed control hearts.|pdf=|usr=}}
+{{tp|p=7498847|t=1995. Parvovirus B19--ein weitverbreitetes, wenig bekanntes Virus. Von Ringelroteln uber Arthropathie bis zur chronischen Anamie.|pdf=|usr=}}
+{{tp|p=1778531|t=1991. Humanes Parvovirus B19--wirklich nur "Ringelroteln"? Aussergewohnliche Krankheitsverlaufe bei Kindern und Jugendlichen.|pdf=|usr=}}
+{{tp|p=31605404|t=2020. Prevention of parvovirus B19-induced repetitive acute kidney failure by subcutaneous immunoglobulins.|pdf=|usr=}}
+{{tp|p=32286103|t=2020. Persistence of Parvovirus B19 in liver from transplanted patients with acute liver failure.|pdf=|usr=}}
+{{tp|p=25034095|t=2016. Gianotti-Crosti syndrome associated with Ebstein-Barr virus and Parvovirus B-19 coinfection in a male adult: case report and review of the literature.|pdf=|usr=}}
+{{tp|p=12746805|t=2003. Glomerulonefriti post-infettive.|pdf=|usr=}}
+{{tp|p=15906067|t=2005. Prevalence of parvovirus B19-specific antibodies and of viral DNA in patients with endogenous uveitis.|pdf=|usr=}}
+{{tp|p=21051853|t=2010. Pregnancy loss ascribable to parvovirus B19/erythrovirus is associated with a high prevalence of trisomy.|pdf=|usr=}}
+{{tp|p=16940737|t=2007. Prolonged parvovirus b19 viremia in spite of neutralizing antibodies after erythema infectiosum in pregnancy.|pdf=|usr=}}
+{{tp|p=11114822|t=2000. Erythroblastopenia and Parvovirus B19 infection in a healthy child.|pdf=|usr=}}
+{{tp|p=24365423|t=2014. Measles, mumps, rubella, and human parvovirus B19 infections and neurologic disease.|pdf=|usr=}}
+{{tp|p=8707582|t=1996. Dermatologische Symptomatik bei Parvovirus B19-Infektionen.|pdf=|usr=}}
+{{tp|p=8567265|t=1995. Das humane Parvovirus B19 und seine klinische Bedeutung.|pdf=|usr=}}
+{{tp|p=2537803|t=1989. Die Parvovirus B19-Infektion: nicht nur das Exanthem der "Ringelroteln".|pdf=|usr=}}
+{{tp|p=18230640|t=2008. Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis.|pdf=|usr=}}
+{{tp|p=9352328|t=1997. Parvovirus [correction of Parovirus] B19-induced red cell aplasia in solid-organ transplant recipients. Two case reports and review of the literature.|pdf=|usr=}}
+{{tp|p=17178665|t=2006. Parvovirus B19 infection in children with a variety of hematological disorders.|pdf=|usr=}}
+{{tp|p=16019474|t=2005. Acquired red cell aplasia in association with the use of recombinant erythropoietin in chronic renal failure.|pdf=|usr=}}
+{{tp|p=21969057|t=2012. Acute fulminant hepatitis with bone marrow failure in an adult due to parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=7489971|t=1995. Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia.|pdf=|usr=}}
+{{tp|p=22872003|t=2012. miRNA as activity markers in Parvo B19 associated heart disease.|pdf=|usr=}}
+{{tp|p=7713756|t=1995. Combined immunocytochemistry and non-isotopic in situ hybridization for the ultrastructural investigation of human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=8360079|t=1993. Intracellular localization of parvovirus B19 nucleic acid at the ultrastructural level by in situ hybridization with digoxigenin-labelled probes.|pdf=|usr=}}
+{{tp|p=8557804|t=1995. Viral arthritis: the lessons of parvovirus B19.|pdf=|usr=}}
+{{tp|p=16972759|t=2006. Role of integrin cross-regulation in parvovirus B19 targeting.|pdf=|usr=}}
+{{tp|p=16386644|t=2005. IgE, CD8(+)CD60+ T cells and IFN-alpha in human immunity to parvovirus B19 in selective IgA deficiency.|pdf=|usr=}}
+{{tp|p=26475096|t=2015. PRDM1 expression via human parvovirus B19 infection plays a role in the pathogenesis of Hashimoto thyroiditis.|pdf=|usr=}}
+{{tp|p=23683879|t=2013. Post-infectious acute glomerulonephritis and transient coagulation factor XIII deficiency associated with acute parvovirus B19 infection in a young woman--reply.|pdf=|usr=}}
+{{tp|p=23683878|t=2013. Post-infectious acute glomerulonephritis and transient coagulation factor XIII deficiency associated with acute parvovirus B19 infection in a young woman.|pdf=|usr=}}
+{{tp|p=22939574|t=2013. Kikuchi-Fujimoto lymphadenitis: role of parvovirus B-19, Epstein-Barr virus, human herpesvirus 6, and human herpesvirus 8.|pdf=|usr=}}
+{{tp|p=22819999|t=2012. Proliferative glomerulonephritis with monoclonal immunoglobulin G3kappa deposits in association with parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=12874772|t=2003. Acute parvovirus B19 infection associated with myocarditis in an immunocompetent adult.|pdf=|usr=}}
+{{tp|p=12605372|t=2003. Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease.|pdf=|usr=}}
+{{tp|p=11274646|t=2001. Fatal parvovirus myocarditis in a 5-year-old girl.|pdf=|usr=}}
+{{tp|p=11112222|t=2000. Fatal intrauterine adenoviral endomyocarditis with aortic and pulmonary valve stenosis: diagnosis by polymerase chain reaction.|pdf=|usr=}}
+{{tp|p=10685629|t=2000. Unusual bone marrow manifestations of parvovirus B19 infection in immunocompromised patients.|pdf=|usr=}}
+{{tp|p=10821497|t=2000. The cutaneous manifestations of human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=10029458|t=1999. Parvovirus B19 in fetal hydrops.|pdf=|usr=}}
+{{tp|p=9781644|t=1998. Polymerase chain reaction amplification of archival material for Epstein-Barr virus, cytomegalovirus, human herpesvirus 6, and parvovirus B19 in children with bone marrow hemophagocytosis.|pdf=|usr=}}
+{{tp|p=9224741|t=1997. Human parvovirus B19 in bone marrows from adults with acquired immunodeficiency syndrome: a comparative study using in situ hybridization and immunohistochemistry.|pdf=|usr=}}
+{{tp|p=20818959|t=2010. Pregnancy-associated parvovirus B19 infection causing postinfectious glomerulonephritis.|pdf=|usr=}}
+{{tp|p=19064815|t=2009. Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study.|pdf=|usr=}}
+{{tp|p=12880679|t=2003. Tumor necrosis factor (TNF)alpha and its soluble receptor (sTNFR) p75 during acute human parvovirus B19 infection in children.|pdf=|usr=}}
+{{tp|p=16041107|t=2005. Acute liver failure and severe hemophagocytosis secondary to parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=31741634|t=2019. Parvovirus B19 Infection in Human Bone Marrow Mesenchymal Stem Cells Affects Gene Expression of IL-6 and TNF-alpha and also Affects Hematopoietic Stem Cells Differentiation.|pdf=|usr=}}
+{{tp|p=12452123|t=2000. Erythrovirus B19 infection in humans.|pdf=|usr=}}
+{{tp|p=9529776|t=1998. Raised IgM antibodies to parvovirus B19 in juvenile rheumatoid arthritis.|pdf=|usr=}}
+{{tp|p=32036592|t=2020. Acute Necrotizing Encephalopathy of Childhood Associated with Human Parvovirus B19 Infection.|pdf=|usr=}}
+{{tp|p=22544695|t=2013. Immune thrombocytopenic purpura due to mixed viral infections.|pdf=|usr=}}
+{{tp|p=19347671|t=2009. Red baby syndrome a new disease due to parvovirus B-19 observed in Kerala.|pdf=|usr=}}
+{{tp|p=17978457|t=2007. Laryngitis and neutropenia from parvovirus-B19.|pdf=|usr=}}
+{{tp|p=30940465|t=2019. Infections with DNA Viruses, Adenovirus, Polyomaviruses, and Parvovirus B19 in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies.|pdf=|usr=}}
+{{tp|p=20466274|t=2010. Viral impact on long-term kidney graft function.|pdf=|usr=}}
+{{tp|p=16297742|t=2005. Viral arthritis.|pdf=|usr=}}
+{{tp|p=1315813|t=1992. Impact of child day care on infectious diseases in adults.|pdf=|usr=}}
+{{tp|p=14556063|t=2003. Influenza B pneumonia with Staphylococcus aureus superinfection associated with parvovirus B19 and concomitant agranulocytosis.|pdf=|usr=}}
+{{tp|p=10219641|t=1999. Human parvovirus B19-associated disease in bone marrow transplantation.|pdf=|usr=}}
+{{tp|p=1917040|t=1991. Acute obstructive respiratory diseases in infants and children associated with parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=2544532|t=1989. Human parvovirus B19 infection associated with vascular purpura and vasculitis.|pdf=|usr=}}
+{{tp|p=2822582|t=1987. Human parvovirus B19 infection and juvenile chronic polyarthritis.|pdf=|usr=}}
+{{tp|p=18280593|t=2009. Giant cell myocarditis triggered by a parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=17098306|t=2007. Tako-Tsubo cardiomyopathy (apical ballooning) with parvovirus B19 genome in endomyocardial biopsy.|pdf=|usr=}}
+{{tp|p=17010458|t=2006. Cardiac troponin I release in non-ischemic reversible myocardial injury from parvovirus B19 myocarditis.|pdf=|usr=}}
+{{tp|p=26147127|t=2015. Remitting seronegative symmetrical synovitis with pitting edema associated with parvovirus B19 infection: two new cases and review of the comorbidities.|pdf=|usr=}}
+{{tp|p=23113722|t=2013. Sweet's syndrome and acute parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=15540900|t=2004. Successful treatment with cyclosporine and high-dose gamma immunoglobulin for persistent parvovirus B19 infection in a patient with refractory autoimmune hemolytic anemia.|pdf=|usr=}}
+{{tp|p=15218970|t=2004. Successful bone marrow transplantation for severe aplastic anemia in a patient with persistent human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=15239401|t=2004. Fulminant hemophagocytic syndrome with a high interferon gamma level diagnosed as macrophage activation syndrome.|pdf=|usr=}}
+{{tp|p=11594514|t=2001. Expression of p53 and Ki-67 antigen in bone marrow giant proerythroblasts associated with human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=9631589|t=1998. Increase of platelet-associated IgG (PA-IgG) and hemophagocytosis of neutrophils and platelets in parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=18384396|t=2009. Promoter methylation of P15(INK4B) gene is possibly associated with parvovirus B19 infection in adult acute leukemias.|pdf=|usr=}}
+{{tp|p=28573901|t=2017. A Case Report of Parvovirus B19 Infection in a Renal Allograft.|pdf=|usr=}}
+{{tp|p=10036637|t=1998. Human parvovirus B19 in rheumatoid arthritis.|pdf=|usr=}}
+{{tp|p=16503960|t=2006. Parvovirus encephalitis and pneumonia in an immunocompetent adult.|pdf=|usr=}}
+{{tp|p=18536522|t=2008. Human bocavirus--a novel parvovirus to infect humans.|pdf=|usr=}}
+{{tp|p=18431072|t=2008. Variants of parvovirus B19: bioinformatical evaluation of nested PCR assays.|pdf=|usr=}}
+{{tp|p=25582535|t=2015. Viral infections in acute graft-versus-host disease: a review of diagnostic and therapeutic approaches.|pdf=|usr=}}
+{{tp|p=24726401|t=2014. Different patterns of skin manifestations associated with parvovirus B19 primary infection in adults.|pdf=|usr=}}
+{{tp|p=25454032|t=2014. Exanthems associated with parvovirus B19 infection in adults.|pdf=|usr=}}
+{{tp|p=22980284|t=2012. Wells syndrome in a child triggered by parvovirus B19 infection?|pdf=|usr=}}
+{{tp|p=19293017|t=2009. Bullous papular-purpuric gloves and socks syndrome in a 42-year-old female: molecular detection of parvovirus B19 DNA in lesional skin.|pdf=|usr=}}
+{{tp|p=17224386|t=2007. Wells' syndrome after primoinfection by parvovirus B19 in a child.|pdf=|usr=}}
+{{tp|p=16635678|t=2006. Presence of perineuritis in a case of papular purpuric gloves and socks syndrome associated with mononeuritis multiplex attributable to B19 parvovirus.|pdf=|usr=}}
+{{tp|p=12399769|t=2002. Gloves and socks syndrome: early and late histopathologic features.|pdf=|usr=}}
+{{tp|p=1401292|t=1992. Koplik spots and a purpuric eruption associated with parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=26320984|t=2015. Non HCV-related infectious cryoglobulinemia vasculitis: Results from the French nationwide CryoVas survey and systematic review of the literature.|pdf=|usr=}}
+{{tp|p=32127272|t=2020. Viral Myocarditis-Incidence, Diagnosis and Management.|pdf=|usr=}}
+{{tp|p=8151074|t=1994. Human parvovirus B19 antibodies in infantile autism.|pdf=|usr=}}
+{{tp|p=1654342|t=1991. Tonic pupils and human parvovirus (B19) infection.|pdf=|usr=}}
+{{tp|p=26644521|t=2016. The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease.|pdf=|usr=}}
+{{tp|p=17039168|t=2001. Pericardial effusion and cardiomyopathy following arthritis with parvovirus B19 infection: response to intravenous immunoglobulin.|pdf=|usr=}}
+{{tp|p=17039152|t=2001. Can parvovirus B19 infection trigger adult Still's disease? Report of a case controlled with infliximab.|pdf=|usr=}}
+{{tp|p=19078035|t=1996. Parvovirus b19 infection associated with acute hepatitis, arthralgias, and rash.|pdf=|usr=}}
+{{tp|p=30897374|t=2019. The risk of maternal parvovirus B19 infection during pregnancy on fetal loss and fetal hydrops: A systematic review and meta-analysis.|pdf=|usr=}}
+{{tp|p=27664778|t=2016. Detection of parvovirus B19 DNA in blood: Viruses or DNA remnants?|pdf=|usr=}}
+{{tp|p=27130981|t=2016. Focal epilepsy as a long term sequela of Parvovirus B19 encephalitis.|pdf=|usr=}}
+{{tp|p=26433772|t=2015. Human parvovirus B19 and autoimmune diseases. Review of the literature and pathophysiological hypotheses.|pdf=|usr=}}
+{{tp|p=23916377|t=2013. Low-level DNAemia of parvovirus B19 (genotypes 1-3) in adult transplant recipients is not associated with anaemia.|pdf=|usr=}}
+{{tp|p=23522566|t=2013. Increased IL-6 detection in adult and pediatric lymphoid tissue harboring parvovirus B19.|pdf=|usr=}}
+{{tp|p=23182456|t=2013. Neurologic consequence of a parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=22789138|t=2012. PVB19-associated purpuric-petechial eruption with Henoch Schonlein-like distribution.|pdf=|usr=}}
+{{tp|p=19058999|t=2009. Placental endothelial cells can be productively infected by Parvovirus B19.|pdf=|usr=}}
+{{tp|p=18313977|t=2008. Fulminant myocarditis associated with parvovirus B19 infection in a child.|pdf=|usr=}}
+{{tp|p=17174596|t=2007. A possible parvovirus B19 encephalitis in an immunocompetent adult patient.|pdf=|usr=}}
+{{tp|p=17337241|t=2007. Parvovirus B19-brain interactions: infection, autoimmunity, or both?|pdf=|usr=}}
+{{tp|p=16569510|t=2006. Genetic variants of parvovirus B19 identified in the United Kingdom: implications for diagnostic testing.|pdf=|usr=}}
+{{tp|p=15797368|t=2005. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.|pdf=|usr=}}
+{{tp|p=15288611|t=2004. Analysing myocardial tissue from explanted hearts of heart transplant recipients and multi-organ donors for the presence of parvovirus B19 DNA.|pdf=|usr=}}
+{{tp|p=15288608|t=2004. Long-term parvovirus B19 viraemia associated with pure red cell aplasia after allogeneic bone marrow transplantation.|pdf=|usr=}}
+{{tp|p=12927746|t=2003. B19 virus genome diversity: epidemiological and clinical correlations.|pdf=|usr=}}
+{{tp|p=12637086|t=2003. B19 virus infection in renal transplant recipients.|pdf=|usr=}}
+{{tp|p=12367657|t=2002. Presence of parvovirus B19 DNA in chronic urticaric and healthy human skin.|pdf=|usr=}}
+{{tp|p=12367647|t=2002. Chronic human parvovirus B19 infection in rheumatic disease of childhood and adolescence.|pdf=|usr=}}
+{{tp|p=11166667|t=2001. Chronic autoimmune thrombopenia/neutropenia in a boy with persistent parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=10548133|t=1999. Acute parvovirus B19 infection in connection with a flare of systemic lupus erythematodes in a female patient.|pdf=|usr=}}
+{{tp|p=10405890|t=1999. Parvovirus B19 infection in thoracic organ transplant recipients.|pdf=|usr=}}
+{{tp|p=29185410|t=2017. Parvovirus B19: A Rare Cause of Post-renal Transplant Anemia.|pdf=|usr=}}
+{{tp|p=19586495|t=2009. Fulminant and accelerated presentation of dermatomyositis in two previously healthy young adult males: a potential role for endotheliotropic viral infection.|pdf=|usr=}}
+{{tp|p=18537856|t=2008. Parvovirus B19-associated catastrophic endothelialitis with a Degos-like presentation.|pdf=|usr=}}
+{{tp|p=15268707|t=2004. Pityriasis lichenoides: a cytotoxic T-cell-mediated skin disorder. Evidence of human parvovirus B19 DNA in nine cases.|pdf=|usr=}}
+{{tp|p=14675284|t=2004. Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma.|pdf=|usr=}}
+{{tp|p=12453298|t=2002. Parvovirus B19 associated adult Henoch Schonlein purpura.|pdf=|usr=}}
+{{tp|p=11168747|t=2001. The cutaneous pathology of lupus erythematosus: a review.|pdf=|usr=}}
+{{tp|p=11100810|t=2000. A causal role for parvovirus B19 infection in adult dermatomyositis and other autoimmune syndromes.|pdf=|usr=}}
+{{tp|p=9870672|t=1998. A distinctive cutaneous reaction pattern indicative of infection by reactive arthropathy-associated microbial pathogens: the superantigen ID reaction.|pdf=|usr=}}
+{{tp|p=7560352|t=1995. Human parvovirus B19 infection: immunohistochemical and electron microscopic studies of skin lesions.|pdf=|usr=}}
+{{tp|p=27238731|t=2017. Hypocomplementemia is a diagnostic clue for parvovirus B19 infection in adults.|pdf=|usr=}}
+{{tp|p=18808380|t=2009. Viral exanthems in childhood--infectious (direct) exanthems. Part 2: Other viral exanthems.|pdf=|usr=}}
+{{tp|p=16684303|t=2006. Parvovirus B19 primary infection with vasculitis: DNA identification in cutaneous lesions and sera.|pdf=|usr=}}
+{{tp|p=15857474|t=2005. Cutaneous necrosis during paroxysmal nocturnal haemoglobinuria: role of parvovirus B19?|pdf=|usr=}}
+{{tp|p=24931854|t=2014. Sudden cardiac death from parvovirus B19 myocarditis in a young man with Brugada syndrome.|pdf=|usr=}}
+{{tp|p=12570225|t=2003. Fatal parvovirus B19 myocarditis in an 8-year-old boy.|pdf=|usr=}}
+{{tp|p=30924765|t=2019. Secondary structure of DNA released from purified capsids of human parvovirus B19 under moderate denaturing conditions.|pdf=|usr=}}
+{{tp|p=20007355|t=2010. Antibody to parvovirus B19 nonstructural protein is associated with chronic arthralgia in patients with chronic fatigue syndrome/myalgic encephalomyelitis.|pdf=|usr=}}
+{{tp|p=18753240|t=2008. A third genotype of the human parvovirus PARV4 in sub-Saharan Africa.|pdf=|usr=}}
+{{tp|p=18089740|t=2008. Simultaneous persistence of multiple genome variants of human parvovirus B19.|pdf=|usr=}}
+{{tp|p=17251559|t=2007. Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes.|pdf=|usr=}}
+{{tp|p=16963753|t=2006. Phylogenetic analysis of human parvovirus B19, indicating two subgroups of genotype 1 in Vietnamese patients.|pdf=|usr=}}
+{{tp|p=17098972|t=2006. Short regions of sequence identity between the genomes of human and rodent parvoviruses and their respective hosts occur within host genes for the cytoskeleton, cell adhesion and Wnt signalling.|pdf=|usr=}}
+{{tp|p=11807219|t=2002. A transgenic mouse model for non-immune hydrops fetalis induced by the NS1 gene of human parvovirus B19.|pdf=|usr=}}
+{{tp|p=11369893|t=2001. Cellular transcription factors that interact with p6 promoter elements of parvovirus B19.|pdf=|usr=}}
+{{tp|p=11125172|t=2001. The VP1-unique region of parvovirus B19: amino acid variability and antigenic stability.|pdf=|usr=}}
+{{tp|p=11714978|t=2001. Circulating tumour necrosis factor-alpha and interferon-gamma are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue.|pdf=|usr=}}
+{{tp|p=10725428|t=2000. Integrity and full coding sequence of B19 virus DNA persisting in human synovial tissue.|pdf=|usr=}}
+{{tp|p=10092001|t=1999. Infection of apheresis cells by parvovirus B19.|pdf=|usr=}}
+{{tp|p=9519836|t=1998. Persistence of parvovirus B19 DNA in testis of patients with testicular germ cell tumours.|pdf=|usr=}}
+{{tp|p=9010306|t=1997. Establishment of a cell line expressing human parvovirus B19 non-structural protein from an inducible promoter.|pdf=|usr=}}
+{{tp|p=8922470|t=1996. Genetic diversity of human parvovirus B19: sequence analysis of the VP1/VP2 gene from multiple isolates.|pdf=|usr=}}
+{{tp|p=8683195|t=1996. Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: human megakaryocytic leukaemia cells are non-permissive for AAV infection.|pdf=|usr=}}
+{{tp|p=8760426|t=1996. Sequence variability among different parvovirus B19 isolates.|pdf=|usr=}}
+{{tp|p=7595371|t=1995. A new genome type of human parvovirus B19 present in sera of patients with encephalopathy.|pdf=|usr=}}
+{{tp|p=7730807|t=1995. Morphology and antigenicity of recombinant B19 parvovirus capsids expressed in transfected COS-7 cells.|pdf=|usr=}}
+{{tp|p=7534811|t=1995. Antibodies to parvovirus B19 NS-1 protein in infected individuals.|pdf=|usr=}}
+{{tp|p=8207413|t=1994. Differential transcription, without replication, of non-structural and structural genes of human parvovirus B19 in the UT7/EPO cell as demonstrated by in situ hybridization.|pdf=|usr=}}
+{{tp|p=8376975|t=1993. Trans-activation of the long terminal repeat of human immunodeficiency virus type 1 by the parvovirus B19 NS1 gene product.|pdf=|usr=}}
+{{tp|p=1645153|t=1992. Haemagglutination by parvovirus B19.|pdf=|usr=}}
+{{tp|p=2824662|t=1987. Structure and mapping of the DNA of human parvovirus B19.|pdf=|usr=}}
+{{tp|p=3819702|t=1987. Structural and functional homology of parvovirus and papovavirus polypeptides.|pdf=|usr=}}
+{{tp|p=18342755|t=2008. Myocardial pro-inflammatory cytokine expression and cellular rejection in pediatric heart transplant recipients.|pdf=|usr=}}
+{{tp|p=18582815|t=2008. Unexplained chronic anemia and leukopenia in lung transplant recipients secondary to parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=16210141|t=2005. High prevalence of cardiotropic viruses in myocardial tissue from explanted hearts of heart transplant recipients and heart donors: a 3-year retrospective study from a German patients' pool.|pdf=|usr=}}
+{{tp|p=11448804|t=2001. Association of parvovirus B19 with plasma cell-rich myocardial infiltrates after heart transplantation.|pdf=|usr=}}
+{{tp|p=8878766|t=1996. Transient aplastic anemia caused by parvovirus B19 infection in a heart transplant recipient.|pdf=|usr=}}
+{{tp|p=8031818|t=1994. Severe pneumonia after heart transplantation as a result of human parvovirus B19.|pdf=|usr=}}
+{{tp|p=10645765|t=1999. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted expression from parvovirus B19p6 promoter in primary human hematopoietic progenitor cells.|pdf=|usr=}}
+{{tp|p=12586308|t=2003. Parvovirus B19 and "cryptogenic" chronic hepatitis.|pdf=|usr=}}
+{{tp|p=12076880|t=2002. Acute viral hepatitis A and parvovirus B19 infections complicated by pure red cell aplasia and autoimmune hemolytic anemia.|pdf=|usr=}}
+{{tp|p=9382984|t=1997. Human parvovirus B19 infection associated with idiopathic thrombocytopenic purpura in a child following liver transplantation.|pdf=|usr=}}
+{{tp|p=27050929|t=2016. ANA testing in the presence of acute and chronic infections.|pdf=|usr=}}
+{{tp|p=17582502|t=2007. Intrathyroidal persistence of human parvovirus B19 DNA in a patient with Hashimoto's thyroiditis.|pdf=|usr=}}
+{{tp|p=16313965|t=2006. Immune reconstitution syndrome associated with parvovirus B19-induced pure red cell aplasia during highly active antiretroviral therapy.|pdf=|usr=}}
+{{tp|p=10468132|t=1999. Parvovirus B19 infection induces apoptosis of erythroid cells in vitro and in vivo.|pdf=|usr=}}
+{{tp|p=9661947|t=1998. A case of Guillain-Barre syndrome associated with human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=8852550|t=1996. Autoantibodies following parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=20799048|t=2011. Immune reconstitution to parvovirus B19 and resolution of anemia in a patient treated with highly active antiretroviral therapy.|pdf=|usr=}}
+{{tp|p=18936893|t=2008. Intravenous immunoglobulin therapy for severe arthritis associated with human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=11810534|t=2000. Hepatic dysfunction due to parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=28961998|t=2018. Human Parvovirus B19 (B19V) Up-regulates CXCR4 Surface Expression of Circulating Angiogenic Cells: Implications for Cardiac Ischemia in B19V Cardiomyopathy.|pdf=|usr=}}
+{{tp|p=27789725|t=2017. The Chemokine CXCL-10 Is a Marker of Infection Stage in Individuals With DNAemia Due to Parvovirus B19.|pdf=|usr=}}
+{{tp|p=25805750|t=2015. Impaired Endothelial Regeneration Through Human Parvovirus B19-Infected Circulating Angiogenic Cells in Patients With Cardiomyopathy.|pdf=|usr=}}
+{{tp|p=20158391|t=2010. Interferon beta modulates endothelial damage in patients with cardiac persistence of human parvovirus b19 infection.|pdf=|usr=}}
+{{tp|p=19099488|t=2009. Investigation of intrarenal viral infections in kidney transplant recipients unveils an association between parvovirus B19 and chronic allograft injury.|pdf=|usr=}}
+{{tp|p=18491974|t=2008. Seroepidemiology of human bocavirus defined using recombinant virus-like particles.|pdf=|usr=}}
+{{tp|p=16779720|t=2006. The immune response to parvovirus B19 exposure in previously seronegative and seropositive individuals.|pdf=|usr=}}
+{{tp|p=16425138|t=2006. Activation of synoviocytes by the secreted phospholipase A2 motif in the VP1-unique region of parvovirus B19 minor capsid protein.|pdf=|usr=}}
+{{tp|p=15962222|t=2005. Single-nucleotide polymorphisms associated with symptomatic infection and differential human gene expression in healthy seropositive persons each implicate the cytoskeleton, integrin signaling, and oncosuppression in the pathogenesis of human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=15122524|t=2004. B cell memory is directed toward conformational epitopes of parvovirus B19 capsid proteins and the unique region of VP1.|pdf=|usr=}}
+{{tp|p=14976602|t=2004. Persistent parvovirus B19 infection without the development of chronic anemia in HIV-infected and -uninfected children: the Women and Infants Transmission Study.|pdf=|usr=}}
+{{tp|p=12404168|t=2002. Human parvovirus Bb19 detection in asymptomatic blood donors: association with increased neopterin concentrations.|pdf=|usr=}}
+{{tp|p=12195370|t=2002. Association of symptomatic acute human parvovirus B19 infection with human leukocyte antigen class I and II alleles.|pdf=|usr=}}
+{{tp|p=9952368|t=1999. Quantitative analysis of neutralizing immune responses to human parvovirus B19 using a novel reverse transcriptase-polymerase chain reaction-based assay.|pdf=|usr=}}
+{{tp|p=10395869|t=1999. Prevalence of antibodies to human parvovirus B19 nonstructural protein in persons with various clinical outcomes following B19 infection.|pdf=|usr=}}
+{{tp|p=7594678|t=1995. Parvovirus B19 clearance from peripheral blood after acute infection.|pdf=|usr=}}
+{{tp|p=7594677|t=1995. Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: implications for pathogenesis.|pdf=|usr=}}
+{{tp|p=7594654|t=1995. Multiple glycosphingolipids determine the tissue tropism of parvovirus B19.|pdf=|usr=}}
+{{tp|p=7876624|t=1995. Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity.|pdf=|usr=}}
+{{tp|p=8440942|t=1993. Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence.|pdf=|usr=}}
+{{tp|p=2172397|t=1990. Immunoglobulins in the prophylaxis of parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=2153742|t=1990. Numbness and tingling of fingers associated with parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=2156940|t=1990. Human parvoviruses.|pdf=|usr=}}
+{{tp|p=2760505|t=1989. B19 parvovirus replicates in erythroid leukemic cells in vitro.|pdf=|usr=}}
+{{tp|p=30978354|t=2019. Effects of Parvovirus B19 In Vitro Infection on Monocytes from Patients with Systemic Sclerosis: Enhanced Inflammatory Pathways by Caspase-1 Activation and Cytokine Production.|pdf=|usr=}}
+{{tp|p=28060552|t=2017. The Root Extract of Gentiana macrophylla Pall. Alleviates B19-NS1-Exacerbated Liver Injuries in NZB/W F1 Mice.|pdf=|usr=}}
+{{tp|p=22977072|t=2013. The lack of routine surveillance of Parvovirus B19 infection in pregnancy prevents an accurate understanding of this regular cause of fetal loss and the risks posed by occupational exposure.|pdf=|usr=}}
+{{tp|p=15150324|t=2004. Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19.|pdf=|usr=}}
+{{tp|p=11444773|t=2001. Lymphocyte recognition of human parvovirus B19 non-structural (NS1) protein: associations with occurrence of acute and chronic arthropathy?|pdf=|usr=}}
+{{tp|p=32603480|t=2020. Intratonsillar detection of 27 distinct viruses: A cross-sectional study.|pdf=|usr=}}
+{{tp|p=30011073|t=2018. Identification of potential pathogenic viruses in patients with acute myocarditis using next-generation sequencing.|pdf=|usr=}}
+{{tp|p=26705119|t=2016. Epidemiologic study of human parvovirus B19 infection in East China.|pdf=|usr=}}
+{{tp|p=26241406|t=2016. Serum level of C-reactive protein is not a parameter to determine the difference between viral and atypical bacterial infections.|pdf=|usr=}}
+{{tp|p=26756922|t=2016. Identification of recombination in the NS1 and VPs genes of parvovirus B19.|pdf=|usr=}}
+{{tp|p=25965702|t=2015. Atypical exanthems associated with Parvovirus B19 (B19V) infection in children and adults.|pdf=|usr=}}
+{{tp|p=24760746|t=2015. Erythrovirus B19 and autoimmune thyroid diseases. Review of the literature and pathophysiological hypotheses.|pdf=|usr=}}
+{{tp|p=25946433|t=2015. Large-scale multiplex polymerase chain reaction assay for diagnosis of viral reactivations after allogeneic hematopoietic stem cell transplantation.|pdf=|usr=}}
+{{tp|p=24037981|t=2014. Serology indicates cytomegalovirus infection is associated with varicella-zoster virus reactivation.|pdf=|usr=}}
+{{tp|p=23983182|t=2013. Selective reactivation of human herpesvirus 6 in patients with autoimmune connective tissue diseases.|pdf=|usr=}}
+{{tp|p=23588740|t=2013. Frequent occurrence of parvovirus B19 DNAemia in the first year after kidney transplantation.|pdf=|usr=}}
+{{tp|p=22711355|t=2012. Occurrence of human bocaviruses and parvovirus 4 in solid tissues.|pdf=|usr=}}
+{{tp|p=21837800|t=2011. Genotype-specific effects on left ventricular function in parvovirus B19-positive patients with dilated cardiomyopathy.|pdf=|usr=}}
+{{tp|p=21108352|t=2011. Identification and characterization of acute infection with parvovirus B19 genotype 2 in immunocompromised patients in Poland.|pdf=|usr=}}
+{{tp|p=20572082|t=2010. Low level myocardial parvovirus B19 persistence is a frequent finding in patients with heart disease but unrelated to ongoing myocardial injury.|pdf=|usr=}}
+{{tp|p=19774687|t=2009. Prevalence of persistent and latent viruses in untreated patients infected with HIV-1 from Ghana, West Africa.|pdf=|usr=}}
+{{tp|p=19856479|t=2009. Intrahepatic long-term persistence of parvovirus B19 and its role in chronic viral hepatitis.|pdf=|usr=}}
+{{tp|p=18712818|t=2008. Detection of cytomegalovirus, parvovirus B19 and herpes simplex viruses in cases of intrauterine fetal death: association with pathological findings.|pdf=|usr=}}
+{{tp|p=18814251|t=2008. Tissue persistence of parvovirus B19 genotypes in asymptomatic persons.|pdf=|usr=}}
+{{tp|p=18461615|t=2008. Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy.|pdf=|usr=}}
+{{tp|p=17607784|t=2007. Dose-by-dose virological and hematological responses to intravenous immunoglobulin in an immunocompromised patient with persistent parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=17935173|t=2007. Parvovirus B19 infection in Chile: markers of infection and immunity in patients with clinical symptoms.|pdf=|usr=}}
+{{tp|p=16998895|t=2006. Genetic drift of parvovirus B19 is found in AIDS patients with persistent B19 infection.|pdf=|usr=}}
+{{tp|p=16998885|t=2006. Concurrent detection of human herpesvirus type 6 and measles-specific IgMs during acute exanthematic human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=16299723|t=2006. Establishment of functional B cell memory against parvovirus B19 capsid proteins may be associated with resolution of persistent infection.|pdf=|usr=}}
+{{tp|p=16299714|t=2006. Aberrant cellular immune responses in humans infected persistently with parvovirus B19.|pdf=|usr=}}
+{{tp|p=15543592|t=2005. Association between enterovirus endomyocardial infection and late severe cardiac events in some adult patients receiving heart transplants.|pdf=|usr=}}
+{{tp|p=15543575|t=2005. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.|pdf=|usr=}}
+{{tp|p=15258981|t=2004. Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis.|pdf=|usr=}}
+{{tp|p=12767014|t=2003. Ex vivo cytokine responses against parvovirus B19 antigens in previously infected pregnant women.|pdf=|usr=}}
+{{tp|p=11992589|t=2002. Parvovirus B19 nonstructural (NS1) protein as a transactivator of interleukin-6 synthesis: common pathway in inflammatory sequelae of human parvovirus infections?|pdf=|usr=}}
+{{tp|p=11782935|t=2002. Baculovirus expression of erythrovirus V9 capsids and screening by ELISA: serologic cross-reactivity with erythrovirus B19.|pdf=|usr=}}
+{{tp|p=11536251|t=2001. Persistence of parvovirus B19 DNA in synovium of patients with haemophilic arthritis.|pdf=|usr=}}
+{{tp|p=11536250|t=2001. Evidence for persistence of parvovirus B19 DNA in livers of adults.|pdf=|usr=}}
+{{tp|p=10935990|t=2000. Four putative subtypes of human parvovirus B19 based on amino acid polymorphism in the C-terminal region of non-structural protein.|pdf=|usr=}}
+{{tp|p=9783686|t=1998. Analysis of genetic diversity in the VP1 unique region gene of human parvovirus B19 using the mismatch detection method and direct nucleotide sequencing.|pdf=|usr=}}
+{{tp|p=9783685|t=1998. Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin.|pdf=|usr=}}
+{{tp|p=9365887|t=1997. Evidence for persistence of human parvovirus B19 DNA in bone marrow.|pdf=|usr=}}
+{{tp|p=8825713|t=1996. Follow-up study of clinical and immunological findings in patients presenting with acute parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=7636495|t=1995. Persistent B19 parvovirus infections in haemophilic HIV-1 infected patients.|pdf=|usr=}}
+{{tp|p=8083666|t=1994. Case report: detection of parvovirus B19 in a skin biopsy of a patient with erythema infectiosum.|pdf=|usr=}}
+{{tp|p=1583466|t=1992. Replication and cytopathology of human parvovirus B19 in human umbilical cord blood erythroid progenitor cells.|pdf=|usr=}}
+{{tp|p=1722505|t=1991. Detection of B19 parvovirus in human fetal tissues by electron microscopy.|pdf=|usr=}}
+{{tp|p=1646854|t=1991. Detection of B19 parvovirus in human fetal tissues by in situ hybridisation.|pdf=|usr=}}
+{{tp|p=2164559|t=1990. Electron microscopic detection of human parvovirus (B19) in a patient with HIV infection.|pdf=|usr=}}
+{{tp|p=2828533|t=1988. Intrauterine infection with human parvovirus B19: a light and electron microscopy study.|pdf=|usr=}}
+{{tp|p=3694180|t=1987. Detection of parvovirus B19 DNA, antigen, and particles in the human fetus.|pdf=|usr=}}
+{{tp|p=3973569|t=1985. Detection of human parvovirus using a molecularly cloned probe.|pdf=|usr=}}
+{{tp|p=25487255|t=2015. Down-regulation of inwardly rectifying Kir2.1 K+ channels by human parvovirus B19 capsid protein VP1.|pdf=|usr=}}
+{{tp|p=12455712|t=2002. Virus-related glomerular diseases: histological and clinical aspects.|pdf=|usr=}}
+{{tp|p=9238623|t=1997. Aplastic anemia due to B19 parvovirus infection in cadaveric renal transplant recipients: an underestimated infectious disease in the immunocompromised host.|pdf=|usr=}}
+{{tp|p=21287183|t=2011. Mononeuropathy multiplex associated with acute parvovirus B19 infection: characteristics, treatment and outcome.|pdf=|usr=}}
+{{tp|p=21327846|t=2011. Parvovirus B19 infection antedating Guillain-Barre' syndrome variant with prominent facial diplegia.|pdf=|usr=}}
+{{tp|p=20339862|t=2010. Parainfectious myelitis associated with parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=32779109|t=2020. Acute viral encephalitis associated with human parvovirus B19 infection: unexpectedly diagnosed by metagenomic next-generation sequencing.|pdf=|usr=}}
+{{tp|p=28831691|t=2017. Parvovirus B19 infection associated with hemolytic anemia and cranial polyneuropathy.|pdf=|usr=}}
+{{tp|p=28895082|t=2017. Clinical manifestations and treatment outcomes of parvovirus B19 encephalitis in immunocompetent adults.|pdf=|usr=}}
+{{tp|p=16877300|t=2006. Detection of adeno-associated virus 2 and parvovirus B19 in the human dorsolateral prefrontal cortex.|pdf=|usr=}}
+{{tp|p=14982731|t=2004. Middle cerebral artery thrombosis in course of parvovirus B19 infection in a young adult: A new risk factor for stroke?|pdf=|usr=}}
+{{tp|p=11031695|t=2000. Chronic parvovirus B-19 meningoencephalitis with additional detection of Epstein-Barr virus DNA in the cerebrospinal fluid of an immunocompetent patient.|pdf=|usr=}}
+{{tp|p=30634881|t=2019. Trisomy 21 and hydrops fetalis: parvovirus B19 or transient abnormal myelopoiesis?|pdf=|usr=}}
+{{tp|p=12173996|t=2002. Parvovirus B19 in the acute arthropathies and juvenile rheumatoid arthritis.|pdf=|usr=}}
+{{tp|p=8445486|t=1993. Ultrastructural features of fetal erythroid precursors infected with parvovirus B19 in vitro: evidence of cell death by apoptosis.|pdf=|usr=}}
+{{tp|p=1313862|t=1992. Immunohistological detection of human parvovirus B19 in formalin-fixed, paraffin-embedded tissues.|pdf=|usr=}}
+{{tp|p=23919909|t=2013. Anti-N-methyl-D-aspartate receptor encephalitis and parvovirus B19: A possible link?|pdf=|usr=}}
+{{tp|p=22316626|t=2012. Parvovirus B19 and necrotizing enterocolitis in neonates.|pdf=|usr=}}
+{{tp|p=11562626|t=2001. Cerebrovascular complications and parvovirus infection in homozygous sickle cell disease.|pdf=|usr=}}
+{{tp|p=7699536|t=1995. Life-threatening infection in two children with hemoglobin S-beta-thalassemia.|pdf=|usr=}}
+{{tp|p=8429430|t=1993. Human parvovirus B19-associated arthritis in children.|pdf=|usr=}}
+{{tp|p=8463907|t=1993. Acute splenic sequestration together with aplastic crisis caused by human parvovirus B19 in patients with sickle cell disease.|pdf=|usr=}}
+{{tp|p=1689774|t=1990. Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients.|pdf=|usr=}}
+{{tp|p=2550601|t=1989. Hepatic disease associated with intrauterine parvovirus B19 infection in a newborn premature infant.|pdf=|usr=}}
+{{tp|p=29432306|t=2018. Parvovirus B19-associated Hemophagocytic Lymphohistiocytosis in a Patient With Glucose-6-phosphate Dehydrogenase Deficiency.|pdf=|usr=}}
+{{tp|p=24390447|t=2015. Myeloid leukemia of Down syndrome: relation to parvovirus B19 infection and wilms tumor gene (WT1) expression.|pdf=|usr=}}
+{{tp|p=24072236|t=2014. Long-term parvovirus B19 infections with genetic drift after cord blood transplantation complicated by persistent CD4+ lymphocytopenia.|pdf=|usr=}}
+{{tp|p=21617562|t=2011. Parvovirus B19-associated hemophagocytic lymphohistiocytosis in a child with precursor B-cell acute lymphoblastic leukemia under maintenance chemotherapy.|pdf=|usr=}}
+{{tp|p=15956889|t=2005. Classic transient erythroblastopenia of childhood with human parvovirus B19 genome detection in the blood and bone marrow.|pdf=|usr=}}
+{{tp|p=11972099|t=2002. Transient erythroblastopenia of childhood: prospective study of 10 patients with special reference to viral infections.|pdf=|usr=}}
+{{tp|p=8556383|t=1996. Transient erythroblastopenia in a child with Kawasaki syndrome: probable parvovirus B19 infection?|pdf=|usr=}}
+{{tp|p=16318623|t=2005. Intrauterine therapy for parvovirus B19 infected symptomatic fetus using B19 IgG-rich high titer gammaglobulin.|pdf=|usr=}}
+{{tp|p=11249292|t=2000. Dermatologic manifestations of infectious diseases in pregnancy.|pdf=|usr=}}
+{{tp|p=17150255|t=2007. Is parvovirus B19 the cause for autoimmunity against the angiotensin II type receptor?|pdf=|usr=}}
+{{tp|p=21632693|t=2011. Association of parvovirus B19 infection with systemic lupus erythematosus: role of Th1 predominance.|pdf=|usr=}}
+{{tp|p=21041264|t=2010. Parvovirus B19-associated systemic lupus erythematosus: clinical mimicry or autoimmune induction?|pdf=|usr=}}
+{{tp|p=18484700|t=2008. Incidence and clinical significance of parvovirus B19 infection in patients with rheumatoid arthritis.|pdf=|usr=}}
+{{tp|p=17477467|t=2007. Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis.|pdf=|usr=}}
+{{tp|p=16511938|t=2006. Parvovirus B19 infection in patients with rheumatoid arthritis in Taiwan.|pdf=|usr=}}
+{{tp|p=15693107|t=2005. Parvovirus B19: another agent associated with remitting seronegative symmetrical synovitis with pitting edema.|pdf=|usr=}}
+{{tp|p=12610801|t=2003. Infections preceding early arthritis in southern Sweden: a prospective population-based study.|pdf=|usr=}}
+{{tp|p=11911112|t=2002. Chronic fatigue syndrome and arthralgia following parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=11669178|t=2001. Antibodies to beta 2-glycoprotein I and cardiolipin with symptoms suggestive of systemic lupus erythematosus in parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=11036842|t=2000. Parvovirus arthropathy outbreak in southwestern United States.|pdf=|usr=}}
+{{tp|p=10555914|t=1999. Remission of juvenile rheumatoid arthritis after infection with parvovirus B19.|pdf=|usr=}}
+{{tp|p=9150091|t=1997. Postpartum lupus erythematosus associated with parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=8823689|t=1996. Human parvovirus infection: rheumatic manifestations, angioedema, C1 esterase inhibitor deficiency, ANA positivity, and possible onset of systemic lupus erythematosus.|pdf=|usr=}}
+{{tp|p=7791179|t=1995. Parvovirus B19 associated monoarthritis in a 5-year-old boy.|pdf=|usr=}}
+{{tp|p=7932438|t=1994. Chronic modulation of the autoimmune response following parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=8308782|t=1993. Established fibromyalgia syndrome and parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=8371233|t=1993. Lupus-like presentation of human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=1556683|t=1992. Lupus-like presentation of human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=2159072|t=1990. Autoantibodies in sera from patients with parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=2550630|t=1989. Anti-DNA and antilymphocyte antibodies during acute infection with human parvovirus B19.|pdf=|usr=}}
+{{tp|p=22971793|t=1993. Brachial neuritis after human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=28941869|t=2017. Transcription-associated mutational pressure in the Parvovirus B19 genome: Reactivated genomes contribute to the variability of viral populations.|pdf=|usr=}}
+{{tp|p=1648152|t=1991. The evolution of defective and autonomous parvoviruses.|pdf=|usr=}}
+{{tp|p=19203989|t=2009. Parvovirus B19-induced thrombocytopenia and anemia in a child with fatal fulminant hepatic failure coinfected with hepatitis A and E viruses.|pdf=|usr=}}
+{{tp|p=16316402|t=2005. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection.|pdf=|usr=}}
+{{tp|p=16316401|t=2005. CD4(+) T-cell responses against the VP1-unique region in individuals with recent and persistent parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=16316400|t=2005. Human parvovirus B19 infection and antiphospholipid-syndrome: the two sides of one medal?|pdf=|usr=}}
+{{tp|p=16316398|t=2005. Pathophysiology and aetiological diagnosis of inflammatory myocardial diseases with a special focus on parvovirus B19.|pdf=|usr=}}
+{{tp|p=16316397|t=2005. Human parvovirus B19: a new emerging pathogen of inflammatory cardiomyopathy.|pdf=|usr=}}
+{{tp|p=16316396|t=2005. Pathogenesis of parvovirus B19 infection: host gene variability, and possible means and effects of virus persistence.|pdf=|usr=}}
+{{tp|p=16316395|t=2005. Pathogenesis of aleutian mink disease parvovirus and similarities to b19 infection.|pdf=|usr=}}
+{{tp|p=16316388|t=2005. Proceedings of International Parvovirus Meeting 2005. July 15-16, 2005. Leipzig, Germany.|pdf=|usr=}}
+{{tp|p=23764418|t=2013. Impaired genome encapsidation restricts the in vitro propagation of human parvovirus B19.|pdf=|usr=}}
+{{tp|p=15381351|t=2004. Hypoxia enables B19 erythrovirus to yield abundant infectious progeny in a pluripotent erythroid cell line.|pdf=|usr=}}
+{{tp|p=12445941|t=2003. Evaluation of anti-parvovirus B19 activity in sera by assay using quantitative polymerase chain reaction.|pdf=|usr=}}
+{{tp|p=16264157|t=2005. Parvovirus B19 and onset of juvenile dermatomyositis.|pdf=|usr=}}
+{{tp|p=2157074|t=1990. Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum.|pdf=|usr=}}
+{{tp|p=32335625|t=2020. Adult-onset Still's Disease: A Case Report.|pdf=|usr=}}
+{{tp|p=23478734|t=2012. Pure red cell aplasia caused by Parvo B19 virus in a kidney transplant recipient.|pdf=|usr=}}
+{{tp|p=28062379|t=2018. Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection.|pdf=|usr=}}
+{{tp|p=12639611|t=2003. Parvovirus B19 and autoimmune diseases.|pdf=|usr=}}
+{{tp|p=10680086|t=1999. Role of human parvovirus B19 in the pathogenesis of rheumatoid arthritis.|pdf=|usr=}}
+{{tp|p=24483023|t=2013. [An adult case of acute pericarditis and glomerulonephritis associated with human parvovirus B19 infection].|pdf=|usr=}}
+{{tp|p=1405390|t=1992. Nierenaffektion bei Parvovirus B 19-Infektion eines Kindes.|pdf=|usr=}}
+{{tp|p=1745035|t=1991. Obstruktive Respirationstrakterkrankungen bei Kindern und Parvovirus B19-Infektion.|pdf=|usr=}}
+{{tp|p=1660551|t=1991. Blutbildbefunde bei Kindern mit Parvovirus B19-Infektion (Ringelroteln/Erythema infectiosum).|pdf=|usr=}}
+{{tp|p=2164118|t=1990. Seropravalenz von Antikorpern gegen das humane Parvovirus B 19 (Ringelroteln/Erythema infectiosum) in der DDR-Bevolkerung.|pdf=|usr=}}
+{{tp|p=2544763|t=1989. Vaskulare Purpura und andere Gefass- und Kreislaufalterationen bei Kindern mit akuter Parvovirus B19-Infektion. Bericht uber 3 eigene Beobachtungen.|pdf=|usr=}}
+{{tp|p=29660757|t=2018. Spektrum von klinischen Prasentationen der Parvovirus B19 Infektion in Kindern mit Hamato-Onkologische Erkrankungen: Eine Fallserie.|pdf=|usr=}}
+{{tp|p=22052631|t=2011. Stem cell transplantation in 6 children with parvovirus B19- induced severe aplastic anaemia or myelodysplastic syndrome.|pdf=|usr=}}
+{{tp|p=17405071|t=2007. Renal complications associated with human parvovirus B19 infection in early childhood.|pdf=|usr=}}
+{{tp|p=16125597|t=2005. Rheumatoid arthritis, type 1 diabetes, and Graves' disease after acute parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=15064032|t=2004. Rubella.|pdf=|usr=}}
+{{tp|p=11551584|t=2001. Association of human parvovirus B19 infection with acute meningoencephalitis.|pdf=|usr=}}
+{{tp|p=11009166|t=2000. Digital arterial occlusive disease.|pdf=|usr=}}
+{{tp|p=11071192|t=2000. Severe digital arterial occlusive disease and acute parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=10501383|t=1999. Parvovirus B19 and the pathogenesis of rheumatoid arthritis: a case for historical reasoning.|pdf=|usr=}}
+{{tp|p=10073544|t=1999. Parvovirus B19 infection and fulminant hepatitis.|pdf=|usr=}}
+{{tp|p=9820308|t=1998. Detection of an erythrovirus sequence distinct from B19 in a child with acute anaemia.|pdf=|usr=}}
+{{tp|p=9848349|t=1998. Acute parvovirus B19 infection associated with fulminant hepatitis of favourable prognosis in young children.|pdf=|usr=}}
+{{tp|p=9734945|t=1998. Parvovirus B19 and acute hepatitis in adults.|pdf=|usr=}}
+{{tp|p=9107245|t=1997. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy.|pdf=|usr=}}
+{{tp|p=8622394|t=1996. Human parvovirus B19 infection associated with acute hepatitis.|pdf=|usr=}}
+{{tp|p=8684141|t=1996. Human parvovirus B19 infection and hepatitis.|pdf=|usr=}}
+{{tp|p=7674787|t=1995. Persistent infection of human parvovirus B19 in a normal subject.|pdf=|usr=}}
+{{tp|p=7605434|t=1995. Life-threatening human parvovirus B19 infection in immunocompetent haemophilia.|pdf=|usr=}}
+{{tp|p=7799719|t=1995. Is Still's disease associated with parvovirus B19 infection?|pdf=|usr=}}
+{{tp|p=7637482|t=1995. Glomerulonephritis after human parvovirus infection in homozygous sickle-cell disease.|pdf=|usr=}}
+{{tp|p=7715366|t=1995. Persistent parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=7910278|t=1994. Active or recent parvovirus B19 infection in children with Kawasaki disease.|pdf=|usr=}}
+{{tp|p=7910276|t=1994. Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent?|pdf=|usr=}}
+{{tp|p=7913176|t=1994. Polyarteritis nodosa and parvovirus B19.|pdf=|usr=}}
+{{tp|p=7912323|t=1994. Human parvovirus B19 infection in Kawasaki disease.|pdf=|usr=}}
+{{tp|p=7912322|t=1994. Human parvovirus B19 infection in Kawasaki disease.|pdf=|usr=}}
+{{tp|p=7905974|t=1994. Parvovirus B19 and erosive polyarthritis.|pdf=|usr=}}
+{{tp|p=7914998|t=1994. Transient disturbance of consciousness and hepatic dysfunction associated with human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=8098810|t=1993. Heart failure after parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=8098420|t=1993. Adult Still's disease associated with acute human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=8098419|t=1993. Human parvovirus B19 and arthritis.|pdf=|usr=}}
+{{tp|p=8094512|t=1993. Persistent arthritis after human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=8102466|t=1993. Neuralgic amyotrophy after parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=1349370|t=1992. Viral-associated haemophagocytosis with parvovirus-B19-related pancytopenia.|pdf=|usr=}}
+{{tp|p=1351981|t=1992. Parvovirus-B19-related pancytopenia in children with HIV infection.|pdf=|usr=}}
+{{tp|p=1346840|t=1992. Polyarteritis nodosa and parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=1671156|t=1991. Parvovirus B19-infected erythroblasts in fetal cord blood.|pdf=|usr=}}
+{{tp|p=2893953|t=1988. B19 parvovirus infection of myocardial cells.|pdf=|usr=}}
+{{tp|p=2895293|t=1988. Fetal cell tropism of human parvovirus B19.|pdf=|usr=}}
+{{tp|p=6140462|t=1984. Nakatani antigen and human parvovirus (B19)|pdf=|usr=}}
+{{tp|p=6134886|t=1983. Aplastic crisis due to parvovirus infection in pyruvate kinase deficiency.|pdf=|usr=}}
+{{tp|p=6117755|t=1981. Parvovirus B19 finds a disease.|pdf=|usr=}}
+{{tp|p=7934594|t=1994. Immune-mediated inner ear disease and parvovirus B19.|pdf=|usr=}}
+{{tp|p=8401184|t=1993. Electron microscopic identification of parvovirus virions in erythroid and granulocytic-line cells in a patient with human parvovirus B19 induced pancytopenia.|pdf=|usr=}}
+{{tp|p=28945149|t=2018. Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis.|pdf=|usr=}}
+{{tp|p=27060064|t=2016. Systematic review of case reports of antiphospholipid syndrome following infection.|pdf=|usr=}}
+{{tp|p=24285096|t=2014. Collapsing glomerulopathy in collagen vascular-like disease.|pdf=|usr=}}
+{{tp|p=20511275|t=2010. Clinical and molecular evidence for association of SLE with parvovirus B19.|pdf=|usr=}}
+{{tp|p=11035424|t=2000. Parvovirus B19 infection associated with the production of anti-neutrophil cytoplasmic antibody (ANCA) and anticardiolipin antibody (aCL).|pdf=|usr=}}
+{{tp|p=1845362|t=1991. Parvovirus B19 infection can induce histiocytic necrotizing lymphadenitis (Kikuchi's disease) associated with systemic lupus erythematosus.|pdf=|usr=}}
+{{tp|p=1304627|t=1992. In situ hybridisation: principles and applications.|pdf=|usr=}}
+{{tp|p=7861814|t=1995. Systemic monocyte and T-cell activation in a patient with human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=16987488|t=2006. Neuralgia amiotrofica bilateral precipitada por infeccion por el parvovirus B19.|pdf=|usr=}}
+{{tp|p=10996879|t=2000. Presencia de anticuerpos anticardiolipina en el curso de un proceso de poliartritis por Parvovirus B19.|pdf=|usr=}}
+{{tp|p=17196758|t=2007. Parvovirus B19 infection of brain: possible role of gender in determining mental illness and autoimmune thyroid disorders.|pdf=|usr=}}
+{{tp|p=16850174|t=2006. Seltene Ursache einer Anamie bei einer nierentransplantierten Patientin.|pdf=|usr=}}
+{{tp|p=21546176|t=2011. Cryoglobulinemie grave secondaire a une primo-infection au Parvovirus B19.|pdf=|usr=}}
+{{tp|p=14689308|t=2004. Frequent detection of parvovirus B19 genome in the myocardium of adult patients with idiopathic dilated cardiomyopathy.|pdf=|usr=}}
+{{tp|p=12920583|t=2004. Molecular pathology of inflammatory cardiomyopathy.|pdf=|usr=}}
+{{tp|p=9574901|t=1998. Persistent parvovirus B19 infections in immunocompromised children.|pdf=|usr=}}
+{{tp|p=9680929|t=1998. Persistent B19 parvovirus infection in pediatric malignancies.|pdf=|usr=}}
+{{tp|p=18509278|t=2008. Immunohistological detection of Parvovirus B19 capsid proteins in endomyocardial biopsies from dilated cardiomyopathy patients.|pdf=|usr=}}
+{{tp|p=19043365|t=2008. Parvovirus B19 profiles in patients presenting with acute myocarditis and chronic dilated cardiomyopathy.|pdf=|usr=}}
+{{tp|p=16193712|t=2005. Nefritis tubulo intersticial asociada a parvovirus B19.|pdf=|usr=}}
+{{tp|p=21116804|t=2011. The detection of parvoviruses.|pdf=|usr=}}
+{{tp|p=9664388|t=1998. Immunogold probes in electron microscopy.|pdf=|usr=}}
+{{tp|p=29428424|t=2018. Parvovirus B19 and in situ immune response in eczema and psoriasis skin lesions of patients from the Brazilian Amazon region.|pdf=|usr=}}
+{{tp|p=2560110|t=1989. Persistent parvovirus B19 infections in humans.|pdf=|usr=}}
+{{tp|p=27337440|t=2016. Parvovirus B19.|pdf=|usr=}}
+{{tp|p=1375519|t=1992. A combined pseudoreplica-immunochemical technique for research and diagnostic virology.|pdf=|usr=}}
+{{tp|p=20680378|t=2011. Clinical findings in parvovirus B19 infection in 30 adult patients in Kyoto.|pdf=|usr=}}
+{{tp|p=20607339|t=2010. Pericarditis and pleuritis associated with human parvovirus B19 infection in a systemic lupus erythematosus patient.|pdf=|usr=}}
+{{tp|p=24383775|t=2001. Human parvovirus B19 infection mimicking systemic lupus erythematosus.|pdf=|usr=}}
+{{tp|p=26878856|t=2016. Possible involvement of miRNAs in tropism of Parvovirus B19.|pdf=|usr=}}
+{{tp|p=21555155|t=2011. Increased cardiac injury in NZB/W F1 mice received antibody against human parvovirus B19 VP1 unique region protein.|pdf=|usr=}}
+{{tp|p=31922220|t=2020. Effects of antibodies against human parvovirus B19 on angiogenic signaling.|pdf=|usr=}}
+{{tp|p=30106148|t=2018. Selective activation of inflammation factors by human parvovirus B19 and human bocavirus VP1 unique region on H9c2 cardiomyocyte.|pdf=|usr=}}
+{{tp|p=29257322|t=2018. Human parvovirus B19 nonstructural protein NS1 activates NLRP3 inflammasome signaling in adultonset Still's disease.|pdf=|usr=}}
+{{tp|p=27748859|t=2016. Human parvovirus B19 antibodies induce altered membrane protein expression and apoptosis of BeWo trophoblasts.|pdf=|usr=}}
+{{tp|p=20357294|t=2010. Human parvovirus B19-associated myocarditis.|pdf=|usr=}}
+{{tp|p=16641410|t=2006. Elevated sFlt1 level and preeclampsia with parvovirus-induced hydrops.|pdf=|usr=}}
+{{tp|p=14762186|t=2004. Parvovirus B19.|pdf=|usr=}}
+{{tp|p=11357850|t=2001. Treatment of parvovirus B19-associated polyarteritis nodosa with intravenous immune globulin.|pdf=|usr=}}
+{{tp|p=7990901|t=1995. Expression of P antigen in parvovirus B19-infected bone marrow.|pdf=|usr=}}
+{{tp|p=1846224|t=1991. Parvovirus B19 as the cause of a syndrome resembling Lyme arthritis in adults.|pdf=|usr=}}
+{{tp|p=2548099|t=1989. Human parvovirus B19.|pdf=|usr=}}
+{{tp|p=2548098|t=1989. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy.|pdf=|usr=}}
+{{tp|p=2548096|t=1989. Human parvovirus B19 infection among hospital staff members after contact with infected patients.|pdf=|usr=}}
+{{tp|p=3037373|t=1987. Chronic bone marrow failure due to persistent B19 parvovirus infection.|pdf=|usr=}}
+{{tp|p=16265461|t=2005. A rare case of acute 'infective' myocardial infarction triggered by acute parvovirus B19 myocarditis.|pdf=|usr=}}
+{{tp|p=17895931|t=2007. Parvovirus-B19-associated complications in renal transplant recipients.|pdf=|usr=}}
+{{tp|p=6835376|t=1983. A human parvovirus-like virus inhibits haematopoietic colony formation in vitro.|pdf=|usr=}}
+{{tp|p=17403701|t=2007. Acute nephritis induced by human parvovirus B 19 infection.|pdf=|usr=}}
+{{tp|p=17890751|t=2007. Relapsing severe anaemia due to primary parvovirus B19 infection after renal transplantation: a case report and review of the literature.|pdf=|usr=}}
+{{tp|p=16705026|t=2006. Collapsing and non-collapsing focal segmental glomerulosclerosis in kidney transplants.|pdf=|usr=}}
+{{tp|p=15827056|t=2005. What is antibody-mediated pure red cell aplasia (PRCA)?|pdf=|usr=}}
+{{tp|p=12270996|t=2002. Eradication of parvovirus B19 infection after renal transplantation requires reduction of immunosuppression and high-dose immunoglobulin therapy.|pdf=|usr=}}
+{{tp|p=11733638|t=2001. Fibrosing cholestatic hepatitis possibly related to persistent parvovirus B19 infection in a renal transplant recipient.|pdf=|usr=}}
+{{tp|p=10978424|t=2000. Parvovirus B19-related acute hepatitis in an immunosuppressed kidney transplant.|pdf=|usr=}}
+{{tp|p=10069217|t=1999. Concomitant parvovirus B19 and cytomegalovirus infections after living-related renal transplantation.|pdf=|usr=}}
+{{tp|p=9550669|t=1998. Parvovirus B19 infection and unresponsiveness to erythropoietin therapy in haemodialysis patients.|pdf=|usr=}}
+{{tp|p=8672044|t=1996. Chronic parvovirus B19 infection-associated pure red cell anaemia in a kidney transplant recipient.|pdf=|usr=}}
+{{tp|p=8538947|t=1995. Severe aplastic anaemia due to B19 parvovirus infection in renal transplant recipient.|pdf=|usr=}}
+{{tp|p=22177600|t=2012. Purpura febrile et proteinurie chez une patiente de 71 ans.|pdf=|usr=}}
+{{tp|p=21757415|t=2012. Infection par le Parvovirus B19 apres transplantation renale.|pdf=|usr=}}
+{{tp|p=14584298|t=2003. Infection a parvovirus B19 et transplantation renale.|pdf=|usr=}}
+{{tp|p=1641054|t=1992. Infection a parvovirus B19 revelee par une insuffisance renale aigue.|pdf=|usr=}}
+{{tp|p=11598390|t=2001. Renal involvement induced by human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=10364707|t=1999. Correlation between cytomegalovirus infection and Raynaud's phenomenon in lupus nephritis.|pdf=|usr=}}
+{{tp|p=10516501|t=1999. Parvovirus B19 and Schonlein-Henoch purpura in adults.|pdf=|usr=}}
+{{tp|p=10809628|t=2000. Human parvovirus B19 and renal disease?|pdf=|usr=}}
+{{tp|p=10399450|t=1999. Human parvovirus B19: relevance in internal medicine.|pdf=|usr=}}
+{{tp|p=9050335|t=1997. Life-threatening anaemia caused by B19 parvovirus infection in a non-immunocompromised patient.|pdf=|usr=}}
+{{tp|p=20567990|t=2010. Bilateral Holmes-Adie syndrome as an early manifestation of the HIV neuropathy.|pdf=|usr=}}
+{{tp|p=11591864|t=2001. Status epilepticus due to human parvovirus B19 encephalitis in an immunocompetent adult.|pdf=|usr=}}
+{{tp|p=16608124|t=2006. Erythema infectiosum following generalized petechial eruption induced by human parvovirus B19.|pdf=|usr=}}
+{{tp|p=17240885|t=2006. [Tsutsugamushi disease with hemophagocytosis complicated by Parvovirus B19 infection].|pdf=|usr=}}
+{{tp|p=15500141|t=2004. [Secondary nephrotic syndrome induced by infection].|pdf=|usr=}}
+{{tp|p=11155595|t=1998. [A case of systemic lupus erythematosus with pure red cell aplasia possibly caused by persistent infection of human parvovirus B 19].|pdf=|usr=}}
+{{tp|p=8437795|t=1993. Detection of human parvovirus B19 in early spontaneous abortuses using serology, histology, electron microscopy, in situ hybridization, and the polymerase chain reaction.|pdf=|usr=}}
+{{tp|p=14996283|t=2004. Oral manifestations of papular-purpuric 'gloves and socks' syndrome due to parvovirus B19 infection: the first case presented in Greece and review of the literature.|pdf=|usr=}}
+{{tp|p=18243574|t=2009. Detection of the human Parvovirus B19 in nonimmune hydrops fetalis using immunohistochemistry and nested-PCR in formalin-fixed and paraffin-embedded placenta and fetal tissues.|pdf=|usr=}}
+{{tp|p=12116850|t=2002. T lymphocyte responses against human parvovirus B19: small virus, big response.|pdf=|usr=}}
+{{tp|p=12116849|t=2002. Persistence of human parvovirus B19 in human tissues.|pdf=|usr=}}
+{{tp|p=12116846|t=2002. The human parvovirus B19 and its interactions in vivo.|pdf=|usr=}}
+{{tp|p=10214619|t=1999. Traitement des vascularites virales.|pdf=|usr=}}
+{{tp|p=29457859|t=2018. Post-infectious acute glomerulonephritis with podocytopathy induced by parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=1946224|t=1991. Pathomorphologie der fetalen Parvovirus-B19-Infektion.|pdf=|usr=}}
+{{tp|p=28834316|t=2018. History of parvovirus B19 infection is associated with silent cerebral infarcts.|pdf=|usr=}}
+{{tp|p=22872019|t=2013. Parvovirus B19 myocarditis causes significant morbidity and mortality in children.|pdf=|usr=}}
+{{tp|p=23864223|t=2013. Severe constrictive pericarditis after parvovirus B19 and human herpes virus 6 infection in a 9-year-old girl.|pdf=|usr=}}
+{{tp|p=8649911|t=1996. Diverse hematologic effects of parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=1321971|t=1992. Congenital infections and the nervous system.|pdf=|usr=}}
+{{tp|p=30230024|t=2018. Unusual skin manifestations associated with parvovirus B19 primary infection in children.|pdf=|usr=}}
+{{tp|p=22150362|t=2012. Wells' syndrome associated with parvovirus in a 5-year old boy.|pdf=|usr=}}
+{{tp|p=9496814|t=1998. Testing for parvovirus B19 in Henoch-Schonlein syndrome?|pdf=|usr=}}
+{{tp|p=31335286|t=2020. Parvovirus B19 Myocarditis: Looking Beyond the Heart.|pdf=|usr=}}
+{{tp|p=25361230|t=2015. Parvovirus infection: an immunohistochemical study using fetal and placental tissue.|pdf=|usr=}}
+{{tp|p=15022071|t=2004. Collapsing glomerulopathy in a 16-year-old girl with pulmonary tuberculosis: the role of systemic inflammatory mediators.|pdf=|usr=}}
+{{tp|p=14708734|t=2003. Parvovirus infects cardiac myocytes in hydrops fetalis.|pdf=|usr=}}
+{{tp|p=10347273|t=1999. Parvovirus B19: twenty-five years in perspective.|pdf=|usr=}}
+{{tp|p=16020122|t=2005. Human parvovirus B19 associated with idiopathic thrombocytopenic purpura.|pdf=|usr=}}
+{{tp|p=15205085|t=2004. Human parvovirus B19 associated with idiopathic thrombocytopenic purpura.|pdf=|usr=}}
+{{tp|p=8940744|t=1996. Erythrocyte P antigen in beta thalassemia major patients with human parvovirus-B19 infection.|pdf=|usr=}}
+{{tp|p=8940740|t=1996. Severe Shwachman-Diamond syndrome and invasive parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=8721035|t=1996. A case of severe thrombocytopenia due to parvovirus B19 virus.|pdf=|usr=}}
+{{tp|p=8721028|t=1996. Infection-associated hemophagocytic syndrome complicated by infectious lymphoproliferation: a case report.|pdf=|usr=}}
+{{tp|p=26756268|t=2016. Steroid-responsive Status Epilepticus Caused by Human Parvovirus B19 Encephalitis.|pdf=|usr=}}
+{{tp|p=23429554|t=2013. Successful immunotherapy in life-threatening parvovirus B19 infection in a child.|pdf=|usr=}}
+{{tp|p=22217972|t=2012. Acute liver failure as the initial manifestation of Wilson disease triggered by human parvovirus b19 infection.|pdf=|usr=}}
+{{tp|p=22418658|t=2012. Acute cerebellitis and concurrent encephalitis associated with parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=22173134|t=2012. Fatal parvovirus B19 myocarditis in children and possible dysimmune mechanism.|pdf=|usr=}}
+{{tp|p=19483661|t=2009. Coinfection of parvovirus b19 with other hepatitis viruses leading to fulminant hepatitis of unfavorable outcome in children.|pdf=|usr=}}
+{{tp|p=19238110|t=2009. Absence of parvoviral genomes in endothelial cells of Kawasaki disease patients with coronary artery lesions.|pdf=|usr=}}
+{{tp|p=18520445|t=2008. Acute encephalopathy with human parvovirus B19 infection in hereditary spherocytosis.|pdf=|usr=}}
+{{tp|p=14872194|t=2004. Autoimmune hemolytic anemia and autoimmune hepatitis associated with parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=11791095|t=2002. Parvovirus B19 and parvovirus V9 are not associated with Henoch-Schonlein purpura in children.|pdf=|usr=}}
+{{tp|p=10819350|t=2000. Lack of association between Kawasaki syndrome and infection with parvovirus B19, human herpesvirus 8, TT virus, GB virus C/hepatitis G virus or Chlamydia pneumoniae.|pdf=|usr=}}
+{{tp|p=10223704|t=1999. Chronic parvovirus B19 meningitis in a child with acute lymphocytic leukemia.|pdf=|usr=}}
+{{tp|p=9076823|t=1997. Detection of human parvovirus B19 DNA in cerebrospinal fluid.|pdf=|usr=}}
+{{tp|p=7845728|t=1994. Parvovirus B19 infection in a hypogammaglobulinemic infant with neurologic disorders and anemia: successful immunoglobulin therapy.|pdf=|usr=}}
+{{tp|p=28745457|t=2017. Discrimination of Diamond-Blackfan anemia from parvovirus B19 infection by RBC glutathione.|pdf=|usr=}}
+{{tp|p=19500282|t=2009. Self-limited lupus-like presentation of human parvovirus B19 infection in a 1-year-old girl.|pdf=|usr=}}
+{{tp|p=10703246|t=2000. Henoch-Schonlein purpura nephritis associated with human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=11192536|t=2000. Childhood idiopathic thrombocytopenic purpura associated with human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=10530073|t=1999. Pancytopenia with hemophagocytosis secondary to parvovirus B19 infection in a family with hereditary spherocytosis.|pdf=|usr=}}
+{{tp|p=20526852|t=2010. Resolution of Henoch-Schonlein purpura nephritis after acquired IgA deficiency.|pdf=|usr=}}
+{{tp|p=15747163|t=2005. Central nervous system vasculitis secondary to parvovirus B19 infection in a pediatric renal transplant patient.|pdf=|usr=}}
+{{tp|p=12883967|t=2003. Renal involvement in human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=12644924|t=2003. Nephrotic syndrome associated with human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=10454787|t=1999. Parvovirus glomerulonephritis in a patient with sickle cell disease.|pdf=|usr=}}
+{{tp|p=9203192|t=1997. Chronic anemia as a complication of parvovirus B19 infection in a pediatric kidney transplant patient.|pdf=|usr=}}
+{{tp|p=7917866|t=1994. Dual infection with human herpesvirus type 6 and parvovirus B19 in a renal transplant recipient.|pdf=|usr=}}
+{{tp|p=25035141|t=2014. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion caused by human parvovirus b19 infection: a case of two brothers with hereditary spherocytosis.|pdf=|usr=}}
+{{tp|p=18054695|t=2008. Hemolytic anemia presenting with idiopathic intracranial hypertension.|pdf=|usr=}}
+{{tp|p=12657425|t=2003. Case of stroke in a 7-year-old male after parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=10513695|t=1999. Fetal brain infection with human parvovirus B19.|pdf=|usr=}}
+{{tp|p=8390649|t=1993. Diagnosis and incidence of fetal parvovirus infection in an autopsy series: II. DNA amplification.|pdf=|usr=}}
+{{tp|p=8390648|t=1993. Diagnosis and incidence of fetal parvovirus infection in an autopsy series: I. Histology.|pdf=|usr=}}
+{{tp|p=1448397|t=1992. Histopathologic variability of finding erythroid inclusions with intrauterine parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=2842740|t=1988. Electron microscopic identification of parvovirus virions in erythroid-line cells in fatal hydrops fetalis.|pdf=|usr=}}
+{{tp|p=9566279|t=1998. Detection of parvovirus B19 infection in first and second trimester fetal loss.|pdf=|usr=}}
+{{tp|p=9353830|t=1997. Congenital parvovirus infection.|pdf=|usr=}}
+{{tp|p=9025846|t=1996. Polymerase chain reaction amplification of archival material for parvovirus B19 in children with transient erythroblastopenia of childhood.|pdf=|usr=}}
+{{tp|p=8963632|t=1996. Fatal fat embolism syndrome in a child with undiagnosed hemoglobin S/beta+ thalassemia: a complication of acute parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=9859908|t=1998. Parvovirus B19-associated interstitial lung disease, hepatitis, and myositis.|pdf=|usr=}}
+{{tp|p=20136725|t=2011. Long-term remission of recurrent severe anemia as a result of parvovirus B19 infection in a pediatric renal transplant recipient.|pdf=|usr=}}
+{{tp|p=17096771|t=2006. Severe parvovirus B19 encephalitis after renal transplantation.|pdf=|usr=}}
+{{tp|p=16269055|t=2005. Acute renal failure in a pediatric kidney allograft recipient treated with intravenous immunoglobulin for parvovirus B19 induced pure red cell aplasia.|pdf=|usr=}}
+{{tp|p=12890002|t=2003. Anemia in children after transplantation: etiology and the effect of immunosuppressive therapy on erythropoiesis.|pdf=|usr=}}
+{{tp|p=11560750|t=2001. Parvovirus B19 infection in pediatric solid-organ and bone marrow transplantation.|pdf=|usr=}}
+{{tp|p=23129076|t=2012. Common variable immunodeficiency presenting with persistent parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=12175970|t=2002. Apoptotic activity in villous trophoblast cells during B19 infection correlates with clinical outcome: assessment by the caspase-related M30 Cytodeath antibody.|pdf=|usr=}}
+{{tp|p=9950151|t=1999. Globoside expression within the human placenta.|pdf=|usr=}}
+{{tp|p=8668619|t=1996. Parvovirus B19 infection. Associated diseases, common and uncommon.|pdf=|usr=}}
+{{tp|p=29211607|t=1994. Acute polyarthritis.|pdf=|usr=}}
+{{tp|p=8202421|t=1994. Acute polyarthritis. Fifth disease passed from child to adult.|pdf=|usr=}}
+{{tp|p=2847129|t=1988. Parvovirus infections. From benign to life-threatening.|pdf=|usr=}}
+{{tp|p=10327150|t=1999. Fetal parvovirus B19 infection associated with myocardial necrosis.|pdf=|usr=}}
+{{tp|p=8750289|t=1995. Prevalence and clinical significance of anticardiolipin antibodies in pregnancies complicated by parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=10189908|t=1999. Ptosis revelant une primo-infection a Parvovirus B19.|pdf=|usr=}}
+{{tp|p=8949610|t=1996. Manifestations cutanees de l'infection a parvovirus B19.|pdf=|usr=}}
+{{tp|p=7899371|t=1995. Les manifestations rhumatologiques de l'infection a parvovirus B19.|pdf=|usr=}}
+{{tp|p=8493234|t=1993. Vascularite avec cryoglobuline mixte au cours d'une infection par le parvovirus humain B19.|pdf=|usr=}}
+{{tp|p=23113616|t=2013. Human parvovirus B19-induced acute glomerulonephritis: a case report.|pdf=|usr=}}
+{{tp|p=20446792|t=2010. Parvovirus B19-induced multisystemic vasculitis and acute endocapillary proliferative glomerulonephritis in a child.|pdf=|usr=}}
+{{tp|p=20662703|t=2010. Endocapillary glomerulonephritis secondary to human parvovirus B19 presenting with nephrotic syndrome: a report of two cases and a review of the literature.|pdf=|usr=}}
+{{tp|p=16526324|t=2006. Glomerulonephritis associating parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=10783955|t=2000. Presumed parvovirus B19-associated retinal pigment epitheliopathy.|pdf=|usr=}}
+{{tp|p=22112282|t=2012. Sindrome del tunel carpiano bilateral e infeccion por parvovirus B19.|pdf=|usr=}}
+{{tp|p=27220938|t=2016. The role of human parvovirus B19 and hepatitis C virus in the development of thyroid disorders.|pdf=|usr=}}
+{{tp|p=2847280|t=1988. Human parvovirus B19: historical and clinical review.|pdf=|usr=}}
+{{tp|p=9830727|t=1998. Feto-placentary pathology in human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=25060808|t=2015. OEdeme facial matinal, insuffisance renale et anemie : petite cause, grands effets.|pdf=|usr=}}
+{{tp|p=18926604|t=2009. Anticorps antiphospholipide, syndrome des anticorps antiphospholipides et infections virales.|pdf=|usr=}}
+{{tp|p=15471600|t=2004. Manifestations systemiques des infections a Parvovirus B19.|pdf=|usr=}}
+{{tp|p=12763177|t=2003. Placards pseudocellulitiques multiples et signe de Koplick: une forme originale de primo-infection a parvovirus B19 de l'adulte.|pdf=|usr=}}
+{{tp|p=7901884|t=1993. Periarterite noueuse et infection par le parvovirus B19.|pdf=|usr=}}
+{{tp|p=32720461|t=2020. An overview of the immune mechanisms of viral myocarditis.|pdf=|usr=}}
+{{tp|p=25855476|t=2015. The role of parvovirus B19 and the immune response in the pathogenesis of acute leukemia.|pdf=|usr=}}
+{{tp|p=25962796|t=2015. A review of blood diseases and cytopenias associated with human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=20586082|t=2010. The expanding range of parvoviruses which infect humans.|pdf=|usr=}}
+{{tp|p=14625883|t=2003. Parvovirus B19 and the pathogenesis of anaemia.|pdf=|usr=}}
+{{tp|p=12740833|t=2003. Neurological manifestations of human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=10398485|t=1997. The Simian Parvoviruses.|pdf=|usr=}}
+{{tp|p=9476277|t=1997. Lupus syndrome after parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=9010974|t=1996. Rheumatic manifestations due to human parvovirus B19. A report of four cases.|pdf=|usr=}}
+{{tp|p=9010973|t=1996. Parvovirus B19 infection and rheumatic diseases.|pdf=|usr=}}
+{{tp|p=19480999|t=2009. Parvovirus B19: its role in chronic arthritis.|pdf=|usr=}}
+{{tp|p=9606764|t=1998. Rheumatic manifestations of parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=8502782|t=1993. Parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=1662820|t=1991. Infectious etiology of rheumatoid arthritis.|pdf=|usr=}}
+{{tp|p=20012869|t=2010. Gender differences in the relationship of anti-parvovirus B19 IgG with antinuclear antibody and C-reactive protein in clinical adult serum samples.|pdf=|usr=}}
+{{tp|p=18807045|t=2009. Anasarca as the presenting manifestation of parvovirus B19 associated juvenile dermatomyositis.|pdf=|usr=}}
+{{tp|p=17028860|t=2007. A case of pure red cell aplasia and systemic lupus erythematosus caused by human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=15322815|t=2005. The relationship between arthritis and human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=15088118|t=2005. Parvovirus B19-induced multisystem disease simulating systemic vasculitis in a young child.|pdf=|usr=}}
+{{tp|p=7839075|t=1994. Prevalence of antihuman parvovirus B19 IgG antibodies in patients with refractory rheumatoid arthritis and polyarticular juvenile rheumatoid arthritis.|pdf=|usr=}}
+{{tp|p=1439481|t=1992. Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis.|pdf=|usr=}}
+{{tp|p=32556240|t=2020. Parvovirus B19 activates in vitro normal human dermal fibroblasts: a possible implication in skin fibrosis and systemic sclerosis.|pdf=|usr=}}
+{{tp|p=22157685|t=2012. Antibodies to common infectious agents in coronary artery disease patients with and without rheumatic conditions.|pdf=|usr=}}
+{{tp|p=12364654|t=2002. Parvovirus B19 infection associated with myelosuppression and cutaneous polyarteritis nodosa.|pdf=|usr=}}
+{{tp|p=12096244|t=2002. High mutation rate in the NS1 gene of parvovirus B19 DNA amplified from skeletal muscle of a case of mixed connective tissue disease.|pdf=|usr=}}
+{{tp|p=11709613|t=2001. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients.|pdf=|usr=}}
+{{tp|p=11257151|t=2001. Human parvovirus B19 infection in patients with systemic lupus erythematosus.|pdf=|usr=}}
+{{tp|p=10986312|t=2000. Dermatomyositis associated with the presence of parvovirus B19 DNA in muscle.|pdf=|usr=}}
+{{tp|p=10952747|t=2000. Antibodies to parvovirus B19 non-structural protein are associated with chronic but not acute arthritis following B19 infection.|pdf=|usr=}}
+{{tp|p=11002730|t=2000. [A case of Guillain-Barre syndrome (GBS) following human parvovirus B19 infection].|pdf=|usr=}}
+{{tp|p=1300262|t=1992. [An adult case of transverse myelitis with erythema infectiosum].|pdf=|usr=}}
+{{tp|p=9311285|t=1997. [Human parvovirus B19 infection mimicking systemic lupus erythematosus: case report].|pdf=|usr=}}
+{{tp|p=21284565|t=2011. Association of parvovirus B19 infection with acute icteric hepatitis in adults.|pdf=|usr=}}
+{{tp|p=19883162|t=2010. The VP1-unique region of parvovirus B19 induces myocardial injury in mice.|pdf=|usr=}}
+{{tp|p=19922076|t=2009. Association of parvovirus B19 infection with glomerulonephritis in an immunocompetent host: a case report.|pdf=|usr=}}
+{{tp|p=16138433|t=2005. Effusive-constrictive pericarditis associated with human parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=15370668|t=2004. Human parvovirus B19 non-structural protein (NS1) induces apoptosis through mitochondria cell death pathway in COS-7 cells.|pdf=|usr=}}
+{{tp|p=15307588|t=2004. Parvovirus B19-related anaemia after renal transplantation.|pdf=|usr=}}
+{{tp|p=11874173|t=2002. A case of persistent anemia in a renal transplant recipient: association with parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=10225391|t=1998. Parvovirus B19 infection associated with myocarditis following adult cardiac transplantation.|pdf=|usr=}}
+{{tp|p=8685646|t=1995. Parvovirus B19 infection associated with encephalitis in a patient suffering from malignant lymphoma.|pdf=|usr=}}
+{{tp|p=22043904|t=2012. Severe glomerulonephritis and encephalopathy associated with parvovirus B19 infection mimicking systemic lupus erythematosus.|pdf=|usr=}}
+{{tp|p=7777831|t=1995. The variable clinical picture of arthritis induced by human parvovirus B19. Report of seven adult cases and review of the literature.|pdf=|usr=}}
+{{tp|p=8211117|t=1993. Erythrocyte P antigen: cellular receptor for B19 parvovirus.|pdf=|usr=}}
+{{tp|p=3738514|t=1986. Replication of the B19 parvovirus in human bone marrow cell cultures.|pdf=|usr=}}
+{{tp|p=15692957|t=2005. Lupus-like presentation of parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=10342389|t=1999. Human parvovirus B19 infection: its relationship with systemic lupus erythematosus.|pdf=|usr=}}
+{{tp|p=10342388|t=1999. Parvovirus infection mimicking systemic lupus erythematosus in a pediatric population.|pdf=|usr=}}
+{{tp|p=9572708|t=1998. Autoantibodies and common viral illnesses.|pdf=|usr=}}
+{{tp|p=7604297|t=1995. Parvovirus infection mimicking systemic lupus erythematosus.|pdf=|usr=}}
+{{tp|p=1561488|t=1992. Parvovirus infection of the human fetus and newborn.|pdf=|usr=}}
+{{tp|p=2838911|t=1988. Hematologic and hematopoietic consequences of B19 parvovirus infection.|pdf=|usr=}}
+{{tp|p=27772627|t=2016. Not the Usual Viral Suspects: Parvovirus B19, West Nile Virus, and Human T-Cell Lymphotrophic Virus Infections After Kidney Transplantation.|pdf=|usr=}}
+{{tp|p=12704581|t=2003. Collapsing glomerulopathy.|pdf=|usr=}}
+{{tp|p=24195363|t=2013. [Regulatory effect of 11 kDa protein of parvovirus B19 on NF-kappaB pathway in Hela cells].|pdf=|usr=}}
+{{tp|p=12503064|t=2002. Human parvovirus B19-induced cell cycle arrest and apoptosis.|pdf=|usr=}}
+{{tp|p=24432604|t=2013. [The course of parvovirus B19 infection during pregnancy after kidney transplantation].|pdf=|usr=}}
+{{tp|p=10227760|t=1998. The efficacy of therapeutic plasmapheresis for the treatment of fatal hemophagocytic syndrome: two case reports.|pdf=|usr=}}
+{{tp|p=21190433|t=2011. Parvovirus B19 infection in Hashimoto's thyroiditis, papillary thyroid carcinoma, and anaplastic thyroid carcinoma.|pdf=|usr=}}
+{{tp|p=26778837|t=2016. Update of the human parvovirus B19 biology.|pdf=|usr=}}
+{{tp|p=17900278|t=2008. Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins.|pdf=|usr=}}
+{{tp|p=17880601|t=2007. Molecular mechanism underlying B19 virus inactivation and comparison to other parvoviruses.|pdf=|usr=}}
+{{tp|p=17524097|t=2007. Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals.|pdf=|usr=}}
+{{tp|p=11896304|t=2002. Transfusion medicine illustrated. Giant pronormoblasts due to parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=30586222|t=2019. Atraumatic splenic rupture following IVIg for parvovirus B19 pure red cell aplasia post renal transplant.|pdf=|usr=}}
+{{tp|p=28741797|t=2017. Risk factors and long-term outcomes of parvovirus B19 infection in kidney transplant patients.|pdf=|usr=}}
+{{tp|p=22931551|t=2012. How many times can parvovirus B19-related anemia recur in solid organ transplant recipients?|pdf=|usr=}}
+{{tp|p=19594866|t=2009. Pancreas allograft thrombosis following intravenous immunoglobulin administration to treat parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=15984946|t=2005. Long-term remission of recurrent parvovirus-B associated anemia in a renal transplant recipient induced by treatment with immunoglobulin and positive seroconversion.|pdf=|usr=}}
+{{tp|p=12421463|t=2002. Donor-transmitted parvovirus infection in a kidney transplant recipient presenting as pancytopenia and allograft dysfunction.|pdf=|usr=}}
+{{tp|p=32591136|t=2020. Pure Red Cell Aplasia Related to Parvovirus B19 Infection in Simultaneous Pancreas and Kidney Recipient: A Case Report.|pdf=|usr=}}
+{{tp|p=32389489|t=2020. Successful Treatment of Anemia With Anaplastic and Microangiopathic Characteristics in a Kidney Transplant Recipient With Parvovirus B19 Infection: A Case Report.|pdf=|usr=}}
+{{tp|p=32276841|t=2020. Pure Red Cell Aplasia and Antibody-Mediated Rejection: Double Trouble in 1 Kidney Transplant Recipient Solved by Intravenous Immunoglobulin Infusion: A Case Report.|pdf=|usr=}}
+{{tp|p=31351772|t=2019. Parvovirus B19-Associated Anemia in Kidney Transplant Recipients: A Single-Center Experience.|pdf=|usr=}}
+{{tp|p=31101193|t=2019. Parvovirus B19 Infection as a Rare Cause of Fulminant Liver Failure: A Case Report.|pdf=|usr=}}
+{{tp|p=23726627|t=2013. Clinical investigation of human parvovirus B19 infection after renal transplantation in China.|pdf=|usr=}}
+{{tp|p=19010248|t=2008. Severe anemia from parvovirus b19 infection in pediatric renal transplant recipients: two case reports.|pdf=|usr=}}
+{{tp|p=16980079|t=2006. Recurrent anemia in kidney transplant recipients with parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=16387138|t=2005. Parvovirus B19 infection in an isolated pancreas transplant recipient.|pdf=|usr=}}
+{{tp|p=16387104|t=2005. Renal anemia aggravated by long-term parvovirus B19 and cytomegalovirus infection in a renal transplant patient: case report and evaluation of B19 seroprevalence in dialysis patients.|pdf=|usr=}}
+{{tp|p=12493423|t=2002. Parvovirus B19 infection and IGF system components in relation to erythropoiesis in dialyzed patients and kidney transplant recipients.|pdf=|usr=}}
+{{tp|p=11377483|t=2001. Monoclonal anti-CD52 antibodies: a potential mode of therapy for parvovirus B(19) hepatitis.|pdf=|usr=}}
+{{tp|p=11120023|t=2000. Discontinuation of immunosuppressive antimetabolite for parvovirus B19-associated anemia in kidney transplant patients.|pdf=|usr=}}
+{{tp|p=11120017|t=2000. Pure red cell aplasia due to parvovirus B19 infection in a renal transplant patient: a case report.|pdf=|usr=}}
+{{tp|p=10456000|t=1999. Acute parvovirus infection in a heart transplant recipient.|pdf=|usr=}}
+{{tp|p=9123540|t=1997. Unusual incidence of aplastic anaemia due to B-19 parvovirus infection in renal transplant recipients.|pdf=|usr=}}
+{{tp|p=29762456|t=2018. Parvovirus B19 Induced Red Cell Aplasia in a Heart Transplant Patient Diagnosed on Pleural Fluid.|pdf=|usr=}}
+{{tp|p=15785387|t=2005. Pure red cell aplasia associated with parvovirus B19 infection in renal transplantation: the first case report in Mexico.|pdf=|usr=}}
+{{tp|p=14743003|t=2004. Parvovirus B19 infection-associated red-cell aplasia in renal-transplant recipients: clues from the bone marrow.|pdf=|usr=}}
+{{tp|p=12042652|t=2002. A role for chronic parvovirus B19 infection in liver dysfunction in renal transplant recipients?|pdf=|usr=}}
+{{tp|p=11889431|t=2002. Chronic parvovirus B19 infection in a pediatric lung transplanted patient.|pdf=|usr=}}
+{{tp|p=11211196|t=2001. Nosocomial outbreak of parvovirus B19 infection in a renal transplant unit.|pdf=|usr=}}
+{{tp|p=10852625|t=2000. Parvovirus B19 in kidney transplant patients.|pdf=|usr=}}
+{{tp|p=10910292|t=2000. Human parvovirus B19 infection presenting as persistent anemia in renal transplant recipients.|pdf=|usr=}}
+{{tp|p=10949207|t=2000. Splenectomy for idiopathic thrombocytopenic purpura after living-related liver transplantation.|pdf=|usr=}}
+{{tp|p=9422430|t=1997. Parvovirus B19 infection-related complications in renal transplant recipients: treatment with intravenous immunoglobulin.|pdf=|usr=}}
+{{tp|p=15552021|t=2004. Manifestations rhumatologiques de l'infection a parvovirus B19.|pdf=|usr=}}
+{{tp|p=18078665|t=2007. Neurologiske symptomer og akut hepatitis associeret til parvovirus B19.|pdf=|usr=}}
+{{tp|p=1509571|t=1992. Akut vasculitis og arthritis forarsaget af Parvovirus B 19 infektion.|pdf=|usr=}}
+{{tp|p=7941039|t=1994. Immunoelectron microscopic identification of human parvovirus B19.|pdf=|usr=}}
+{{tp|p=9569471|t=1998. Nucleic acid immunization protects dogs against challenge with virulent canine parvovirus.|pdf=|usr=}}
+{{tp|p=12510554|t=2002. Digital arterial occlusive disease and parvovirus B19 infection.|pdf=|usr=}}
+{{tp|p=32412895|t=2020. New Insights of Human Parvovirus B19 in Modulating Erythroid Progenitor Cell Differentiation.|pdf=|usr=}}
+{{tp|p=17931112|t=2007. An association between parvovirus B19 and Kikuchi-Fujimoto disease.|pdf=|usr=}}
+{{tp|p=12536309|t=2003. Parvovirus B19: a pathogen responsible for more than hematologic disorders.|pdf=|usr=}}
+{{tp|p=1980555|t=1990. In situ hybridization for the detection of human parvovirus B19 nucleic acid sequences in paraffin-embedded specimens.|pdf=|usr=}}
+{{tp|p=8030266|t=1994. The structure of human parvovirus B19 at 8 A resolution.|pdf=|usr=}}
+{{tp|p=8517014|t=1993. Identification and characterization of a family of 11-kDa proteins encoded by the human parvovirus B19.|pdf=|usr=}}
+{{tp|p=8337823|t=1993. A novel protein encoded by small RNAs of parvovirus B19.|pdf=|usr=}}
+{{tp|p=1641977|t=1992. Parvovirus B19 replication in human umbilical cord blood cells.|pdf=|usr=}}
+{{tp|p=1871964|t=1991. Preliminary X-ray crystallographic investigation of human parvovirus B19.|pdf=|usr=}}
+{{tp|p=1926783|t=1991. Upstream sequences within the terminal hairpin positively regulate the P6 promoter of B19 parvovirus.|pdf=|usr=}}
+{{tp|p=2024472|t=1991. Indiscriminate activity from the B19 parvovirus p6 promoter in nonpermissive cells.|pdf=|usr=}}
+{{tp|p=2053277|t=1991. Analysis of splice junctions and in vitro and in vivo translation potential of the small, abundant B19 parvovirus RNAs.|pdf=|usr=}}
+{{tp|p=2408228|t=1990. Cloning of the human parvovirus B19 genome and structural analysis of its palindromic termini.|pdf=|usr=}}
+{{tp|p=3824910|t=1987. A transcriptional promoter of the human parvovirus B19 active in vitro and in vivo.|pdf=|usr=}}
+{{tp|p=3824909|t=1987. In vitro identification of a B19 parvovirus promoter.|pdf=|usr=}}
+{{tp|p=23114653|t=2013. The effects of the 11 kDa protein and the putative X protein on the p6 promoter activity of Parvovirus B19 in Hela cells.|pdf=|usr=}}
+{{tp|p=27071853|t=2016. Enhanced inhibition of parvovirus B19 replication by cidofovir in extendedly exposed erythroid progenitor cells.|pdf=|usr=}}
+{{tp|p=27270128|t=2016. Nonstructural protein (NS1) of human parvovirus B19 stimulates host innate immunity and blunts the exogenous type I interferon signaling in vitro.|pdf=|usr=}}
+{{tp|p=24998884|t=2014. Persistent parvovirus B19 infection in non-erythroid tissues: possible role in the inflammatory and disease process.|pdf=|usr=}}
+{{tp|p=23770153|t=2013. Adenovirus vector-mediated RNA interference for the inhibition of human parvovirus B19 replication.|pdf=|usr=}}
+{{tp|p=24100233|t=2013. Single-cell chemiluminescence imaging of parvovirus B19 life cycle.|pdf=|usr=}}
+{{tp|p=15990190|t=2005. Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures.|pdf=|usr=}}
+{{tp|p=9620213|t=1998. Typing of European strains of parvovirus B19 by restriction endonuclease analyses and sequencing: identification of evolutionary lineages and evidence of recombination of markers from different lineages.|pdf=|usr=}}
+{{tp|p=11816291|t=2001. Stezenia interleukin 6 oraz 12 u kobiet ciezarnych zakazonych ludzkim parwowirusem B19 i niezakazonych.|pdf=|usr=}}
+{{tp|p=1964320|t=1990. Infektion mit Parvovirus B19: Typischer Verlauf der Ringelroteln (Erythema infectiosum) und die Komplikationen.|pdf=|usr=}}
+{{tp|p=27761646|t=2016. Virale Arthritiden und Vaskulitiden.|pdf=|usr=}}
+{{tp|p=21128048|t=2010. Virale Arthritiden.|pdf=|usr=}}
+{{tp|p=8023586|t=1994. Humanes Parvovirus B19 (HPV-B19), eine klinische Ubersicht mit Betonung der rheumatologischen Manifestationen.|pdf=|usr=}}
+{{tp|p=20388386|t=2010. [Viral nephropathy].|pdf=|usr=}}
 ===red cell items===
 -neglected-